#cosmic_gene	tier	UniProt_accession	UniProt_genes	UniProt_status	UniProt_protein_name	somatic_mutations	germline_mutations	role_TSG	role_oncogene	role_fusion protein	genetics_dominant	genetics_recessive	actionability_level	resistance_mutations	dominant_mutation_type-fusion	dominant_mutation_type-translocation	dominant_mutation_type-missense_mutations	dominant_mutation_type-splice_site_mutations	dominant_mutation_type-nonsense_mutations	dominant_mutation_type-frameshift_mutations	dominant_mutation_type-large_deletions	dominant_mutation_type-amplification	dominant_mutation_type-other_mutations	tissue_epithelial	tissue_leukaemia-lymphoma	tissue_mesenchymal	tissue_other_tissue	hallmark_angiogenesis	hallmark_replicative_immortality	hallmark_energetics	hallmark_immune_evasion	hallmark_apoptosis	hallmark_genomic_instability	hallmark_metastasis	hallmark_proliferative_signaling	hallmark_growth_suppression	hallmark_inflammation	cancer_type(s)
A1CF	2	Q9NQ94	A1CF ACF ASP	reviewed	APOBEC1 complementation factor (APOBEC1-stimulating protein)	1	0	0	1	0	0	0	-	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	melanoma
ABI1	1	Q8IZP0	ABI1 SSH3BP1	reviewed	Abl interactor 1 (Abelson interactor 1) (Abi-1) (Abl-binding protein 4) (AblBP4) (Eps8 SH3 domain-binding protein) (Eps8-binding protein) (Nap1-binding protein) (Nap1BP) (Spectrin SH3 domain-binding protein 1) (e3B1)	1	0	1	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	1	1	0	AML
ABL1	1	P00519	ABL1 ABL JTK7	reviewed	Tyrosine-protein kinase ABL1 (EC 2.7.10.2) (Abelson murine leukemia viral oncogene homolog 1) (Abelson tyrosine-protein kinase 1) (Proto-oncogene c-Abl) (p150)	1	0	0	1	1	1	0	1	1	1	1	1	0	0	0	0	0	0	0	1	0	0	1	0	1	0	1	1	1	1	0	0	CML, ALL, T-ALL
ABL2	1	P42684	ABL2 ABLL ARG	reviewed	Tyrosine-protein kinase ABL2 (EC 2.7.10.2) (Abelson murine leukemia viral oncogene homolog 2) (Abelson tyrosine-protein kinase 2) (Abelson-related gene protein) (Tyrosine-protein kinase ARG)	1	0	0	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	AML
ACKR3	1	P25106	ACKR3 CMKOR1 CXCR7 GPR159 RDC1	reviewed	Atypical chemokine receptor 3 (C-X-C chemokine receptor type 7) (CXC-R7) (CXCR-7) (Chemokine orphan receptor 1) (G-protein coupled receptor 159) (G-protein coupled receptor RDC1 homolog) (RDC-1)	1	0	0	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	0	1	0	1	0	0	0	1	0	1	1	0	0	lipoma
ACSL3	1	O95573	ACSL3 ACS3 FACL3 LACS3	reviewed	Fatty acid CoA ligase Acsl3 (Arachidonate--CoA ligase) (EC 6.2.1.15) (Long-chain acyl-CoA synthetase 3) (LACS 3) (Long-chain-fatty-acid--CoA ligase 3) (EC 6.2.1.3) (Medium-chain acyl-CoA ligase Acsl3) (EC 6.2.1.2)	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	prostate
ACSL6	2	Q9UKU0	ACSL6 ACS2 FACL6 KIAA0837 LACS5	reviewed	Long-chain-fatty-acid--CoA ligase 6 (EC 6.2.1.3) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Long-chain acyl-CoA synthetase 6) (LACS 6)	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	AML, AEL
ACVR1	1	Q04771	ACVR1 ACVRLK2	reviewed	Activin receptor type-1 (EC 2.7.11.30) (Activin receptor type I) (ACTR-I) (Activin receptor-like kinase 2) (ALK-2) (Serine/threonine-protein kinase receptor R1) (SKR1) (TGF-B superfamily receptor type I) (TSR-I)	1	0	0	1	0	1	0	-	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	1	0	1	1	0	0	DIPG
ACVR2A	1	P27037	ACVR2A ACVR2	reviewed	Activin receptor type-2A (EC 2.7.11.30) (Activin receptor type IIA) (ACTR-IIA) (ACTRIIA)	1	0	1	0	0	0	1	-	0	0	0	1	0	1	1	0	0	0	1	0	0	0	0	0	0	0	1	1	1	1	1	0	large intestine carcinoma, stomach carcinoma, pancreatic carcinoma, biliary tract, oesophagus
AFDN	1	P55196	AFDN AF6 MLLT4	reviewed	Afadin (ALL1-fused gene from chromosome 6 protein) (Protein AF-6) (Afadin adherens junction formation factor)	1	0	0	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	AL
AFF1	1	P51825	AFF1 AF4 FEL MLLT2 PBM1	reviewed	AF4/FMR2 family member 1 (ALL1-fused gene from chromosome 4 protein) (Protein AF-4) (Protein FEL) (Proto-oncogene AF4)	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	AL
AFF3	1	P51826	AFF3 LAF4	reviewed	AF4/FMR2 family member 3 (Lymphoid nuclear protein related to AF4) (Protein LAF-4)	1	0	0	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	ALL, T-ALL
AFF4	1	Q9UHB7	AFF4 AF5Q31 MCEF HSPC092	reviewed	AF4/FMR2 family member 4 (ALL1-fused gene from chromosome 5q31 protein) (Protein AF-5q31) (Major CDK9 elongation factor-associated protein)	1	0	0	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	1	0	0	ALL
AKAP9	2	Q99996	AKAP9 AKAP350 AKAP450 KIAA0803	reviewed	A-kinase anchor protein 9 (AKAP-9) (A-kinase anchor protein 350 kDa) (AKAP 350) (hgAKAP 350) (A-kinase anchor protein 450 kDa) (AKAP 450) (AKAP 120-like protein) (Centrosome- and Golgi-localized PKN-associated protein) (CG-NAP) (Protein hyperion) (Protein kinase A-anchoring protein 9) (PRKA9) (Protein yotiao)	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	papillary thyroid
AKT1	1	P31749	AKT1 PKB RAC	reviewed	RAC-alpha serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase B) (PKB) (Protein kinase B alpha) (PKB alpha) (Proto-oncogene c-Akt) (RAC-PK-alpha)	1	0	0	1	0	1	0	-	0	0	0	1	0	0	0	0	0	0	1	0	0	0	1	0	1	0	1	1	1	1	1	0	breast, colorectal, ovarian, NSCLC
AKT2	1	P31751	AKT2	reviewed	RAC-beta serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase Akt-2) (Protein kinase B beta) (PKB beta) (RAC-PK-beta)	1	0	0	1	0	1	0	-	0	0	0	0	0	0	0	0	1	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	ovarian, pancreatic
AKT3	2	Q9Y243	AKT3 PKBG	reviewed	RAC-gamma serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase Akt-3) (Protein kinase B gamma) (PKB gamma) (RAC-PK-gamma) (STK-2)	1	0	0	1	0	0	0	-	0	0	0	0	0	0	0	0	1	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	GBM
ALDH2	2	P05091	ALDH2 ALDM	reviewed	Aldehyde dehydrogenase, mitochondrial (EC 1.2.1.3) (ALDH class 2) (ALDH-E2) (ALDHI)	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	leiomyoma
ALK	1	Q9UM73	ALK	reviewed	ALK tyrosine kinase receptor (EC 2.7.10.1) (Anaplastic lymphoma kinase) (CD antigen CD246)	1	1	0	1	1	1	0	1	1	1	1	1	0	0	0	0	1	0	1	1	1	0	0	0	0	0	1	0	1	1	0	0	ALCL, NSCLC, neuroblastoma, inflammatory myofibroblastic tumour, Spitzoid tumour, neuroblastoma
AMER1	1	Q5JTC6	AMER1 FAM123B WTX	reviewed	APC membrane recruitment protein 1 (Amer1) (Protein FAM123B) (Wilms tumor gene on the X chromosome protein)	1	0	1	0	0	0	1	-	0	0	0	1	0	1	1	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0	Wilms tumour
ANK1	2	P16157	ANK1 ANK	reviewed	Ankyrin-1 (ANK-1) (Ankyrin-R) (Erythrocyte ankyrin)	1	0	0	0	0	0	0	-	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	CCRCC
APC	1	P25054	APC DP2.5	reviewed	Adenomatous polyposis coli protein (Protein APC) (Deleted in polyposis 2.5)	1	1	1	0	0	0	1	-	0	0	0	1	1	1	1	1	0	0	1	0	1	1	0	0	0	0	1	1	1	0	1	0	colorectal, pancreatic, desmoid, hepatoblastoma, glioma, other CNS, colorectal, pancreatic, desmoid, hepatoblastoma, glioma, other CNS
APOBEC3B	1	Q9UH17	APOBEC3B	reviewed	DNA dC->dU-editing enzyme APOBEC-3B (A3B) (EC 3.5.4.38) (Phorbolin-1-related protein) (Phorbolin-2/3)	0	1	1	1	0	0	1	-	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	1	0	0	0	1	breast cancer
AR	1	P10275	AR DHTR NR3C4	reviewed	Androgen receptor (Dihydrotestosterone receptor) (Nuclear receptor subfamily 3 group C member 4)	1	1	0	1	0	1	0	-	1	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	1	0	0	1	0	0	prostate
ARAF	2	P10398	ARAF ARAF1 PKS PKS2	reviewed	Serine/threonine-protein kinase A-Raf (EC 2.7.11.1) (Proto-oncogene A-Raf) (Proto-oncogene A-Raf-1) (Proto-oncogene Pks)	1	0	0	1	0	0	0	2	0	0	0	1	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	cholangiocarcinoma, lung adenocarcinoma, Langerhans cell histiocytosis
ARHGAP26	1	Q9UNA1	ARHGAP26 GRAF KIAA0621 OPHN1L	reviewed	Rho GTPase-activating protein 26 (GTPase regulator associated with focal adhesion kinase) (Oligophrenin-1-like protein) (Rho-type GTPase-activating protein 26)	1	0	1	0	1	1	0	-	0	1	1	0	1	0	1	0	0	0	0	1	0	0	0	0	0	0	0	0	1	1	1	0	AML, MDS
ARHGAP35	1	Q9NRY4	ARHGAP35 GRF1 GRLF1 KIAA1722 P190A p190ARHOGAP	reviewed	Rho GTPase-activating protein 35 (Glucocorticoid receptor DNA-binding factor 1) (Glucocorticoid receptor repression factor 1) (GRF-1) (Rho GAP p190A) (p190-A)	1	0	1	0	0	0	0	-	0	0	0	1	0	1	1	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	endometrial carcinoma
ARHGAP5	2	Q13017	ARHGAP5 RHOGAP5	reviewed	Rho GTPase-activating protein 5 (Rho-type GTPase-activating protein 5) (p190-B)	1	0	0	1	0	0	0	-	0	0	0	1	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	colon cancer, glioma
ARHGEF10	2	O15013	ARHGEF10 KIAA0294	reviewed	Rho guanine nucleotide exchange factor 10	1	0	1	0	0	0	0	-	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	colon cancer
ARHGEF10L	2	Q9HCE6	ARHGEF10L GRINCHGEF KIAA1626	reviewed	Rho guanine nucleotide exchange factor 10-like protein (GrinchGEF)	1	0	1	0	0	0	0	-	0	0	0	0	0	0	0	1	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	lymphoma
ARHGEF12	1	Q9NZN5	ARHGEF12 KIAA0382 LARG	reviewed	Rho guanine nucleotide exchange factor 12 (Leukemia-associated RhoGEF)	1	0	1	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	AML
ARID1A	1	O14497	ARID1A BAF250 BAF250A C1orf4 OSA1 SMARCF1	reviewed	AT-rich interactive domain-containing protein 1A (ARID domain-containing protein 1A) (B120) (BRG1-associated factor 250) (BAF250) (BRG1-associated factor 250a) (BAF250A) (Osa homolog 1) (hOSA1) (SWI-like protein) (SWI/SNF complex protein p270) (SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin subfamily F member 1) (hELD)	1	0	1	0	1	0	1	-	0	1	1	1	1	1	1	1	0	0	1	0	0	0	0	1	0	0	1	1	1	0	1	0	clear cell ovarian carcinoma, RCC, breast
ARID1B	1	Q8NFD5	ARID1B BAF250B DAN15 KIAA1235 OSA2	reviewed	AT-rich interactive domain-containing protein 1B	1	0	1	0	0	0	1	-	0	0	0	1	0	1	1	0	0	1	1	0	0	0	0	0	0	0	0	1	1	1	1	0	breast, hepatocellular carcinoma, clear cell ovarian carcinoma
ARID2	1	Q68CP9	ARID2 BAF200 KIAA1557	reviewed	AT-rich interactive domain-containing protein 2 (ARID domain-containing protein 2) (BRG1-associated factor 200) (BAF200) (Zinc finger protein with activation potential) (Zipzap/p200)	1	0	1	0	0	0	1	-	0	0	0	0	1	1	1	0	0	0	1	0	0	0	0	0	0	0	0	1	0	0	1	0	hepatocellular carcinoma
ARNT	1	P27540	ARNT BHLHE2	reviewed	Aryl hydrocarbon receptor nuclear translocator (ARNT protein) (Class E basic helix-loop-helix protein 2) (bHLHe2) (Dioxin receptor, nuclear translocator) (Hypoxia-inducible factor 1-beta) (HIF-1-beta) (HIF1-beta)	1	0	1	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	1	0	1	0	0	0	1	0	0	0	AML
ASPSCR1	1	Q9BZE9	ASPSCR1 ASPL RCC17 TUG UBXD9 UBXN9	reviewed	Tether containing UBX domain for GLUT4 (Alveolar soft part sarcoma chromosomal region candidate gene 1 protein) (Alveolar soft part sarcoma locus) (Renal papillary cell carcinoma protein 17) (UBX domain-containing protein 9)	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	alveolar soft part sarcoma
ASXL1	1	Q8IXJ9	ASXL1 KIAA0978	reviewed	Polycomb group protein ASXL1 (Additional sex combs-like protein 1)	1	0	1	0	0	0	1	-	1	0	0	1	0	1	1	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	MDS, CMML
ASXL2	2	Q76L83	ASXL2 ASXH2 KIAA1685	reviewed	Putative Polycomb group protein ASXL2 (Additional sex combs-like protein 2)	1	0	1	0	0	0	0	-	0	0	0	0	0	1	1	0	0	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	melanoma, CCRCC, AML
ATF1	1	P18846	ATF1	reviewed	Cyclic AMP-dependent transcription factor ATF-1 (cAMP-dependent transcription factor ATF-1) (Activating transcription factor 1) (Protein TREB36)	1	0	0	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	1	0	1	0	0	0	0	0	0	0	0	0	0	0	malignant melanoma of soft parts, angiomatoid fibrous histiocytoma
ATIC	1	P31939	ATIC PURH OK/SW-cl.86	reviewed	"Bifunctional purine biosynthesis protein ATIC (AICAR transformylase/inosine monophosphate cyclohydrolase) (ATIC) [Cleaved into: Bifunctional purine biosynthesis protein ATIC, N-terminally processed] [Includes: Phosphoribosylaminoimidazolecarboxamide formyltransferase (EC 2.1.2.3) (5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase) (AICAR formyltransferase) (AICAR transformylase); Inosine 5'-monophosphate cyclohydrolase (IMP cyclohydrolase) (EC 3.5.4.10) (IMP synthase) (Inosinicase)]"	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	ALCL
ATM	1	Q13315	ATM	reviewed	Serine-protein kinase ATM (EC 2.7.11.1) (Ataxia telangiectasia mutated) (A-T mutated)	1	1	1	0	0	0	1	1	0	0	0	1	1	1	1	1	0	0	0	1	0	1	0	1	0	0	1	1	1	0	0	1	T-PLL, leukaemia, lymphoma, medulloblastoma, glioma
ATP1A1	1	P05023	ATP1A1	reviewed	Sodium/potassium-transporting ATPase subunit alpha-1 (Na(+)/K(+) ATPase alpha-1 subunit) (EC 7.2.2.13) (Sodium pump subunit alpha-1)	1	0	1	1	0	1	0	-	0	0	0	1	0	0	0	0	0	1	1	0	0	0	0	0	0	0	1	0	1	0	0	0	adrenal aldosterone producing adenoma
ATP2B3	1	Q16720	ATP2B3	reviewed	Plasma membrane calcium-transporting ATPase 3 (PMCA3) (EC 7.2.2.10) (Plasma membrane calcium ATPase isoform 3) (Plasma membrane calcium pump isoform 3)	1	0	1	0	0	1	0	-	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	1	0	adrenal aldosterone producing adenoma
ATR	1	Q13535	ATR FRP1	reviewed	Serine/threonine-protein kinase ATR (EC 2.7.11.1) (Ataxia telangiectasia and Rad3-related protein) (FRAP-related protein 1)	1	1	1	0	0	1	0	-	0	0	0	1	0	0	1	0	0	0	1	1	0	0	0	0	1	0	1	1	0	0	1	0	endometrial, gastric, epithelial ovarian, myeloma, oropharyngeal
ATRX	1	P46100	ATRX RAD54L XH2	reviewed	Transcriptional regulator ATRX (EC 3.6.4.12) (ATP-dependent helicase ATRX) (X-linked helicase II) (X-linked nuclear protein) (XNP) (Znf-HX)	1	0	1	0	0	0	1	-	0	0	0	1	0	1	1	0	0	0	1	0	0	0	0	0	0	0	0	1	0	0	0	0	pancreatic neuroendocrine tumours, paediatric GBM
AXIN1	1	O15169	AXIN1 AXIN	reviewed	Axin-1 (Axis inhibition protein 1) (hAxin)	1	0	1	0	0	0	1	-	0	0	0	1	1	1	1	1	0	0	1	0	0	1	0	1	0	0	1	0	0	0	1	0	colorectal, endometrial, prostate, hepatocellular carcinoma, hepatoblastoma, sporadic medulloblastoma
AXIN2	1	Q9Y2T1	AXIN2	reviewed	Axin-2 (Axin-like protein) (Axil) (Axis inhibition protein 2) (Conductin)	1	1	1	0	0	0	1	-	0	0	0	1	0	1	1	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	1	0	colorectal carcinoma, stomach carcinoma, hepatocellular carcinoma, colorectal carcinoma
B2M	1	P61769	B2M	reviewed	Beta-2-microglobulin	1	0	1	0	0	0	1	-	0	0	0	1	0	1	1	0	0	0	1	1	0	0	0	0	0	1	0	0	0	0	0	0	DLBCL, melanoma, colorectal adenocarcinoma
BAP1	1	Q92560	BAP1 KIAA0272 hucep-6	reviewed	Ubiquitin carboxyl-terminal hydrolase BAP1 (EC 3.4.19.12) (BRCA1-associated protein 1) (Cerebral protein 6)	1	1	1	0	0	0	1	-	0	0	0	1	1	1	1	0	0	1	1	0	0	0	0	0	1	0	1	1	1	1	0	0	uveal melanoma, breast, NSCLC, RCC, mesothelioma, skin and uveal melanoma, kidney cancer
BARD1	1	Q99728	BARD1	reviewed	BRCA1-associated RING domain protein 1 (BARD-1) (EC 2.3.2.27) (RING-type E3 ubiquitin transferase BARD1)	1	1	1	0	0	0	0	1	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	1	1	1	1	1	0	breast cancer, ovarian cancer, breast cancer, endometrioid cancer
BAX	1	Q07812	BAX BCL2L4	reviewed	Apoptosis regulator BAX (Bcl-2-like protein 4) (Bcl2-L-4)	1	0	1	0	0	0	0	-	0	0	0	1	0	0	1	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	colorectal cancer
BAZ1A	2	Q9NRL2	BAZ1A ACF1 WCRF180 HSPC317	reviewed	Bromodomain adjacent to zinc finger domain protein 1A (ATP-dependent chromatin-remodeling protein) (ATP-utilizing chromatin assembly and remodeling factor 1) (hACF1) (CHRAC subunit ACF1) (Williams syndrome transcription factor-related chromatin-remodeling factor 180) (WCRF180) (hWALp1)	1	0	1	0	0	0	0	-	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	uterine carcinosarcoma, colon cancer
BCL10	1	O95999	BCL10	reviewed	B-cell lymphoma/leukemia 10	1	0	1	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	1	1	1	1	0	0	MALT
BCL11A	1	Q9H165	BCL11A CTIP1 EVI9 KIAA1809 ZNF856	reviewed	B-cell lymphoma/leukemia 11A (BCL-11A) (B-cell CLL/lymphoma 11A) (COUP-TF-interacting protein 1) (Ecotropic viral integration site 9 protein homolog) (EVI-9) (Zinc finger protein 856)	1	0	0	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	1	0	0	0	0	0	0	0	0	B-CLL
BCL11B	1	Q9C0K0	BCL11B CTIP2 RIT1	reviewed	B-cell lymphoma/leukemia 11B (BCL-11B) (B-cell CLL/lymphoma 11B) (COUP-TF-interacting protein 2) (Radiation-induced tumor suppressor gene 1 protein) (hRit1)	1	0	1	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	T-ALL
BCL2	1	P10415	BCL2	reviewed	Apoptosis regulator Bcl-2	1	0	0	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	NHL, CLL
BCL2L12	2	Q9HB09	BCL2L12 BPR	reviewed	Bcl-2-like protein 12 (Bcl2-L-12) (Bcl-2-related proline-rich protein)	1	0	0	1	0	0	0	-	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	melanoma, SCC
BCL3	1	P20749	BCL3 BCL4 D19S37	reviewed	B-cell lymphoma 3 protein (BCL-3) (Proto-oncogene BCL3)	1	0	0	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	CLL
BCL6	1	P41182	BCL6 BCL5 LAZ3 ZBTB27 ZNF51	reviewed	B-cell lymphoma 6 protein (BCL-6) (B-cell lymphoma 5 protein) (BCL-5) (Protein LAZ-3) (Zinc finger and BTB domain-containing protein 27) (Zinc finger protein 51)	1	0	0	1	1	1	0	-	0	1	1	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	NHL, CLL
BCL7A	1	Q4VC05	BCL7A	reviewed	B-cell CLL/lymphoma 7 protein family member A	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	BNHL
BCL9	1	O00512	BCL9	reviewed	B-cell CLL/lymphoma 9 protein (B-cell lymphoma 9 protein) (Bcl-9) (Protein legless homolog)	1	0	0	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	1	1	0	0	B-ALL
BCL9L	1	Q86UU0	BCL9L DLNB11	reviewed	B-cell CLL/lymphoma 9-like protein (B-cell lymphoma 9-like protein) (BCL9-like protein) (Protein BCL9-2)	1	0	1	1	0	0	0	-	0	0	0	1	0	0	1	0	0	0	1	0	0	0	0	0	0	0	0	1	1	1	0	0	colorectal cancer, endometrial carcinoma, gastric cancer
BCLAF1	2	Q9NYF8	BCLAF1 BTF KIAA0164	reviewed	Bcl-2-associated transcription factor 1 (Btf) (BCLAF1 and THRAP3 family member 1)	1	0	0	0	0	0	0	-	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	melanoma, SCC
BCOR	1	Q6W2J9	BCOR KIAA1575	reviewed	BCL-6 corepressor (BCoR)	1	0	1	0	1	0	1	-	0	1	1	0	1	1	1	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	1	0	retinoblastoma, AML, APL (translocation)
BCORL1	1	Q5H9F3	BCORL1	reviewed	BCL-6 corepressor-like protein 1 (BCoR-L1) (BCoR-like protein 1)	1	0	1	1	0	0	0	-	0	0	0	1	0	1	1	0	0	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	AML, HNSCC
BCR	1	P11274	BCR BCR1 D22S11	reviewed	Breakpoint cluster region protein (EC 2.7.11.1) (Renal carcinoma antigen NY-REN-26)	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	CML, ALL, AML
BIRC3	1	Q13489	BIRC3 API2 MIHC RNF49	reviewed	Baculoviral IAP repeat-containing protein 3 (EC 2.3.2.27) (Apoptosis inhibitor 2) (API2) (Cellular inhibitor of apoptosis 2) (C-IAP2) (IAP homolog C) (Inhibitor of apoptosis protein 1) (hIAP-1) (hIAP1) (RING finger protein 49) (RING-type E3 ubiquitin transferase BIRC3) (TNFR2-TRAF-signaling complex protein 1)	1	0	1	1	1	1	0	-	0	1	1	1	0	1	1	1	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	CLL, MALT, MCL, MM
BIRC6	2	Q9NR09	BIRC6 KIAA1289	reviewed	Baculoviral IAP repeat-containing protein 6 (EC 2.3.2.27) (BIR repeat-containing ubiquitin-conjugating enzyme) (BRUCE) (RING-type E3 ubiquitin transferase BIRC6) (Ubiquitin-conjugating BIR domain enzyme apollon) (APOLLON)	1	0	0	1	1	0	0	-	0	1	1	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	melanoma, gastric adenocarcinoma, lung adenocarcinoma
BLM	1	P54132	BLM RECQ2 RECQL3	reviewed	Bloom syndrome protein (EC 3.6.4.12) (DNA helicase, RecQ-like type 2) (RecQ2) (RecQ protein-like 3)	0	1	1	0	0	0	1	-	0	0	0	1	0	1	1	0	0	0	1	1	0	0	0	0	0	0	1	1	0	0	1	0	leukaemia, lymphoma, skin squamous cell, other tumour types
BMP5	2	P22003	BMP5	reviewed	Bone morphogenetic protein 5 (BMP-5)	1	0	0	0	0	0	0	-	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	melanoma
BMPR1A	1	P36894	BMPR1A ACVRLK3 ALK3	reviewed	Bone morphogenetic protein receptor type-1A (BMP type-1A receptor) (BMPR-1A) (EC 2.7.11.30) (Activin receptor-like kinase 3) (ALK-3) (Serine/threonine-protein kinase receptor R5) (SKR5) (CD antigen CD292)	0	1	1	1	0	0	1	-	0	0	0	1	0	1	1	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	gastrointestinal polyps
BRAF	1	P15056	BRAF BRAF1 RAFB1	reviewed	Serine/threonine-protein kinase B-raf (EC 2.7.11.1) (Proto-oncogene B-Raf) (p94) (v-Raf murine sarcoma viral oncogene homolog B1)	1	0	0	1	1	1	0	1	1	1	1	1	0	0	0	0	0	1	1	0	0	1	0	0	0	0	1	0	0	1	0	0	melanoma, colorectal, papillary thyroid, borderline ovarian, NSCLC, cholangiocarcinoma, pilocytic astrocytoma, Spitzoid tumour, pancreas acinar carcinoma, melanocytic nevus, prostate, gastric
BRCA1	1	P38398	BRCA1 RNF53	reviewed	Breast cancer type 1 susceptibility protein (EC 2.3.2.27) (RING finger protein 53) (RING-type E3 ubiquitin transferase BRCA1)	1	1	1	0	0	0	1	1	0	0	0	1	1	1	1	1	0	0	1	0	0	0	1	0	1	0	1	1	1	0	0	0	ovarian, breast, ovarian
BRCA2	1	P51587	BRCA2 FACD FANCD1	reviewed	Breast cancer type 2 susceptibility protein (Fanconi anemia group D1 protein)	1	1	1	0	0	0	1	1	0	0	0	1	1	1	1	1	0	0	1	1	0	0	0	0	0	0	1	1	0	0	0	0	breast, ovarian, pancreatic, breast, ovarian, pancreatic, leukaemia  (FANCB, FANCD1)
BRD3	1	Q15059	BRD3 KIAA0043 RING3L	reviewed	Bromodomain-containing protein 3 (RING3-like protein)	1	0	0	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	lethal midline carcinoma of young people
BRD4	1	O60885	BRD4 HUNK1	reviewed	Bromodomain-containing protein 4 (Protein HUNK1)	1	0	0	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	1	0	0	0	0	1	0	0	1	0	0	1	0	0	lethal midline carcinoma of young people
BRIP1	1	Q9BX63	BRIP1 BACH1 FANCJ	reviewed	Fanconi anemia group J protein (Protein FACJ) (EC 3.6.4.13) (ATP-dependent RNA helicase BRIP1) (BRCA1-associated C-terminal helicase 1) (BRCA1-interacting protein C-terminal helicase 1) (BRCA1-interacting protein 1)	0	1	1	0	0	0	1	1	0	0	0	1	0	1	1	0	0	0	1	1	0	0	0	0	0	0	0	1	0	0	0	0	AML, leukaemia, breast
BTG1	1	P62324	BTG1	reviewed	Protein BTG1 (B-cell translocation gene 1 protein)	1	0	1	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	B-CLL
BTG2	2	P78543	BTG2 PC3	reviewed	Protein BTG2 (BTG family member 2) (NGF-inducible anti-proliferative protein PC3)	1	0	1	0	0	0	0	-	0	0	0	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	DLBCL
BTK	1	Q06187	BTK AGMX1 ATK BPK	reviewed	Tyrosine-protein kinase BTK (EC 2.7.10.2) (Agammaglobulinemia tyrosine kinase) (ATK) (B-cell progenitor kinase) (BPK) (Bruton tyrosine kinase)	1	0	1	1	0	1	0	-	1	0	0	1	0	0	0	0	0	0	0	1	0	0	0	1	0	0	1	1	0	0	0	0	CLL, mantle cell lymphoma, WM
BUB1B	1	O60566	BUB1B BUBR1 MAD3L SSK1	reviewed	Mitotic checkpoint serine/threonine-protein kinase BUB1 beta (EC 2.7.11.1) (MAD3/BUB1-related protein kinase) (hBUBR1) (Mitotic checkpoint kinase MAD3L) (Protein SSK1)	0	1	1	0	0	0	1	-	0	0	0	1	1	1	1	0	0	0	0	0	1	0	0	0	0	0	1	1	1	1	0	0	rhabdomyosarcoma
C15orf65	2	H3BRN8	C15orf65	reviewed	Uncharacterized protein C15orf65	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	PMBL, Hodgkin lymphoma
CACNA1D	1	Q01668	CACNA1D CACH3 CACN4 CACNL1A2 CCHL1A2	reviewed	Voltage-dependent L-type calcium channel subunit alpha-1D (Calcium channel, L type, alpha-1 polypeptide, isoform 2) (Voltage-gated calcium channel subunit alpha Cav1.3)	1	0	0	1	0	1	0	-	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	adrenal aldosterone producing adenoma
CALR	1	P27797	CALR CRTC	reviewed	Calreticulin (CRP55) (Calregulin) (Endoplasmic reticulum resident protein 60) (ERp60) (HACBP) (grp60)	1	0	0	1	0	1	0	-	0	0	0	1	0	0	1	0	0	0	0	1	0	0	1	0	0	0	1	0	1	1	0	0	MPN, MDS
CAMTA1	1	Q9Y6Y1	CAMTA1 KIAA0833 MSTP023	reviewed	Calmodulin-binding transcription activator 1	1	0	1	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	epithelioid haemangioendothelioma
CANT1	1	Q8WVQ1	CANT1 SHAPY	reviewed	Soluble calcium-activated nucleotidase 1 (SCAN-1) (EC 3.6.1.6) (Apyrase homolog) (Putative MAPK-activating protein PM09) (Putative NF-kappa-B-activating protein 107)	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	prostate
CARD11	1	Q9BXL7	CARD11 CARMA1	reviewed	Caspase recruitment domain-containing protein 11 (CARD-containing MAGUK protein 1) (Carma 1)	1	0	0	1	0	1	0	-	0	0	0	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	DLBCL
CARS	1	P49589	CARS1 CARS	reviewed	Cysteine--tRNA ligase, cytoplasmic (EC 6.1.1.16) (Cysteinyl-tRNA synthetase) (CysRS)	1	0	1	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	ALCL
CASP3	2	P42574	CASP3 CPP32	reviewed	"Caspase-3 (CASP-3) (EC 3.4.22.56) (Apopain) (Cysteine protease CPP32) (CPP-32) (Protein Yama) (SREBP cleavage activity 1) (SCA-1) [Cleaved into: Caspase-3 subunit p17; Caspase-3 subunit p12]"	1	0	1	0	0	0	0	-	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	ovarian cancer
CASP8	1	Q14790	CASP8 MCH5	reviewed	"Caspase-8 (CASP-8) (EC 3.4.22.61) (Apoptotic cysteine protease) (Apoptotic protease Mch-5) (CAP4) (FADD-homologous ICE/ced-3-like protease) (FADD-like ICE) (FLICE) (ICE-like apoptotic protease 5) (MORT1-associated ced-3 homolog) (MACH) [Cleaved into: Caspase-8 subunit p18; Caspase-8 subunit p10]"	1	0	1	0	0	0	1	-	0	0	0	0	1	1	1	0	0	0	1	0	0	0	1	0	0	0	1	0	1	1	0	1	hepatocellular, oral squamous cell, breast
CASP9	2	P55211	CASP9 MCH6	reviewed	"Caspase-9 (CASP-9) (EC 3.4.22.62) (Apoptotic protease Mch-6) (Apoptotic protease-activating factor 3) (APAF-3) (ICE-like apoptotic protease 6) (ICE-LAP6) [Cleaved into: Caspase-9 subunit p35; Caspase-9 subunit p10]"	1	0	1	0	0	0	0	-	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	glioma
CBFA2T3	1	O75081	CBFA2T3 MTG16 MTGR2 ZMYND4	reviewed	Protein CBFA2T3 (MTG8-related protein 2) (Myeloid translocation gene on chromosome 16 protein) (hMTG16) (Zinc finger MYND domain-containing protein 4)	1	0	1	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	1	0	0	0	0	0	1	0	AML
CBFB	1	Q13951	CBFB	reviewed	Core-binding factor subunit beta (CBF-beta) (Polyomavirus enhancer-binding protein 2 beta subunit) (PEA2-beta) (PEBP2-beta) (SL3-3 enhancer factor 1 subunit beta) (SL3/AKV core-binding factor beta subunit)	1	0	1	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0	0	0	AML
CBL	1	P22681	CBL CBL2 RNF55	reviewed	E3 ubiquitin-protein ligase CBL (EC 2.3.2.27) (Casitas B-lineage lymphoma proto-oncogene) (Proto-oncogene c-Cbl) (RING finger protein 55) (RING-type E3 ubiquitin transferase CBL) (Signal transduction protein CBL)	1	0	1	1	1	1	1	-	0	1	1	1	1	0	0	0	0	1	0	1	0	0	0	0	0	0	0	0	1	1	0	0	AML, JMML, MDS
CBLB	1	Q13191	CBLB RNF56 Nbla00127	reviewed	E3 ubiquitin-protein ligase CBL-B (EC 2.3.2.27) (Casitas B-lineage lymphoma proto-oncogene b) (RING finger protein 56) (RING-type E3 ubiquitin transferase CBL-B) (SH3-binding protein CBL-B) (Signal transduction protein CBL-B)	1	0	1	0	0	0	1	-	0	0	0	1	1	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	1	0	1	0	AML
CBLC	1	Q9ULV8	CBLC CBL3 RNF57	reviewed	E3 ubiquitin-protein ligase CBL-C (EC 2.3.2.27) (RING finger protein 57) (RING-type E3 ubiquitin transferase CBL-C) (SH3-binding protein CBL-3) (SH3-binding protein CBL-C) (Signal transduction protein CBL-C)	1	0	1	1	0	0	1	-	0	0	0	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	AML
CCDC6	1	Q16204	CCDC6 D10S170 TST1	reviewed	Coiled-coil domain-containing protein 6 (Papillary thyroid carcinoma-encoded protein) (Protein H4)	1	0	1	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	1	1	0	0	1	0	papillary thyroid, CML, NSCLC
CCNB1IP1	1	Q9NPC3	CCNB1IP1 C14orf18 HEI10	reviewed	E3 ubiquitin-protein ligase CCNB1IP1 (EC 2.3.2.27) (Cyclin-B1-interacting protein 1) (Human enhancer of invasion 10) (RING-type E3 ubiquitin transferase CCNB1IP1)	1	0	1	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	1	0	0	0	leiomyoma
CCNC	2	P24863	CCNC	reviewed	Cyclin-C (SRB11 homolog) (hSRB11)	1	0	1	0	0	0	0	-	0	0	0	0	0	0	0	1	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	T-ALL
CCND1	1	P24385	CCND1 BCL1 PRAD1	reviewed	G1/S-specific cyclin-D1 (B-cell lymphoma 1 protein) (BCL-1) (BCL-1 oncogene) (PRAD1 oncogene)	1	0	0	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	1	1	0	0	0	0	1	0	0	1	1	0	0	0	CLL, B-ALL, breast
CCND2	1	P30279	CCND2	reviewed	G1/S-specific cyclin-D2	1	0	0	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	NHL,CLL
CCND3	1	P30281	CCND3	reviewed	G1/S-specific cyclin-D3	1	0	0	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	MM
CCNE1	1	P24864	CCNE1 CCNE	reviewed	G1/S-specific cyclin-E1	1	0	0	1	0	1	0	-	0	0	0	0	0	0	0	0	1	0	1	0	0	0	0	1	0	0	0	0	0	1	0	0	serous ovarian
CCR4	2	P51679	CCR4 CMKBR4	reviewed	C-C chemokine receptor type 4 (C-C CKR-4) (CC-CKR-4) (CCR-4) (CCR4) (K5-5) (CD antigen CD194)	1	0	0	1	0	0	0	-	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	adult T-cell leukaemia/lymphoma
CCR7	2	P32248	CCR7 CMKBR7 EBI1 EVI1	reviewed	C-C chemokine receptor type 7 (C-C CKR-7) (CC-CKR-7) (CCR-7) (BLR2) (CDw197) (Epstein-Barr virus-induced G-protein coupled receptor 1) (EBI1) (EBV-induced G-protein coupled receptor 1) (MIP-3 beta receptor) (CD antigen CD197)	1	0	0	1	0	0	0	-	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	adult T-cell leukaemia/lymphoma
CD209	2	Q9NNX6	CD209 CLEC4L	reviewed	CD209 antigen (C-type lectin domain family 4 member L) (Dendritic cell-specific ICAM-3-grabbing non-integrin 1) (DC-SIGN) (DC-SIGN1) (CD antigen CD209)	1	0	0	0	0	0	0	-	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	prostate carcinoma
CD274	1	Q9NZQ7	CD274 B7H1 PDCD1L1 PDCD1LG1 PDL1	reviewed	Programmed cell death 1 ligand 1 (PD-L1) (PDCD1 ligand 1) (Programmed death ligand 1) (hPD-L1) (B7 homolog 1) (B7-H1) (CD antigen CD274)	1	0	1	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	PMBL, Hodgkin lymphoma
CD28	2	P10747	CD28	reviewed	T-cell-specific surface glycoprotein CD28 (TP44) (CD antigen CD28)	1	0	0	1	0	0	0	-	0	0	0	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	T-cell lymphoma
CD74	1	P04233	CD74 DHLAG	reviewed	HLA class II histocompatibility antigen gamma chain (HLA-DR antigens-associated invariant chain) (Ia antigen-associated invariant chain) (Ii) (CD antigen CD74) [Cleaved into: Class-II-associated invariant chain peptide (CLIP)]	1	0	0	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	NSCLC
CD79A	1	P11912	CD79A IGA MB1	reviewed	B-cell antigen receptor complex-associated protein alpha chain (Ig-alpha) (MB-1 membrane glycoprotein) (Membrane-bound immunoglobulin-associated protein) (Surface IgM-associated protein) (CD antigen CD79a)	1	0	0	1	0	1	0	-	0	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	1	0	0	DLBCL, WM
CD79B	1	P40259	CD79B B29 IGB	reviewed	B-cell antigen receptor complex-associated protein beta chain (B-cell-specific glycoprotein B29) (Ig-beta) (Immunoglobulin-associated B29 protein) (CD antigen CD79b)	1	0	0	1	0	1	0	-	0	0	0	1	1	0	0	0	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	DLBCL, WM
CDC73	1	Q6P1J9	CDC73 C1orf28 HRPT2	reviewed	Parafibromin (Cell division cycle protein 73 homolog) (Hyperparathyroidism 2 protein)	1	1	1	0	0	0	1	-	0	0	0	1	0	1	1	0	0	0	1	0	1	0	0	0	0	0	1	0	1	0	1	0	parathyroid adenoma, parathyroid adenoma, multiple ossifying jaw fibroma
CDH1	1	P12830	CDH1 CDHE UVO	reviewed	"Cadherin-1 (CAM 120/80) (Epithelial cadherin) (E-cadherin) (Uvomorulin) (CD antigen CD324) [Cleaved into: E-Cad/CTF1; E-Cad/CTF2; E-Cad/CTF3]"	1	1	1	0	0	0	1	-	0	0	0	1	1	1	1	0	0	0	1	0	0	0	0	0	1	0	0	0	1	0	0	0	lobular breast, gastric, gastric
CDH10	2	Q9Y6N8	CDH10	reviewed	Cadherin-10 (T2-cadherin)	1	1	1	0	0	0	0	-	0	0	0	1	0	1	1	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	melanoma, pancreatic ductal adenocarcinoma
CDH11	1	P55287	CDH11	reviewed	Cadherin-11 (OSF-4) (Osteoblast cadherin) (OB-cadherin)	1	0	1	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	1	0	0	0	aneurysmal bone cyst
CDH17	2	Q12864	CDH17	reviewed	Cadherin-17 (Intestinal peptide-associated transporter HPT-1) (Liver-intestine cadherin) (LI-cadherin)	1	0	0	1	0	0	0	-	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	melanoma
CDK12	1	Q9NYV4	CDK12 CRK7 CRKRS KIAA0904	reviewed	Cyclin-dependent kinase 12 (EC 2.7.11.22) (EC 2.7.11.23) (Cdc2-related kinase, arginine/serine-rich) (CrkRS) (Cell division cycle 2-related protein kinase 7) (CDC2-related protein kinase 7) (Cell division protein kinase 12) (hCDK12)	1	0	1	0	0	0	1	1	0	0	0	1	0	1	1	0	0	0	1	0	0	0	0	0	1	0	0	1	0	0	0	0	serous ovarian
CDK4	1	P11802	CDK4	reviewed	Cyclin-dependent kinase 4 (EC 2.7.11.22) (Cell division protein kinase 4) (PSK-J3)	0	1	0	1	0	1	0	-	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	1	0	0	0	0	0	0	0	0	melanoma
CDK6	1	Q00534	CDK6 CDKN6	reviewed	Cyclin-dependent kinase 6 (EC 2.7.11.22) (Cell division protein kinase 6) (Serine/threonine-protein kinase PLSTIRE)	1	0	0	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	ALL
CDKN1A	2	P38936	CDKN1A CAP20 CDKN1 CIP1 MDA6 PIC1 SDI1 WAF1	reviewed	Cyclin-dependent kinase inhibitor 1 (CDK-interacting protein 1) (Melanoma differentiation-associated protein 6) (MDA-6) (p21)	1	0	1	1	0	0	0	-	0	0	0	0	0	1	1	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	bladder cancer
CDKN1B	1	P46527	CDKN1B KIP1	reviewed	Cyclin-dependent kinase inhibitor 1B (Cyclin-dependent kinase inhibitor p27) (p27Kip1)	1	1	1	0	0	0	1	-	0	0	0	0	0	0	1	0	0	0	1	0	0	0	1	0	1	0	1	1	1	0	1	1	breast, small intestine neuroendocrine tumours, pituitary, parathyroid
CDKN2A	1	P42771	CDKN2A CDKN2 MTS1	reviewed	Cyclin-dependent kinase inhibitor 2A (Cyclin-dependent kinase 4 inhibitor A) (CDK4I) (Multiple tumor suppressor 1) (MTS-1) (p16-INK4a) (p16-INK4) (p16INK4A)	1	1	1	0	0	0	1	-	0	0	0	1	1	1	1	1	0	0	1	1	1	1	1	0	0	0	1	0	1	0	1	0	melanoma, multiple other tumour types, melanoma, pancreatic
CDKN2C	1	P42773	CDKN2C CDKN6	reviewed	Cyclin-dependent kinase 4 inhibitor C (Cyclin-dependent kinase 6 inhibitor) (p18-INK4c) (p18-INK6)	1	0	1	0	0	0	1	-	0	0	0	0	0	0	0	1	0	0	0	1	0	1	0	0	0	0	1	0	0	0	1	0	glioma, MM
CDX2	1	Q99626	CDX2 CDX3	reviewed	Homeobox protein CDX-2 (CDX-3) (Caudal-type homeobox protein 2)	1	0	1	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	AML
CEBPA	1	P49715	CEBPA CEBP	reviewed	CCAAT/enhancer-binding protein alpha (C/EBP alpha)	1	0	1	0	0	1	0	-	0	0	0	1	0	1	1	0	0	0	0	1	0	0	0	0	1	0	1	0	1	1	1	0	AML, MDS
CEP89	2	Q96ST8	CEP89 CCDC123	reviewed	Centrosomal protein of 89 kDa (Cep89) (Centrosomal protein 123) (Cep123) (Coiled-coil domain-containing protein 123)	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	Spitzoid tumour
CHCHD7	1	Q9BUK0	CHCHD7	reviewed	Coiled-coil-helix-coiled-coil-helix domain-containing protein 7	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	salivary adenoma
CHD2	2	O14647	CHD2	reviewed	Chromodomain-helicase-DNA-binding protein 2 (CHD-2) (EC 3.6.4.12) (ATP-dependent helicase CHD2)	1	0	1	0	0	0	0	-	0	0	0	1	0	1	1	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	melanoma, large intestine, CLL, monoclonal B lymphocytosis
CHD4	1	Q14839	CHD4	reviewed	Chromodomain-helicase-DNA-binding protein 4 (CHD-4) (EC 3.6.4.12) (ATP-dependent helicase CHD4) (Mi-2 autoantigen 218 kDa protein) (Mi2-beta)	1	0	0	1	0	1	0	-	0	0	0	1	0	1	1	0	0	0	1	0	0	0	0	0	0	0	0	1	0	0	0	0	uterine serous carcinoma
CHEK2	1	O96017	CHEK2 CDS1 CHK2 RAD53	reviewed	Serine/threonine-protein kinase Chk2 (EC 2.7.11.1) (CHK2 checkpoint homolog) (Cds1 homolog) (Hucds1) (hCds1) (Checkpoint kinase 2)	0	1	1	0	0	0	1	1	0	0	0	0	0	0	1	0	0	0	1	0	0	0	0	0	0	0	1	1	0	0	0	0	breast
CHIC2	2	Q9UKJ5	CHIC2 BTL	reviewed	Cysteine-rich hydrophobic domain-containing protein 2 (BrX-like translocated in leukemia)	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	AML
CHST11	2	Q9NPF2	CHST11	reviewed	Carbohydrate sulfotransferase 11 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 1) (Chondroitin 4-sulfotransferase 1) (C4S-1) (C4ST-1) (C4ST1)	1	0	0	1	1	0	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	B-CLL
CIC	1	Q96RK0	CIC KIAA0306	reviewed	Protein capicua homolog	1	0	1	1	1	0	1	-	0	1	1	1	1	0	1	0	0	0	0	0	1	1	0	0	1	0	0	0	1	0	1	0	oligodendroglioma, soft tissue sarcoma
CIITA	1	P33076	CIITA MHC2TA	reviewed	MHC class II transactivator (CIITA) (EC 2.3.1.-) (EC 2.7.11.1)	1	0	1	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	PMBL, Hodgkin lymphoma
CLIP1	1	P30622	CLIP1 CYLN1 RSN	reviewed	CAP-Gly domain-containing linker protein 1 (Cytoplasmic linker protein 1) (Cytoplasmic linker protein 170 alpha-2) (CLIP-170) (Reed-Sternberg intermediate filament-associated protein) (Restin)	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	Spitzoid tumour
CLP1	2	Q92989	CLP1 HEAB	reviewed	Polyribonucleotide 5'-hydroxyl-kinase Clp1 (EC 2.7.1.78) (Polyadenylation factor Clp1) (Polynucleotide kinase Clp1) (Pre-mRNA cleavage complex II protein Clp1)	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	AML
CLTC	1	Q00610	CLTC CLH17 CLTCL2 KIAA0034	reviewed	Clathrin heavy chain 1 (Clathrin heavy chain on chromosome 17) (CLH-17)	1	0	1	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	1	0	0	0	0	ALCL, renal
CLTCL1	1	P53675	CLTCL1 CLH22 CLTCL CLTD	reviewed	Clathrin heavy chain 2 (Clathrin heavy chain on chromosome 22) (CLH-22)	1	0	1	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0	0	0	ALCL
CNBD1	2	Q8NA66	CNBD1	reviewed	Cyclic nucleotide-binding domain-containing protein 1	1	0	0	0	0	0	0	-	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	gastric cancer, colon cancer
CNBP	1	P62633	CNBP RNF163 ZNF9	reviewed	CCHC-type zinc finger nucleic acid binding protein (Cellular nucleic acid-binding protein) (CNBP) (Zinc finger protein 9)	1	0	1	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	1	0	0	0	aneurysmal bone cyst
CNOT3	1	O75175	CNOT3 KIAA0691 LENG2 NOT3	reviewed	CCR4-NOT transcription complex subunit 3 (CCR4-associated factor 3) (Leukocyte receptor cluster member 2)	1	0	1	0	0	0	1	-	0	0	0	1	0	1	1	0	0	0	0	1	0	0	0	0	0	0	1	0	0	0	1	0	T-ALL
CNTNAP2	2	Q9UHC6	CNTNAP2 CASPR2 KIAA0868	reviewed	Contactin-associated protein-like 2 (Cell recognition molecule Caspr2)	1	0	1	0	0	0	0	-	0	0	0	1	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	glioma, melanoma
CNTRL	1	Q7Z7A1	CNTRL CEP1 CEP110	reviewed	Centriolin (Centrosomal protein 1) (Centrosomal protein of 110 kDa) (Cep110)	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	MPN, NHL
COL1A1	1	P02452	COL1A1	reviewed	Collagen alpha-1(I) chain (Alpha-1 type I collagen)	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	DFSP, aneurysmal bone cyst
COL2A1	1	P02458	COL2A1	reviewed	"Collagen alpha-1(II) chain (Alpha-1 type II collagen) [Cleaved into: Collagen alpha-1(II) chain; Chondrocalcin]"	1	0	0	0	1	0	1	-	0	1	1	1	0	1	1	0	0	0	1	1	1	0	0	0	0	0	0	0	0	0	0	0	chondrosarcoma, enchondroma
COL3A1	2	P02461	COL3A1	reviewed	Collagen alpha-1(III) chain	1	0	0	0	1	0	0	-	0	1	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	lipoblastoma
COX6C	2	P09669	COX6C	reviewed	Cytochrome c oxidase subunit 6C (Cytochrome c oxidase polypeptide VIc)	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	uterine leiomyoma
CPEB3	2	Q8NE35	CPEB3 KIAA0940	reviewed	Cytoplasmic polyadenylation element-binding protein 3 (CPE-BP3) (CPE-binding protein 3) (hCPEB-3)	1	0	1	0	0	0	0	-	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	lung cancer
CREB1	1	P16220	CREB1	reviewed	Cyclic AMP-responsive element-binding protein 1 (CREB-1) (cAMP-responsive element-binding protein 1)	1	0	0	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	clear cell sarcoma, angiomatoid fibrous histiocytoma
CREB3L1	1	Q96BA8	CREB3L1 OASIS PSEC0238	reviewed	Cyclic AMP-responsive element-binding protein 3-like protein 1 (cAMP-responsive element-binding protein 3-like protein 1) (Old astrocyte specifically-induced substance) (OASIS) [Cleaved into: Processed cyclic AMP-responsive element-binding protein 3-like protein 1]	1	0	1	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	0	1	0	1	0	0	0	0	0	1	0	0	0	myxofibrosarcoma
CREB3L2	1	Q70SY1	CREB3L2 BBF2H7	reviewed	Cyclic AMP-responsive element-binding protein 3-like protein 2 (cAMP-responsive element-binding protein 3-like protein 2) (BBF2 human homolog on chromosome 7) [Cleaved into: Processed cyclic AMP-responsive element-binding protein 3-like protein 2]	1	0	0	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0	0	fibromyxoid sarcoma
CREBBP	1	Q92793	CREBBP CBP	reviewed	CREB-binding protein (Histone lysine acetyltransferase CREBBP) (EC 2.3.1.48) (Protein-lysine acetyltransferase CREBBP) (EC 2.3.1.-)	1	0	1	1	1	1	1	-	0	1	1	1	0	1	1	0	0	1	0	1	0	0	0	0	0	0	1	1	1	1	0	0	ALL, AML, DLBCL, B-NHL
CRLF2	1	Q9HC73	CRLF2 CRL2 ILXR TSLPR	reviewed	Cytokine receptor-like factor 2 (Cytokine receptor-like 2) (IL-XR) (Thymic stromal lymphopoietin protein receptor) (TSLP receptor)	1	0	0	1	1	1	0	-	0	1	1	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	B-ALL, Downs associated ALL
CRNKL1	2	Q9BZJ0	CRNKL1 CRN CGI-201 MSTP021	reviewed	Crooked neck-like protein 1 (Crooked neck homolog) (hCrn)	1	0	0	0	0	0	0	-	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	base cell carcinoma
CRTC1	1	Q6UUV9	CRTC1 KIAA0616 MECT1 TORC1 WAMTP1	reviewed	CREB-regulated transcription coactivator 1 (Mucoepidermoid carcinoma translocated protein 1) (Transducer of regulated cAMP response element-binding protein 1) (TORC-1) (Transducer of CREB protein 1)	1	0	0	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	salivary gland mucoepidermoid
CRTC3	1	Q6UUV7	CRTC3 TORC3	reviewed	CREB-regulated transcription coactivator 3 (Transducer of regulated cAMP response element-binding protein 3) (TORC-3) (Transducer of CREB protein 3)	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	salivary gland mucoepidermoid
CSF1R	2	P07333	CSF1R FMS	reviewed	Macrophage colony-stimulating factor 1 receptor (CSF-1 receptor) (CSF-1-R) (CSF-1R) (M-CSF-R) (EC 2.7.10.1) (Proto-oncogene c-Fms) (CD antigen CD115)	1	0	0	1	0	0	0	-	0	0	0	1	0	1	0	0	0	0	1	1	1	0	0	0	0	0	0	0	0	0	0	0	MDS, CML, AML, hemangioblastoma, CCRCC
CSF3R	1	Q99062	CSF3R GCSFR	reviewed	Granulocyte colony-stimulating factor receptor (G-CSF receptor) (G-CSF-R) (CD antigen CD114)	1	0	0	1	0	1	0	-	0	0	0	1	0	1	0	0	0	0	0	1	0	0	0	0	0	0	1	0	1	1	0	0	aCML, CNL,  leukaemia lymphoma and MDS associated with severe congenital neutropenia, CMML, de novo AML, MDS
CSMD3	2	Q7Z407	CSMD3 KIAA1894	reviewed	CUB and sushi domain-containing protein 3 (CUB and sushi multiple domains protein 3)	1	0	1	0	0	0	0	-	0	0	0	1	0	1	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	ovarian cancer, oral SCC, lung cancer
CTCF	1	P49711	CTCF	reviewed	Transcriptional repressor CTCF (11-zinc finger protein) (CCCTC-binding factor) (CTCFL paralog)	1	0	1	0	0	1	0	-	0	0	0	1	0	1	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0	0	0	0	endometrial, breast, head and neck cancer
CTNNA2	2	P26232	CTNNA2 CAPR	reviewed	Catenin alpha-2 (Alpha N-catenin) (Alpha-catenin-related protein)	1	0	0	1	0	0	0	-	0	0	0	1	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	gastric cancer
CTNNB1	1	P35222	CTNNB1 CTNNB OK/SW-cl.35 PRO2286	reviewed	Catenin beta-1 (Beta-catenin)	1	0	0	1	1	1	0	-	1	1	1	1	0	0	0	0	0	1	1	0	1	1	1	1	1	1	1	1	1	1	1	0	colorectal, ovarian,  hepatoblastoma, pleomorphic salivary gland adenoma, other tumour types
CTNND1	2	O60716	CTNND1 KIAA0384	reviewed	Catenin delta-1 (Cadherin-associated Src substrate) (CAS) (p120 catenin) (p120(ctn)) (p120(cas))	1	0	0	0	0	0	0	-	0	0	0	0	0	1	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	large intestine carcinoma
CTNND2	2	Q9UQB3	CTNND2 NPRAP	reviewed	Catenin delta-2 (Delta-catenin) (GT24) (Neural plakophilin-related ARM-repeat protein) (NPRAP) (Neurojungin)	1	0	0	1	0	0	0	-	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	prostae adenocarcinoma, GIST
CUL3	2	Q13618	CUL3 KIAA0617	reviewed	Cullin-3 (CUL-3)	1	0	1	0	0	0	0	-	0	0	0	0	0	1	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	lung cancer
CUX1	1	P39880	CUX1 CUTL1	reviewed	Homeobox protein cut-like 1 (CCAAT displacement protein) (CDP) (CDP/Cux p200) (Homeobox protein cux-1) [Cleaved into: CDP/Cux p110]	1	0	1	1	0	1	0	-	0	0	1	1	1	1	1	0	0	1	1	1	1	1	1	0	0	1	1	1	1	1	1	0	endometrial, melanoma, colorectal, AML, MDS, other tumour types
CXCR4	1	P61073	CXCR4	reviewed	C-X-C chemokine receptor type 4 (CXC-R4) (CXCR-4) (FB22) (Fusin) (HM89) (LCR1) (Leukocyte-derived seven transmembrane domain receptor) (LESTR) (Lipopolysaccharide-associated protein 3) (LAP-3) (LPS-associated protein 3) (NPYRL) (Stromal cell-derived factor 1 receptor) (SDF-1 receptor) (CD antigen CD184)	1	1	0	1	0	1	0	-	0	0	0	1	0	1	1	0	0	0	0	1	0	0	0	0	0	0	0	0	1	1	0	0	WM
CYLD	1	Q9NQC7	CYLD CYLD1 KIAA0849 HSPC057	reviewed	Ubiquitin carboxyl-terminal hydrolase CYLD (EC 3.4.19.12) (Deubiquitinating enzyme CYLD) (Ubiquitin thioesterase CYLD) (Ubiquitin-specific-processing protease CYLD)	1	1	1	0	0	0	1	-	0	0	0	1	1	1	1	0	0	0	1	0	0	0	1	0	0	0	1	0	1	0	1	1	cylindroma, cylindroma
CYP2C8	2	P10632	CYP2C8	reviewed	Cytochrome P450 2C8 (EC 1.14.14.1) (CYPIIC8) (Cytochrome P450 IIC2) (Cytochrome P450 MP-12) (Cytochrome P450 MP-20) (Cytochrome P450 form 1) (S-mephenytoin 4-hydroxylase)	1	0	0	0	0	0	0	-	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	melanoma
CYSLTR2	2	Q9NS75	CYSLTR2 CYSLT2 CYSLT2R PSEC0146	reviewed	Cysteinyl leukotriene receptor 2 (CysLTR2) (G-protein coupled receptor GPCR21) (hGPCR21) (G-protein coupled receptor HG57) (HPN321)	1	0	0	1	0	0	0	-	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	uveal melanoma
DAXX	1	Q9UER7	DAXX BING2 DAP6	reviewed	Death domain-associated protein 6 (Daxx) (hDaxx) (ETS1-associated protein 1) (EAP1) (Fas death domain-associated protein)	1	0	1	1	0	0	1	-	0	0	0	1	0	1	1	0	0	0	1	0	0	0	0	0	0	0	1	1	1	1	0	0	pancreatic neuroendocrine tumour, paediatric glioblastoma
DCAF12L2	2	Q5VW00	DCAF12L2 WDR40C	reviewed	DDB1- and CUL4-associated factor 12-like protein 2 (WD repeat-containing protein 40C)	1	0	0	0	0	0	0	-	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	CRC
DCC	2	P43146	DCC IGDCC1	reviewed	Netrin receptor DCC (Colorectal cancer suppressor) (Immunoglobulin superfamily DCC subclass member 1) (Tumor suppressor protein DCC)	1	0	0	0	0	0	0	-	0	0	0	1	0	1	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	CRC, melanoma, SCC
DCTN1	1	Q14203	DCTN1	reviewed	Dynactin subunit 1 (150 kDa dynein-associated polypeptide) (DAP-150) (DP-150) (p135) (p150-glued)	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	inflammatory myofibroblastic tumour, Spitzoid tumour
DDB2	1	Q92466	DDB2	reviewed	DNA damage-binding protein 2 (DDB p48 subunit) (DDBb) (Damage-specific DNA-binding protein 2) (UV-damaged DNA-binding protein 2) (UV-DDB 2)	0	1	1	1	0	0	1	-	0	0	0	1	0	1	0	0	0	0	1	0	0	0	0	0	0	0	1	1	1	1	0	0	skin basal cell, skin squamous cell, melanoma
DDIT3	1	P35638	DDIT3 CHOP CHOP10 GADD153	reviewed	DNA damage-inducible transcript 3 protein (DDIT-3) (C/EBP zeta) (C/EBP-homologous protein) (CHOP) (C/EBP-homologous protein 10) (CHOP-10) (CCAAT/enhancer-binding protein homologous protein) (Growth arrest and DNA damage-inducible protein GADD153)	1	0	0	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	1	liposarcoma
DDR2	1	Q16832	DDR2 NTRKR3 TKT TYRO10	reviewed	Discoidin domain-containing receptor 2 (Discoidin domain receptor 2) (EC 2.7.10.1) (CD167 antigen-like family member B) (Discoidin domain-containing receptor tyrosine kinase 2) (Neurotrophic tyrosine kinase, receptor-related 3) (Receptor protein-tyrosine kinase TKT) (Tyrosine-protein kinase TYRO10) (CD antigen CD167b)	1	0	0	1	0	1	0	-	0	0	0	1	0	1	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	squamous cell carcinoma, NSCLC
DDX10	1	Q13206	DDX10	reviewed	Probable ATP-dependent RNA helicase DDX10 (EC 3.6.4.13) (DEAD box protein 10)	1	0	1	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	AML*
DDX3X	1	O00571	DDX3X DBX DDX3	reviewed	ATP-dependent RNA helicase DDX3X (EC 3.6.4.13) (CAP-Rf) (DEAD box protein 3, X-chromosomal) (DEAD box, X isoform) (DBX) (Helicase-like protein 2) (HLP2)	1	0	1	0	0	0	0	-	0	0	0	1	0	1	1	0	0	0	0	1	0	1	0	0	1	0	1	0	1	0	1	0	CLL, medulloblastoma
DDX5	1	P17844	DDX5 G17P1 HELR HLR1	reviewed	Probable ATP-dependent RNA helicase DDX5 (EC 3.6.4.13) (DEAD box protein 5) (RNA helicase p68)	1	0	0	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	1	0	1	1	0	0	prostate
DDX6	1	P26196	DDX6 HLR2 RCK	reviewed	Probable ATP-dependent RNA helicase DDX6 (EC 3.6.4.13) (ATP-dependent RNA helicase p54) (DEAD box protein 6) (Oncogene RCK)	1	0	0	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	1	0	0	1	0	0	B-NHL
DEK	1	P35659	DEK	reviewed	Protein DEK	1	0	0	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	AML
DGCR8	2	Q8WYQ5	DGCR8 C22orf12 DGCRK6 LP4941	reviewed	Microprocessor complex subunit DGCR8 (DiGeorge syndrome critical region 8)	1	0	0	1	0	0	0	-	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	Wilms tumour
DICER1	1	Q9UPY3	DICER1 DICER HERNA KIAA0928	reviewed	Endoribonuclease Dicer (EC 3.1.26.3) (Helicase with RNase motif) (Helicase MOI)	1	1	1	0	0	0	1	-	0	0	0	1	0	1	1	0	0	0	1	0	1	1	1	1	0	0	1	1	1	1	0	0	sex cord-stromal tumour, TGCT, embryonal rhabdomyosarcoma, pleuropulmonary blastoma, pituitary blastoma, Wilms tumour, thyroid cancer, other tumour types, pleuropulmonary blastoma
DNAJB1	1	P25685	DNAJB1 DNAJ1 HDJ1 HSPF1	reviewed	DnaJ homolog subfamily B member 1 (DnaJ protein homolog 1) (Heat shock 40 kDa protein 1) (HSP40) (Heat shock protein 40) (Human DnaJ protein 1) (hDj-1)	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	fibrolamellar hepatocellular carcinoma
DNM2	1	P50570	DNM2 DYN2	reviewed	Dynamin-2 (EC 3.6.5.5)	1	0	1	0	0	0	1	-	0	0	0	1	1	1	1	0	0	1	0	1	0	0	1	0	0	0	0	0	1	1	0	0	T-ALL
DNMT3A	1	Q9Y6K1	DNMT3A	reviewed	DNA (cytosine-5)-methyltransferase 3A (Dnmt3a) (EC 2.1.1.37) (Cysteine methyltransferase DNMT3A) (EC 2.1.1.-) (DNA methyltransferase HsaIIIA) (DNA MTase HsaIIIA) (M.HsaIIIA)	1	0	1	0	0	1	0	-	0	0	0	1	1	1	1	0	0	0	0	1	0	0	1	0	1	1	1	0	1	1	0	0	AML
DROSHA	1	Q9NRR4	DROSHA RN3 RNASE3L RNASEN	reviewed	Ribonuclease 3 (EC 3.1.26.3) (Protein Drosha) (Ribonuclease III) (RNase III) (p241)	1	0	1	0	0	0	0	-	0	0	0	1	0	1	1	0	1	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	Wilms tumour, NSCLC, bladder carcinoma
EBF1	1	Q9UH73	EBF1 COE1 EBF	reviewed	Transcription factor COE1 (O/E-1) (OE-1) (Early B-cell factor)	1	0	1	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	lipoma
ECT2L	2	Q008S8	ECT2L C6orf91 LFDH	reviewed	Epithelial cell-transforming sequence 2 oncogene-like (Lung-specific F-box and DH domain-containing protein) (Putative guanine nucleotide exchange factor LFDH)	1	0	0	0	0	0	1	-	0	0	0	1	1	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	ETP ALL
EED	2	O75530	EED	reviewed	Polycomb protein EED (hEED) (Embryonic ectoderm development protein) (WD protein associating with integrin cytoplasmic tails 1) (WAIT-1)	1	0	1	0	0	0	0	-	0	0	0	1	0	0	1	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	malignant peripheral nerve sheath tumours, MDS and related, lung adenocarcinoma
EGFR	1	P00533	EGFR ERBB ERBB1 HER1	reviewed	Epidermal growth factor receptor (EC 2.7.10.1) (Proto-oncogene c-ErbB-1) (Receptor tyrosine-protein kinase erbB-1)	1	1	0	1	0	1	0	1	1	0	0	1	0	0	0	0	1	1	1	0	0	1	1	0	1	1	1	0	1	1	0	0	glioma, NSCLC, NSCLC
EIF1AX	2	P47813	EIF1AX EIF1A EIF4C	reviewed	Eukaryotic translation initiation factor 1A, X-chromosomal (eIF-1A X isoform) (Eukaryotic translation initiation factor 4C) (eIF-4C)	1	0	0	0	0	0	0	-	0	0	0	1	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	uveal melanoma, thyroid cancer (PDTC and ATC), low grade serous ovarian cancer
EIF3E	1	P60228	EIF3E EIF3S6 INT6	reviewed	Eukaryotic translation initiation factor 3 subunit E (eIF3e) (Eukaryotic translation initiation factor 3 subunit 6) (Viral integration site protein INT-6 homolog) (eIF-3 p48)	1	0	1	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	1	0	0	0	1	0	0	0	1	0	1	1	0	0	colorectal
EIF4A2	1	Q14240	EIF4A2 DDX2B EIF4F	reviewed	Eukaryotic initiation factor 4A-II (eIF-4A-II) (eIF4A-II) (EC 3.6.4.13) (ATP-dependent RNA helicase eIF4A-2)	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	NHL
ELF3	2	P78545	ELF3 ERT ESX JEN	reviewed	ETS-related transcription factor Elf-3 (E74-like factor 3) (Epithelial-restricted with serine box) (Epithelium-restricted Ets protein ESX) (Epithelium-specific Ets transcription factor 1) (ESE-1)	1	0	1	0	0	0	0	-	0	0	0	1	0	1	1	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	pancreatic cancer
ELF4	1	Q99607	ELF4 ELFR MEF	reviewed	ETS-related transcription factor Elf-4 (E74-like factor 4) (Myeloid Elf-1-like factor)	1	0	1	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	1	0	0	1	0	0	1	1	0	AML
ELK4	1	P28324	ELK4 SAP1	reviewed	ETS domain-containing protein Elk-4 (Serum response factor accessory protein 1) (SAP-1) (SRF accessory protein 1)	1	0	0	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	1	0	0	1	0	0	prostate
ELL	1	P55199	ELL C19orf17	reviewed	RNA polymerase II elongation factor ELL (Eleven-nineteen lysine-rich leukemia protein)	1	0	1	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	1	1	0	0	0	0	0	0	1	0	AL
ELN	2	P15502	ELN	reviewed	Elastin (Tropoelastin)	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	B-ALL
EML4	1	Q9HC35	EML4 C2orf2 EMAPL4	reviewed	Echinoderm microtubule-associated protein-like 4 (EMAP-4) (Restrictedly overexpressed proliferation-associated protein) (Ropp 120)	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	NSCLC
EP300	1	Q09472	EP300 P300	reviewed	Histone acetyltransferase p300 (p300 HAT) (EC 2.3.1.48) (E1A-associated protein p300) (Histone butyryltransferase p300) (EC 2.3.1.-) (Histone crotonyltransferase p300) (EC 2.3.1.-) (Protein 2-hydroxyisobutyryltransferase p300) (EC 2.3.1.-) (Protein lactyltransferas p300) (EC 2.3.1.-) (Protein propionyltransferase p300) (EC 2.3.1.-)	1	0	1	0	1	0	1	-	0	1	1	1	0	1	1	0	0	1	1	1	0	0	0	0	0	0	1	0	0	0	1	0	colorectal, breast, pancreatic, AML, ALL, DLBCL
EPAS1	1	Q99814	EPAS1 BHLHE73 HIF2A MOP2 PASD2	reviewed	Endothelial PAS domain-containing protein 1 (EPAS-1) (Basic-helix-loop-helix-PAS protein MOP2) (Class E basic helix-loop-helix protein 73) (bHLHe73) (HIF-1-alpha-like factor) (HLF) (Hypoxia-inducible factor 2-alpha) (HIF-2-alpha) (HIF2-alpha) (Member of PAS protein 2) (PAS domain-containing protein 2)	1	0	1	1	0	1	0	-	0	0	0	1	0	0	0	0	0	0	1	0	1	0	1	0	0	0	1	0	1	1	1	1	paraganglioma, pheochromocytoma, central nervous system hemangioblastomas
EPHA3	2	P29320	EPHA3 ETK ETK1 HEK TYRO4	reviewed	Ephrin type-A receptor 3 (EC 2.7.10.1) (EPH-like kinase 4) (EK4) (hEK4) (HEK) (Human embryo kinase) (Tyrosine-protein kinase TYRO4) (Tyrosine-protein kinase receptor ETK1) (Eph-like tyrosine kinase 1)	1	0	0	0	0	0	0	-	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	lung cancer, CRC, melanoma
EPHA7	2	Q15375	EPHA7 EHK3 HEK11	reviewed	Ephrin type-A receptor 7 (EC 2.7.10.1) (EPH homology kinase 3) (EHK-3) (EPH-like kinase 11) (EK11) (hEK11)	1	0	0	0	0	0	0	-	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	CRC, melanoma
EPS15	1	P42566	EPS15 AF1P	reviewed	Epidermal growth factor receptor substrate 15 (Protein Eps15) (Protein AF-1p)	1	0	1	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	ALL
ERBB2	1	P04626	ERBB2 HER2 MLN19 NEU NGL	reviewed	Receptor tyrosine-protein kinase erbB-2 (EC 2.7.10.1) (Metastatic lymph node gene 19 protein) (MLN 19) (Proto-oncogene Neu) (Proto-oncogene c-ErbB-2) (Tyrosine kinase-type cell surface receptor HER2) (p185erbB2) (CD antigen CD340)	1	0	0	1	1	1	0	1	1	1	0	1	0	0	0	0	1	1	1	0	0	0	0	0	1	0	1	0	1	1	0	0	breast, ovarian, other tumour types, NSCLC, gastric
ERBB3	1	P21860	ERBB3 HER3	reviewed	Receptor tyrosine-protein kinase erbB-3 (EC 2.7.10.1) (Proto-oncogene-like protein c-ErbB-3) (Tyrosine kinase-type cell surface receptor HER3)	1	0	0	1	0	1	0	-	0	0	0	1	0	1	0	0	0	0	1	0	0	0	0	0	0	0	1	0	1	1	0	0	colon, gastric, head and neck, bladder, skin
ERBB4	1	Q15303	ERBB4 HER4	reviewed	Receptor tyrosine-protein kinase erbB-4 (EC 2.7.10.1) (Proto-oncogene-like protein c-ErbB-4) (Tyrosine kinase-type cell surface receptor HER4) (p180erbB4) [Cleaved into: ERBB4 intracellular domain (4ICD) (E4ICD) (s80HER4)]	1	1	1	1	0	1	0	-	0	0	0	1	0	1	0	0	0	0	1	0	0	0	0	0	0	0	1	0	0	1	1	0	melanoma, gastric, NSCLC
ERC1	1	Q8IUD2	ERC1 ELKS KIAA1081 RAB6IP2	reviewed	ELKS/Rab6-interacting/CAST family member 1 (ERC-1) (Rab6-interacting protein 2)	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	papillary thyroid, Spitzoid tumour
ERCC2	1	P18074	ERCC2 XPD XPDC	reviewed	General transcription and DNA repair factor IIH helicase subunit XPD (TFIIH subunit XPD) (EC 3.6.4.12) (Basic transcription factor 2 80 kDa subunit) (BTF2 p80) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (TFIIH basal transcription factor complex 80 kDa subunit) (TFIIH 80 kDa subunit) (TFIIH p80) (Xeroderma pigmentosum group D-complementing protein)	0	1	1	0	0	0	1	-	0	0	0	1	1	1	1	0	0	0	1	0	0	0	0	0	0	0	1	1	0	0	0	0	skin basal cell, skin squamous cell, melanoma
ERCC3	1	P19447	ERCC3 XPB XPBC	reviewed	General transcription and DNA repair factor IIH helicase subunit XPB (TFIIH subunit XPB) (EC 3.6.4.12) (Basic transcription factor 2 89 kDa subunit) (BTF2 p89) (DNA excision repair protein ERCC-3) (DNA repair protein complementing XP-B cells) (TFIIH basal transcription factor complex 89 kDa subunit) (TFIIH 89 kDa subunit) (TFIIH p89) (Xeroderma pigmentosum group B-complementing protein)	0	1	1	0	0	0	1	-	0	0	0	1	1	0	0	0	0	0	1	0	0	0	0	0	0	0	1	1	0	0	0	0	skin basal cell, skin squamous cell, melanoma
ERCC4	1	Q92889	ERCC4 ERCC11 XPF	reviewed	DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein)	0	1	1	0	0	0	1	-	0	0	0	1	0	1	1	0	0	0	1	0	0	0	0	0	0	0	0	1	0	0	0	0	skin basal cell, skin squamous cell, melanoma
ERCC5	1	P28715	ERCC5	reviewed	DNA repair protein complementing XP-G cells	0	1	1	0	0	0	1	-	0	0	0	1	0	1	1	0	0	0	1	0	0	0	0	0	0	0	1	1	0	0	0	0	skin basal cell, skin squamous cell, melanoma
ERG	1	P11308	ERG	reviewed	Transcriptional regulator ERG (Transforming protein ERG)	1	0	0	1	1	1	0	-	0	1	1	0	0	0	0	0	1	0	1	1	1	0	0	1	0	0	0	0	0	0	0	0	Ewing sarcoma, prostate, AML
ESR1	1	P03372	ESR1 ESR NR3A1	reviewed	Estrogen receptor (ER) (ER-alpha) (Estradiol receptor) (Nuclear receptor subfamily 3 group A member 1)	1	0	1	1	1	1	0	-	1	1	0	1	0	0	0	0	0	0	1	0	0	0	0	0	0	1	0	0	1	1	1	0	breast
ETNK1	1	Q9HBU6	ETNK1	reviewed	Ethanolamine kinase 1	1	0	1	0	0	1	0	-	0	0	0	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	aCML, CMML, SM-AHD, HES
ETV1	1	P50549	ETV1 ER81	reviewed	ETS translocation variant 1 (Ets-related protein 81)	1	0	0	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	1	0	1	0	0	0	0	0	0	0	0	0	0	0	Ewing sarcoma, prostate
ETV4	1	P43268	ETV4 E1AF PEA3	reviewed	ETS translocation variant 4 (Adenovirus E1A enhancer-binding protein) (E1A-F) (Polyomavirus enhancer activator 3 homolog) (Protein PEA3)	1	0	0	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	1	0	1	0	0	0	0	0	0	0	0	0	0	0	Ewing sarcoma, prostate carcinoma
ETV5	1	P41161	ETV5 ERM	reviewed	ETS translocation variant 5 (Ets-related protein ERM)	1	0	0	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	prostate
ETV6	1	P41212	ETV6 TEL TEL1	reviewed	Transcription factor ETV6 (ETS translocation variant 6) (ETS-related protein Tel1) (Tel)	1	0	1	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	1	1	1	0	0	0	0	0	1	0	1	0	0	0	congenital fibrosarcoma, multiple different leukaemia and lymphoma tumour types including ALL, secretory breast, MDS
EWSR1	1	Q01844	EWSR1 EWS	reviewed	RNA-binding protein EWS (EWS oncogene) (Ewing sarcoma breakpoint region 1 protein)	1	0	0	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	1	1	1	0	0	0	0	0	0	1	0	0	0	0	Ewing sarcoma, desmoplastic small round cell tumour , ALL, clear cell sarcoma, sarcoma, myoepithelioma, mesothelioma
EXT1	1	Q16394	EXT1	reviewed	Exostosin-1 (EC 2.4.1.224) (EC 2.4.1.225) (Glucuronosyl-N-acetylglucosaminyl-proteoglycan/N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase) (Multiple exostoses protein 1) (Putative tumor suppressor protein EXT1)	0	1	1	0	1	0	1	-	0	1	0	1	1	1	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	exostoses, osteosarcoma
EXT2	1	Q93063	EXT2	reviewed	Exostosin-2 (EC 2.4.1.224) (EC 2.4.1.225) (Glucuronosyl-N-acetylglucosaminyl-proteoglycan/N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase) (Multiple exostoses protein 2) (Putative tumor suppressor protein EXT2)	0	1	1	0	0	0	1	-	0	0	0	1	1	1	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	exostoses, osteosarcoma
EZH2	1	Q15910	EZH2 KMT6	reviewed	Histone-lysine N-methyltransferase EZH2 (EC 2.1.1.356) (ENX-1) (Enhancer of zeste homolog 2) (Lysine N-methyltransferase 6)	1	0	1	1	0	1	0	1	0	0	0	1	0	0	0	0	0	0	0	1	0	0	1	0	1	1	1	1	1	1	1	1	DLBCL
EZR	1	P15311	EZR VIL2	reviewed	Ezrin (Cytovillin) (Villin-2) (p81)	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	1	0	1	1	0	0	NSCLC
FAM131B	2	Q86XD5	FAM131B KIAA0773	reviewed	Protein FAM131B	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	pilocytic astrocytoma
FAM135B	2	Q49AJ0	FAM135B C8orfK32	reviewed	Protein FAM135B	1	0	0	0	0	0	0	-	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	SCLC
FAM47C	2	Q5HY64	FAM47C	reviewed	Putative protein FAM47C	1	0	0	0	0	0	0	-	0	0	0	1	0	0	0	0	0	0	1	0	1	0	0	0	0	0	0	0	0	0	0	0	melanoma, clear cell sarcoma of soft parts, SCLC
FANCA	1	O15360	FANCA FAA FACA FANCH	reviewed	Fanconi anemia group A protein (Protein FACA)	0	1	1	0	0	0	1	-	0	0	0	1	1	1	1	1	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	AML, leukaemia
FANCC	1	Q00597	FANCC FAC FACC	reviewed	Fanconi anemia group C protein (Protein FACC)	0	1	1	0	0	0	1	-	0	0	0	1	1	1	1	1	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	AML, leukaemia
FANCD2	1	Q9BXW9	FANCD2 FACD	reviewed	Fanconi anemia group D2 protein (Protein FACD2)	0	1	1	0	0	0	1	-	0	0	0	1	0	1	1	1	0	0	0	1	0	0	0	0	0	0	1	1	1	1	0	1	AML, leukaemia
FANCE	1	Q9HB96	FANCE FACE	reviewed	Fanconi anemia group E protein (Protein FACE)	0	1	1	0	0	0	1	-	0	0	0	0	1	1	1	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	AML, leukaemia
FANCF	1	Q9NPI8	FANCF	reviewed	Fanconi anemia group F protein (Protein FACF)	0	1	1	0	0	0	1	-	0	0	0	0	0	1	1	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	AML, leukaemia
FANCG	1	O15287	FANCG XRCC9	reviewed	Fanconi anemia group G protein (Protein FACG) (DNA repair protein XRCC9)	0	1	1	0	0	0	1	-	0	0	0	1	1	1	1	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	AML, leukaemia
FAS	1	P25445	FAS APT1 FAS1 TNFRSF6	reviewed	Tumor necrosis factor receptor superfamily member 6 (Apo-1 antigen) (Apoptosis-mediating surface antigen FAS) (FASLG receptor) (CD antigen CD95)	1	0	1	0	0	0	1	-	0	0	0	1	0	0	0	0	0	0	1	1	0	1	0	1	0	0	1	0	1	1	0	0	TGCT, nasal NK/T lymphoma, skin squamous cell carcinoma-burn scar related
FAT1	1	Q14517	FAT1 CDHF7 FAT	reviewed	Protocadherin Fat 1 (Cadherin family member 7) (Cadherin-related tumor suppressor homolog) (Protein fat homolog) [Cleaved into: Protocadherin Fat 1, nuclear form]	1	1	1	0	0	0	0	-	0	0	0	1	1	1	1	0	0	0	1	1	0	0	0	0	0	0	1	0	1	0	1	0	oral squamous cell, chemorefractory CLL, head and neck, pancreatic acinar cell carcinoma, pancreatic
FAT3	2	Q8TDW7	FAT3 CDHF15 KIAA1989	reviewed	Protocadherin Fat 3 (hFat3) (Cadherin family member 15) (FAT tumor suppressor homolog 3)	1	0	0	0	0	0	0	-	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	SCC, colon adenocarcinoma, gastric adenocarcinoma
FAT4	1	Q6V0I7	FAT4 CDHF14 FATJ Nbla00548	reviewed	Protocadherin Fat 4 (hFat4) (Cadherin family member 14) (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J)	1	0	1	0	0	0	0	-	0	0	0	1	0	1	0	0	0	0	1	1	0	0	0	0	0	0	0	0	1	0	1	0	lymphoma, pancreatic, head and neck, melanoma, hepatocellular carcinoma
FBLN2	2	P98095	FBLN2	reviewed	Fibulin-2 (FIBL-2)	1	0	1	0	0	0	0	-	0	0	0	1	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	breast cancer, colorectal adenocarcinoma
FBXO11	1	Q86XK2	FBXO11 FBX11 PRMT9 VIT1 UG063H01	reviewed	F-box only protein 11 (Protein arginine N-methyltransferase 9) (Vitiligo-associated protein 1) (VIT-1)	1	0	1	0	0	0	1	-	0	0	0	1	0	0	1	1	0	0	0	1	0	0	0	0	0	0	1	0	1	1	0	0	DLBCL
FBXW7	1	Q969H0	FBXW7 FBW7 FBX30 SEL10	reviewed	F-box/WD repeat-containing protein 7 (Archipelago homolog) (hAgo) (F-box and WD-40 domain-containing protein 7) (F-box protein FBX30) (SEL-10) (hCdc4)	1	0	1	0	0	0	1	-	0	0	0	1	0	1	1	1	0	0	1	1	0	0	0	0	0	0	0	1	0	0	0	0	colorectal, endometrial, T-ALL
FCGR2B	1	P31994	FCGR2B CD32 FCG2 IGFR2	reviewed	Low affinity immunoglobulin gamma Fc region receptor II-b (IgG Fc receptor II-b) (CDw32) (Fc-gamma RII-b) (Fc-gamma-RIIb) (FcRII-b) (CD antigen CD32)	1	0	0	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	1	0	0	0	1	0	ALL
FCRL4	1	Q96PJ5	FCRL4 FCRH4 IFGP2 IRTA1	reviewed	Fc receptor-like protein 4 (FcR-like protein 4) (FcRL4) (Fc receptor homolog 4) (FcRH4) (IFGP family protein 2) (hIFGP2) (Immune receptor translocation-associated protein 1) (CD antigen CD307d)	1	0	0	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	B-NHL
FEN1	2	P39748	FEN1 RAD2	reviewed	Flap endonuclease 1 (FEN-1) (EC 3.1.-.-) (DNase IV) (Flap structure-specific endonuclease 1) (Maturation factor 1) (MF1) (hFEN-1)	0	1	1	0	0	0	0	-	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	breast cancer
FES	1	P07332	FES FPS	reviewed	Tyrosine-protein kinase Fes/Fps (EC 2.7.10.2) (Feline sarcoma/Fujinami avian sarcoma oncogene homolog) (Proto-oncogene c-Fes) (Proto-oncogene c-Fps) (p93c-fes)	1	0	1	1	0	0	0	-	0	0	0	1	0	0	1	0	0	0	1	0	0	0	1	0	0	1	1	0	1	1	1	1	HNSCC, ovarian carcinoma
FEV	1	Q99581	FEV PET1	reviewed	Protein FEV (Fifth Ewing variant protein) (PC12 ETS domain-containing transcription factor 1) (PC12 ETS factor 1) (Pet-1)	1	0	0	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	Ewing sarcoma
FGFR1	1	P11362	FGFR1 BFGFR CEK FGFBR FLG FLT2 HBGFR	reviewed	Fibroblast growth factor receptor 1 (FGFR-1) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1) (BFGFR) (bFGF-R-1) (Fms-like tyrosine kinase 2) (FLT-2) (N-sam) (Proto-oncogene c-Fgr) (CD antigen CD331)	1	0	0	1	1	1	0	2	1	1	1	0	0	0	0	0	0	0	0	1	0	0	0	1	0	0	0	0	1	1	0	0	MPN, NHL, salivary adenoma
FGFR1OP	1	O95684	CEP43 FGFR1OP FOP	reviewed	Centrosomal protein 43 (FGFR1 oncogene partner)	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	MPN, NHL
FGFR2	1	P21802	FGFR2 BEK KGFR KSAM	reviewed	Fibroblast growth factor receptor 2 (FGFR-2) (EC 2.7.10.1) (K-sam) (KGFR) (Keratinocyte growth factor receptor) (CD antigen CD332)	1	0	0	1	1	1	0	1	1	1	0	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	1	0	1	1	0	0	gastric, NSCLC, endometrial
FGFR3	1	P22607	FGFR3 JTK4	reviewed	Fibroblast growth factor receptor 3 (FGFR-3) (EC 2.7.10.1) (CD antigen CD333)	1	0	0	1	1	1	0	1	0	1	1	1	0	0	0	0	0	0	1	1	0	0	0	0	0	0	1	0	0	1	0	0	bladder, MM, T-cell lymphoma
FGFR4	1	P22455	FGFR4 JTK2 TKF	reviewed	Fibroblast growth factor receptor 4 (FGFR-4) (EC 2.7.10.1) (CD antigen CD334)	1	0	0	1	0	1	0	-	1	0	0	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	1	1	0	0	rhabdomyosarcoma
FH	1	P07954	FH	reviewed	Fumarate hydratase, mitochondrial (Fumarase) (HsFH) (EC 4.2.1.2)	0	1	1	0	0	0	1	-	0	0	0	1	0	1	1	0	0	0	1	0	1	0	0	0	0	0	0	0	0	0	0	0	leiomyomatosis, renal
FHIT	1	P49789	FHIT	reviewed	Bis(5'-adenosyl)-triphosphatase (EC 3.6.1.29) (AP3A hydrolase) (AP3Aase) (Adenosine 5'-monophosphoramidase FHIT) (EC 3.9.1.-) (Adenylylsulfatase) (EC 3.6.2.1) (Adenylylsulfate-ammonia adenylyltransferase) (EC 2.7.7.51) (Diadenosine 5',5'''-P1,P3-triphosphate hydrolase) (Dinucleosidetriphosphatase) (Fragile histidine triad protein)	1	0	1	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	1	0	0	0	pleomorphic salivary gland adenoma
FIP1L1	1	Q6UN15	FIP1L1 FIP1 RHE	reviewed	Pre-mRNA 3'-end-processing factor FIP1 (hFip1) (FIP1-like 1 protein) (Factor interacting with PAP) (Rearranged in hypereosinophilia)	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	idiopathic hypereosinophilic syndrome
FKBP9	2	O95302	FKBP9 FKBP60 FKBP63	reviewed	Peptidyl-prolyl cis-trans isomerase FKBP9 (PPIase FKBP9) (EC 5.2.1.8) (63 kDa FK506-binding protein) (63 kDa FKBP) (FKBP-63) (FK506-binding protein 9) (FKBP-9) (Rotamase)	1	0	0	0	0	0	0	-	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	glioma
FLCN	1	Q8NFG4	FLCN BHD	reviewed	Folliculin (BHD skin lesion fibrofolliculoma protein) (Birt-Hogg-Dube syndrome protein)	0	1	1	0	0	0	1	-	0	0	0	1	0	1	1	0	0	0	1	0	1	0	0	0	0	0	0	0	0	0	0	0	renal, fibrofolliculomas, trichodiscomas
FLI1	1	Q01543	FLI1	reviewed	Friend leukemia integration 1 transcription factor (Proto-oncogene Fli-1) (Transcription factor ERGB)	1	0	0	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	Ewing sarcoma
FLNA	2	P21333	FLNA FLN FLN1	reviewed	Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin)	1	0	0	0	0	0	0	-	0	0	0	1	0	0	1	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	phyllodes tumour of the breast
FLT3	1	P36888	FLT3 CD135 FLK2 STK1	reviewed	Receptor-type tyrosine-protein kinase FLT3 (EC 2.7.10.1) (FL cytokine receptor) (Fetal liver kinase-2) (FLK-2) (Fms-like tyrosine kinase 3) (FLT-3) (Stem cell tyrosine kinase 1) (STK-1) (CD antigen CD135)	1	0	0	1	0	1	0	1	1	0	0	1	0	0	0	0	0	1	0	1	0	0	0	0	0	0	1	0	0	1	1	0	AML, ALL
FLT4	1	P35916	FLT4 VEGFR3	reviewed	Vascular endothelial growth factor receptor 3 (VEGFR-3) (EC 2.7.10.1) (Fms-like tyrosine kinase 4) (FLT-4) (Tyrosine-protein kinase receptor FLT4)	1	0	0	1	0	1	0	-	0	0	0	0	0	0	0	0	1	0	0	0	1	0	0	0	0	0	1	0	1	1	0	0	soft tissue sarcoma
FNBP1	2	Q96RU3	FNBP1 FBP17 KIAA0554	reviewed	Formin-binding protein 1 (Formin-binding protein 17) (hFBP17)	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	AML
FOXA1	1	P55317	FOXA1 HNF3A TCF3A	reviewed	Hepatocyte nuclear factor 3-alpha (HNF-3-alpha) (HNF-3A) (Forkhead box protein A1) (Transcription factor 3A) (TCF-3A)	1	0	0	1	0	1	0	-	0	0	0	1	0	0	1	0	0	0	1	0	0	0	0	0	0	0	0	0	1	1	0	0	breast, prostate
FOXL2	1	P58012	FOXL2	reviewed	Forkhead box protein L2	1	0	1	1	0	1	0	-	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	1	1	1	1	1	1	granulosa-cell tumour of the ovary
FOXO1	1	Q12778	FOXO1 FKHR FOXO1A	reviewed	Forkhead box protein O1 (Forkhead box protein O1A) (Forkhead in rhabdomyosarcoma)	1	0	1	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	alveolar rhabdomyosarcoma
FOXO3	1	O43524	FOXO3 FKHRL1 FOXO3A	reviewed	Forkhead box protein O3 (AF6q21 protein) (Forkhead in rhabdomyosarcoma-like 1)	1	0	1	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	AL
FOXO4	1	P98177	FOXO4 AFX AFX1 MLLT7	reviewed	Forkhead box protein O4 (Fork head domain transcription factor AFX1)	1	0	1	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	AL, soft tissue sarcoma
FOXP1	1	Q9H334	FOXP1 HSPC215	reviewed	Forkhead box protein P1 (Mac-1-regulated forkhead) (MFH)	1	0	0	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	ALL
FOXR1	2	Q6PIV2	FOXR1 FOXN5 DLNB13	reviewed	Forkhead box protein R1 (Forkhead box protein N5)	1	0	0	1	1	0	0	-	0	1	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	neuroblastoma
FSTL3	1	O95633	FSTL3 FLRG UNQ674/PRO1308	reviewed	Follistatin-related protein 3 (Follistatin-like protein 3) (Follistatin-related gene protein)	1	0	0	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	B-CLL
FUBP1	1	Q96AE4	FUBP1	reviewed	Far upstream element-binding protein 1 (FBP) (FUSE-binding protein 1) (DNA helicase V) (hDH V)	1	0	0	1	0	0	1	-	0	0	0	0	0	1	1	0	0	0	0	0	0	1	0	0	0	0	1	0	1	1	0	0	oligodendroglioma
FUS	1	P35637	FUS TLS	reviewed	RNA-binding protein FUS (75 kDa DNA-pairing protein) (Oncogene FUS) (Oncogene TLS) (POMp75) (Translocated in liposarcoma protein)	1	0	1	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	1	0	1	0	liposarcoma, AML, Ewing sarcoma, angiomatoid fibrous histiocytoma, fibromyxoid sarcoma
GAS7	1	O60861	GAS7 KIAA0394	reviewed	Growth arrest-specific protein 7 (GAS-7)	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0	0	0	AML*
GATA1	1	P15976	GATA1 ERYF1 GF1	reviewed	Erythroid transcription factor (Eryf1) (GATA-binding factor 1) (GATA-1) (GF-1) (NF-E1 DNA-binding protein)	1	0	1	1	0	1	0	-	0	0	0	1	0	0	1	0	0	0	0	1	0	0	1	0	0	0	1	0	1	1	0	0	megakaryoblastic leukaemia of Downs syndrome
GATA2	1	P23769	GATA2	reviewed	Endothelial transcription factor GATA-2 (GATA-binding protein 2)	1	0	0	1	0	1	0	-	0	0	0	1	0	0	0	0	0	0	0	1	0	0	1	0	0	1	1	0	1	1	1	0	AML (CML blast transformation)
GATA3	1	P23771	GATA3	reviewed	Trans-acting T-cell-specific transcription factor GATA-3 (GATA-binding factor 3)	1	0	1	1	0	0	1	-	0	0	0	0	1	1	1	0	0	0	1	0	0	0	1	0	1	1	1	1	1	1	1	1	breast
GLI1	2	P08151	GLI1 GLI	reviewed	Zinc finger protein GLI1 (Glioma-associated oncogene) (Oncogene GLI)	1	0	0	1	1	0	0	-	0	1	1	0	0	0	1	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	CRC, oesophagus cancer
GMPS	2	P49915	GMPS	reviewed	GMP synthase [glutamine-hydrolyzing] (EC 6.3.5.2) (GMP synthetase) (Glutamine amidotransferase)	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	AML
GNA11	1	P29992	GNA11 GA11	reviewed	Guanine nucleotide-binding protein subunit alpha-11 (G alpha-11) (G-protein subunit alpha-11) (Guanine nucleotide-binding protein G(y) subunit alpha)	1	0	0	1	0	1	0	-	0	0	0	1	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	1	0	0	uveal melanoma, primary central nervous system melanocytic neoplasms
GNAQ	1	P50148	GNAQ GAQ	reviewed	Guanine nucleotide-binding protein G(q) subunit alpha (Guanine nucleotide-binding protein alpha-q)	1	0	0	1	0	1	0	-	0	0	0	1	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	1	0	0	uveal melanoma, primary central nervous system melanocytic neoplasms
GNAS	1	Q5JWF2	GNAS GNAS1	reviewed	Guanine nucleotide-binding protein G(s) subunit alpha isoforms XLas (Adenylate cyclase-stimulating G alpha protein) (Extra large alphas protein) (XLalphas)	1	0	0	1	0	1	0	-	0	0	0	1	0	0	0	0	0	0	1	0	1	0	0	0	0	0	0	0	0	1	1	0	pituitary adenoma, pancreatic intraductal papillary mucinous neoplasm, fibrous dysplasia
GOLGA5	1	Q8TBA6	GOLGA5 RETII RFG5 PIG31	reviewed	Golgin subfamily A member 5 (Cell proliferation-inducing gene 31 protein) (Golgin-84) (Protein Ret-II) (RET-fused gene 5 protein)	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	papillary thyroid, Spitzoid tumour
GOPC	1	Q9HD26	GOPC CAL FIG	reviewed	Golgi-associated PDZ and coiled-coil motif-containing protein (CFTR-associated ligand) (Fused in glioblastoma) (PDZ protein interacting specifically with TC10) (PIST)	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	glioblastoma, cholangiocarcinoma, borderline ovarian
GPC3	1	P51654	GPC3 OCI5	reviewed	"Glypican-3 (GTR2-2) (Intestinal protein OCI-5) (MXR7) [Cleaved into: Glypican-3 alpha subunit; Glypican-3 beta subunit]"	0	1	1	1	0	0	1	-	0	0	0	1	1	1	1	1	0	0	0	0	0	1	0	0	0	0	0	0	1	0	1	0	Wilms tumour
GPC5	2	P78333	GPC5	reviewed	Glypican-5 [Cleaved into: Secreted glypican-5]	1	0	1	0	0	0	0	-	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	lung adenocarcinoma
GPHN	1	Q9NQX3	GPHN GPH KIAA1385	reviewed	"Gephyrin [Includes: Molybdopterin adenylyltransferase (MPT adenylyltransferase) (EC 2.7.7.75) (Domain G); Molybdopterin molybdenumtransferase (MPT Mo-transferase) (EC 2.10.1.1) (Domain E)]"	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	AL
GRIN2A	1	Q12879	GRIN2A NMDAR2A	reviewed	Glutamate receptor ionotropic, NMDA 2A (GluN2A) (Glutamate [NMDA] receptor subunit epsilon-1) (N-methyl D-aspartate receptor subtype 2A) (NMDAR2A) (NR2A) (hNR2A)	1	0	1	0	0	0	1	-	0	0	0	1	0	1	1	0	0	1	1	0	0	0	0	0	0	0	0	0	1	1	1	0	melanoma, colorectal carcinoma, gastric carcinoma, lung carcinoma
GRM3	2	Q14832	GRM3 GPRC1C MGLUR3	reviewed	Metabotropic glutamate receptor 3 (mGluR3)	1	0	0	1	0	0	0	-	0	0	0	1	0	0	0	0	1	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	melanoma, oral SCC
H3F3A	1	P84243	"H3-3A H3.3A H3F3 H3F3A PP781; H3-3B H3.3B H3F3B"	reviewed	Histone H3.3	1	0	0	1	0	1	0	-	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	glioma
H3F3B	1	P84243	"H3-3A H3.3A H3F3 H3F3A PP781; H3-3B H3.3B H3F3B"	reviewed	Histone H3.3	1	0	0	1	0	1	0	-	0	0	0	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	chondroblastoma
HERPUD1	1	Q15011	HERPUD1 HERP KIAA0025 MIF1	reviewed	Homocysteine-responsive endoplasmic reticulum-resident ubiquitin-like domain member 1 protein (Methyl methanesulfonate (MMF)-inducible fragment protein 1)	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	prostate
HEY1	1	Q9Y5J3	HEY1 BHLHB31 CHF2 HERP2 HESR1 HRT1	reviewed	Hairy/enhancer-of-split related with YRPW motif protein 1 (Cardiovascular helix-loop-helix factor 2) (CHF-2) (Class B basic helix-loop-helix protein 31) (bHLHb31) (HES-related repressor protein 1) (Hairy and enhancer of split-related protein 1) (HESR-1) (Hairy-related transcription factor 1) (HRT-1) (hHRT1)	1	0	0	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	1	0	0	mesenchymal chondrosarcoma
HIF1A	1	Q16665	HIF1A BHLHE78 MOP1 PASD8	reviewed	Hypoxia-inducible factor 1-alpha (HIF-1-alpha) (HIF1-alpha) (ARNT-interacting protein) (Basic-helix-loop-helix-PAS protein MOP1) (Class E basic helix-loop-helix protein 78) (bHLHe78) (Member of PAS protein 1) (PAS domain-containing protein 8)	1	0	0	1	0	1	0	-	0	0	0	1	0	1	1	0	0	0	1	0	0	1	1	0	1	1	1	0	1	0	0	0	endometrioid carcinoma, glioblastoma, colorectal, renal, lung, pancreatic
HIP1	1	O00291	HIP1	reviewed	Huntingtin-interacting protein 1 (HIP-1) (Huntingtin-interacting protein I) (HIP-I)	1	0	0	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	1	0	0	0	0	0	CMML, NSCLC
HIST1H3B	1	P68431	"H3C1 H3FA HIST1H3A; H3C2 H3FL HIST1H3B; H3C3 H3FC HIST1H3C; H3C4 H3FB HIST1H3D; H3C6 H3FD HIST1H3E; H3C7 H3FI HIST1H3F; H3C8 H3FH HIST1H3G; H3C10 H3FK HIST1H3H; H3C11 H3FF HIST1H3I; H3C12 H3FJ HIST1H3J"	reviewed	Histone H3.1 (Histone H3/a) (Histone H3/b) (Histone H3/c) (Histone H3/d) (Histone H3/f) (Histone H3/h) (Histone H3/i) (Histone H3/j) (Histone H3/k) (Histone H3/l)	1	0	0	1	0	1	0	-	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	glioma
HIST1H4I	1	P62805	"H4C1 H4/A H4FA HIST1H4A; H4C2 H4/I H4FI HIST1H4B; H4C3 H4/G H4FG HIST1H4C; H4C4 H4/B H4FB HIST1H4D; H4C5 H4/J H4FJ HIST1H4E; H4C6 H4/C H4FC HIST1H4F; H4C8 H4/H H4FH HIST1H4H; H4C9 H4/M H4FM HIST1H4I; H4C11 H4/E H4FE HIST1H4J; H4C12 H4/D H4FD HIST1H4K; H4C13 H4/K H4FK HIST1H4L; H4C14 H4/N H4F2 H4FN HIST2H4 HIST2H4A; H4C15 H4/O H4FO HIST2H4B; H4-16 HIST4H4"	reviewed	Histone H4	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	NHL
HLA-A	1	P04439	HLA-A HLAA	reviewed	HLA class I histocompatibility antigen, A alpha chain (Human leukocyte antigen A) (HLA-A)	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	Spitzoid tumour
HLF	1	Q16534	HLF	reviewed	Hepatic leukemia factor	1	0	0	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	ALL
HMGA1	1	P17096	HMGA1 HMGIY	reviewed	High mobility group protein HMG-I/HMG-Y (HMG-I(Y)) (High mobility group AT-hook protein 1) (High mobility group protein A1) (High mobility group protein R)	1	0	0	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	1	0	1	0	0	0	0	0	0	0	0	0	0	0	microfollicular thyroid adenoma, various benign mesenchymal tumours
HMGA2	1	P52926	HMGA2 HMGIC	reviewed	High mobility group protein HMGI-C (High mobility group AT-hook protein 2)	1	0	0	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	lipoma, leiomyoma, pleomorphic salivary gland adenoma
HNF1A	1	P20823	HNF1A	reviewed	Hepatocyte nuclear factor 1-alpha	1	1	1	0	0	0	1	-	0	0	0	1	0	0	1	0	0	0	1	0	0	0	0	0	0	0	1	0	1	0	1	0	hepatic adenoma, hepatocellular, hepatic adenoma, hepatocellular carcinoma
HNRNPA2B1	1	P22626	HNRNPA2B1 HNRPA2B1	reviewed	Heterogeneous nuclear ribonucleoproteins A2/B1 (hnRNP A2/B1)	1	0	0	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	1	0	1	1	0	1	prostate
HOOK3	1	Q86VS8	HOOK3	reviewed	Protein Hook homolog 3 (h-hook3) (hHK3)	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	papillary thyroid
HOXA11	1	P31270	HOXA11 HOX1I	reviewed	Homeobox protein Hox-A11 (Homeobox protein Hox-1I)	1	0	1	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	1	0	1	1	1	0	CML
HOXA13	1	P31271	HOXA13	reviewed	Homeobox protein Hox-A13	1	0	0	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	AML
HOXA9	1	P31269	HOXA9 HOX1G	reviewed	Homeobox protein Hox-A9 (Homeobox protein Hox-1G)	1	0	1	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	AML*
HOXC11	1	O43248	HOXC11 HOX3H	reviewed	Homeobox protein Hox-C11 (Homeobox protein Hox-3H)	1	0	0	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	AML
HOXC13	1	P31276	HOXC13 HOX3G	reviewed	Homeobox protein Hox-C13 (Homeobox protein Hox-3G)	1	0	0	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	AML
HOXD11	1	P31277	HOXD11 HOX4F	reviewed	Homeobox protein Hox-D11 (Homeobox protein Hox-4F)	1	0	0	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	AML
HOXD13	1	P35453	HOXD13 HOX4I	reviewed	Homeobox protein Hox-D13 (Homeobox protein Hox-4I)	1	0	0	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	AML*
HRAS	1	P01112	HRAS HRAS1	reviewed	GTPase HRas (EC 3.6.5.2) (H-Ras-1) (Ha-Ras) (Transforming protein p21) (c-H-ras) (p21ras) [Cleaved into: GTPase HRas, N-terminally processed]	1	1	0	1	0	1	0	-	0	0	0	1	0	0	0	0	0	0	1	1	1	0	1	0	0	1	1	1	1	1	0	1	infrequent sarcomas, rare other tumour types, rhabdomyosarcoma, ganglioneuroblastoma, bladder
HSP90AA1	1	P07900	HSP90AA1 HSP90A HSPC1 HSPCA	reviewed	Heat shock protein HSP 90-alpha (EC 3.6.4.10) (Heat shock 86 kDa) (HSP 86) (HSP86) (Lipopolysaccharide-associated protein 2) (LAP-2) (LPS-associated protein 2) (Renal carcinoma antigen NY-REN-38)	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	NHL
HSP90AB1	1	P08238	HSP90AB1 HSP90B HSPC2 HSPCB	reviewed	Heat shock protein HSP 90-beta (HSP 90) (Heat shock 84 kDa) (HSP 84) (HSP84)	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	NHL
ID3	2	Q02535	ID3 1R21 BHLHB25 HEIR1	reviewed	DNA-binding protein inhibitor ID-3 (Class B basic helix-loop-helix protein 25) (bHLHb25) (Helix-loop-helix protein HEIR-1) (ID-like protein inhibitor HLH 1R21) (Inhibitor of DNA binding 3) (Inhibitor of differentiation 3)	1	0	1	0	0	0	0	-	0	0	0	1	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	Burkitt lymphoma
IDH1	1	O75874	IDH1 PICD	reviewed	Isocitrate dehydrogenase [NADP] cytoplasmic (IDH) (EC 1.1.1.42) (Cytosolic NADP-isocitrate dehydrogenase) (IDP) (NADP(+)-specific ICDH) (Oxalosuccinate decarboxylase)	1	0	0	1	0	1	0	1	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	glioblastoma
IDH2	1	P48735	IDH2	reviewed	Isocitrate dehydrogenase [NADP], mitochondrial (IDH) (EC 1.1.1.42) (ICD-M) (IDP) (NADP(+)-specific ICDH) (Oxalosuccinate decarboxylase)	1	0	0	1	0	1	0	1	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	glioblastoma
IGF2BP2	2	Q9Y6M1	IGF2BP2 IMP2 VICKZ2	reviewed	Insulin-like growth factor 2 mRNA-binding protein 2 (IGF2 mRNA-binding protein 2) (IMP-2) (Hepatocellular carcinoma autoantigen p62) (IGF-II mRNA-binding protein 2) (VICKZ family member 2)	1	0	1	0	0	0	0	-	0	0	0	0	0	0	0	1	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	lymphoma
IKBKB	1	O14920	IKBKB IKKB	reviewed	Inhibitor of nuclear factor kappa-B kinase subunit beta (I-kappa-B-kinase beta) (IKK-B) (IKK-beta) (IkBKB) (EC 2.7.11.10) (I-kappa-B kinase 2) (IKK2) (Nuclear factor NF-kappa-B inhibitor kinase beta) (NFKBIKB) (Serine/threonine protein kinase IKBKB) (EC 2.7.11.1)	1	0	0	1	0	1	0	-	0	0	0	1	0	0	0	0	0	0	0	1	0	0	1	0	0	1	1	0	1	1	0	1	SMZL
IKZF1	1	Q13422	IKZF1 IK1 IKAROS LYF1 ZNFN1A1	reviewed	DNA-binding protein Ikaros (Ikaros family zinc finger protein 1) (Lymphoid transcription factor LyF-1)	1	0	1	0	1	1	1	-	0	1	1	0	0	0	0	1	0	0	0	1	0	0	0	0	1	1	1	1	1	0	1	1	ALL, DLBCL
IKZF3	1	Q9UKT9	IKZF3 ZNFN1A3	reviewed	Zinc finger protein Aiolos (Ikaros family zinc finger protein 3)	1	0	1	1	0	0	0	-	0	0	0	1	0	1	1	1	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	B-ALL, CLL
IL2	1	P60568	IL2	reviewed	Interleukin-2 (IL-2) (T-cell growth factor) (TCGF) (Aldesleukin)	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	intestinal T-cell lymphoma
IL21R	1	Q9HBE5	IL21R NILR UNQ3121/PRO10273	reviewed	Interleukin-21 receptor (IL-21 receptor) (IL-21R) (Novel interleukin receptor) (CD antigen CD360)	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	NHL
IL6ST	1	P40189	IL6ST	reviewed	Interleukin-6 receptor subunit beta (IL-6 receptor subunit beta) (IL-6R subunit beta) (IL-6R-beta) (IL-6RB) (CDw130) (Interleukin-6 signal transducer) (Membrane glycoprotein 130) (gp130) (Oncostatin-M receptor subunit alpha) (CD antigen CD130)	1	0	0	1	0	1	0	-	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	1	0	1	hepatocellular carcinoma
IL7R	1	P16871	IL7R	reviewed	Interleukin-7 receptor subunit alpha (IL-7 receptor subunit alpha) (IL-7R subunit alpha) (IL-7R-alpha) (IL-7RA) (CDw127) (CD antigen CD127)	1	0	0	1	0	1	0	-	0	0	0	1	0	0	0	0	0	1	0	1	0	0	0	0	0	1	1	0	1	1	0	1	ALL, ETP ALL
IRF4	1	Q15306	IRF4 MUM1	reviewed	Interferon regulatory factor 4 (IRF-4) (Lymphocyte-specific interferon regulatory factor) (LSIRF) (Multiple myeloma oncogene 1) (NF-EM5)	1	0	1	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	MM
IRS4	1	O14654	IRS4	reviewed	Insulin receptor substrate 4 (IRS-4) (160 kDa phosphotyrosine protein) (py160) (Phosphoprotein of 160 kDa) (pp160)	1	0	1	1	0	0	0	-	0	0	1	1	0	0	1	0	0	0	1	1	1	1	0	0	1	1	1	0	1	1	0	0	glioma, rhabdomyosarcoma, melanoma, breast cancer, T-ALL
ISX	2	Q2M1V0	ISX RAXLX	reviewed	Intestine-specific homeobox (RAX-like homeobox)	1	0	0	0	0	0	0	-	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	melanoma
ITGAV	2	P06756	ITGAV MSK8 VNRA VTNR	reviewed	"Integrin alpha-V (Vitronectin receptor) (Vitronectin receptor subunit alpha) (CD antigen CD51) [Cleaved into: Integrin alpha-V heavy chain; Integrin alpha-V light chain]"	1	0	0	0	0	0	0	-	0	0	0	0	0	0	1	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	large intestine carcinoma
ITK	1	Q08881	ITK EMT LYK	reviewed	Tyrosine-protein kinase ITK/TSK (EC 2.7.10.2) (Interleukin-2-inducible T-cell kinase) (IL-2-inducible T-cell kinase) (Kinase EMT) (T-cell-specific kinase) (Tyrosine-protein kinase Lyk)	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	peripheral T-cell lymphoma
JAK1	1	P23458	JAK1 JAK1A JAK1B	reviewed	Tyrosine-protein kinase JAK1 (EC 2.7.10.2) (Janus kinase 1) (JAK-1)	1	0	1	1	0	1	0	-	1	0	0	1	0	0	0	0	0	0	0	1	0	0	0	0	0	1	1	0	0	1	0	0	ALL
JAK2	1	O60674	JAK2	reviewed	Tyrosine-protein kinase JAK2 (EC 2.7.10.2) (Janus kinase 2) (JAK-2)	1	0	0	1	1	1	0	2	1	1	1	1	0	0	0	0	0	1	0	1	0	0	0	0	1	0	1	0	0	1	0	1	ALL, AML, MPN,  CML
JAK3	1	P52333	JAK3	reviewed	Tyrosine-protein kinase JAK3 (EC 2.7.10.2) (Janus kinase 3) (JAK-3) (Leukocyte janus kinase) (L-JAK)	1	0	0	1	0	1	0	-	0	0	0	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	acute megakaryocytic leukaemia, ETP ALL
JAZF1	2	Q86VZ6	JAZF1 TIP27 ZNF802	reviewed	Juxtaposed with another zinc finger protein 1 (TAK1-interacting protein 27) (Zinc finger protein 802)	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	endometrial stromal tumour
JUN	1	P05412	JUN	reviewed	Transcription factor Jun (Activator protein 1) (AP1) (Proto-oncogene c-Jun) (Transcription factor AP-1 subunit Jun) (V-jun avian sarcoma virus 17 oncogene homolog) (p39)	1	0	0	1	0	1	0	-	0	0	0	0	0	0	0	0	1	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	sarcoma
KAT6A	1	Q92794	KAT6A MOZ MYST3 RUNXBP2 ZNF220	reviewed	Histone acetyltransferase KAT6A (EC 2.3.1.48) (MOZ, YBF2/SAS3, SAS2 and TIP60 protein 3) (MYST-3) (Monocytic leukemia zinc finger protein) (Runt-related transcription factor-binding protein 2) (Zinc finger protein 220)	1	0	0	1	1	1	0	-	0	1	1	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	AML
KAT6B	1	Q8WYB5	KAT6B KIAA0383 MORF MOZ2 MYST4	reviewed	Histone acetyltransferase KAT6B (EC 2.3.1.48) (Histone acetyltransferase MOZ2) (MOZ, YBF2/SAS3, SAS2 and TIP60 protein 4) (MYST-4) (Monocytic leukemia zinc finger protein-related factor)	1	0	1	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	AML, leiomyoma
KAT7	2	O95251	KAT7 HBO1 HBOa MYST2	reviewed	Histone acetyltransferase KAT7 (EC 2.3.1.48) (Histone acetyltransferase binding to ORC1) (Lysine acetyltransferase 7) (MOZ, YBF2/SAS3, SAS2 and TIP60 protein 2) (MYST-2)	1	0	0	1	0	0	0	-	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	CCRCC
KCNJ5	1	P48544	KCNJ5 GIRK4	reviewed	G protein-activated inward rectifier potassium channel 4 (GIRK-4) (Cardiac inward rectifier) (CIR) (Heart KATP channel) (Inward rectifier K(+) channel Kir3.4) (IRK-4) (KATP-1) (Potassium channel, inwardly rectifying subfamily J member 5)	1	0	0	1	0	1	0	-	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	adrenal adenoma
KDM5A	1	P29375	KDM5A JARID1A RBBP2 RBP2	reviewed	Lysine-specific demethylase 5A (EC 1.14.11.67) (Histone demethylase JARID1A) (Jumonji/ARID domain-containing protein 1A) (Retinoblastoma-binding protein 2) (RBBP-2) ([histone H3]-trimethyl-L-lysine(4) demethylase 5A)	1	0	0	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	AML
KDM5C	1	P41229	KDM5C DXS1272E JARID1C SMCX XE169	reviewed	Lysine-specific demethylase 5C (EC 1.14.11.67) (Histone demethylase JARID1C) (Jumonji/ARID domain-containing protein 1C) (Protein SmcX) (Protein Xe169) ([histone H3]-trimethyl-L-lysine(4) demethylase 5C)	1	0	1	0	0	0	1	-	0	0	0	1	1	1	1	0	0	0	1	0	0	0	0	0	0	1	1	1	1	1	1	0	clear cell renal carcinoma
KDM6A	1	O15550	KDM6A UTX	reviewed	Lysine-specific demethylase 6A (EC 1.14.11.68) (Histone demethylase UTX) (Ubiquitously-transcribed TPR protein on the X chromosome) (Ubiquitously-transcribed X chromosome tetratricopeptide repeat protein) ([histone H3]-trimethyl-L-lysine(27) demethylase 6A)	1	0	1	1	0	0	1	-	0	0	0	0	1	1	1	1	0	0	1	1	0	0	0	0	0	0	0	0	1	1	0	0	renal cell carcinoma, bladder carcinoma, oesophageal SCC, MM, medulloblastoma, T-ALL, other tumour types
KDR	1	P35968	KDR FLK1 VEGFR2	reviewed	Vascular endothelial growth factor receptor 2 (VEGFR-2) (EC 2.7.10.1) (Fetal liver kinase 1) (FLK-1) (Kinase insert domain receptor) (KDR) (Protein-tyrosine kinase receptor flk-1) (CD antigen CD309)	1	1	0	1	0	1	0	-	1	0	0	1	0	0	0	0	0	0	1	0	0	0	1	1	0	0	0	0	1	1	0	1	NSCLC, angiosarcoma, melanoma
KDSR	1	Q06136	KDSR FVT1 SDR35C1	reviewed	3-ketodihydrosphingosine reductase (KDS reductase) (EC 1.1.1.102) (3-dehydrosphinganine reductase) (Follicular variant translocation protein 1) (FVT-1) (Short chain dehydrogenase/reductase family 35C member 1)	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	B-NHL
KEAP1	1	Q14145	KEAP1 INRF2 KIAA0132 KLHL19	reviewed	Kelch-like ECH-associated protein 1 (Cytosolic inhibitor of Nrf2) (INrf2) (Kelch-like protein 19)	1	0	1	0	0	0	0	-	0	0	0	1	0	1	1	0	0	0	1	0	0	0	0	0	0	0	1	0	0	0	0	0	NSCLC, breast carcinoma
KIAA1549	2	Q9HCM3	KIAA1549	reviewed	UPF0606 protein KIAA1549	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	pilocytic astrocytoma
KIF5B	1	P33176	KIF5B KNS KNS1	reviewed	Kinesin-1 heavy chain (Conventional kinesin heavy chain) (Ubiquitous kinesin heavy chain) (UKHC)	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	NSCLC, Spitzoid tumour
KIT	1	P10721	KIT SCFR	reviewed	Mast/stem cell growth factor receptor Kit (SCFR) (EC 2.7.10.1) (Piebald trait protein) (PBT) (Proto-oncogene c-Kit) (Tyrosine-protein kinase Kit) (p145 c-kit) (v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog) (CD antigen CD117)	1	1	0	1	0	1	0	1	1	0	0	1	0	0	0	0	0	1	1	1	1	1	0	0	0	0	1	0	1	1	0	0	GIST, AML, TGCT, mastocytosis, mucosal melanoma, GIST, epithelioma
KLF4	1	O43474	KLF4 EZF GKLF	reviewed	Krueppel-like factor 4 (Epithelial zinc finger protein EZF) (Gut-enriched krueppel-like factor)	1	0	1	1	0	1	0	-	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	1	0	0	1	0	1	1	1	0	meningioma
KLF6	1	Q99612	KLF6 BCD1 COPEB CPBP ST12	reviewed	Krueppel-like factor 6 (B-cell-derived protein 1) (Core promoter element-binding protein) (GC-rich sites-binding factor GBF) (Proto-oncogene BCD1) (Suppressor of tumorigenicity 12 protein) (Transcription factor Zf9)	1	0	1	0	0	0	1	-	0	0	0	1	0	1	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	prostate, glioma
KLK2	1	P20151	KLK2	reviewed	Kallikrein-2 (EC 3.4.21.35) (Glandular kallikrein-1) (hGK-1) (Tissue kallikrein-2)	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	prostate
KMT2A	1	Q03164	KMT2A ALL1 CXXC7 HRX HTRX MLL MLL1 TRX1	reviewed	"Histone-lysine N-methyltransferase 2A (Lysine N-methyltransferase 2A) (EC 2.1.1.364) (ALL-1) (CXXC-type zinc finger protein 7) (Cysteine methyltransferase KMT2A) (EC 2.1.1.-) (Myeloid/lymphoid or mixed-lineage leukemia) (Myeloid/lymphoid or mixed-lineage leukemia protein 1) (Trithorax-like protein) (Zinc finger protein HRX) [Cleaved into: MLL cleavage product N320 (N-terminal cleavage product of 320 kDa) (p320); MLL cleavage product C180 (C-terminal cleavage product of 180 kDa) (p180)]"	1	0	0	1	1	1	0	-	0	1	1	0	0	0	0	0	0	1	0	1	0	0	1	1	0	1	1	0	1	1	0	1	AML, ALL
KMT2C	1	Q8NEZ4	KMT2C HALR KIAA1506 MLL3	reviewed	Histone-lysine N-methyltransferase 2C (Lysine N-methyltransferase 2C) (EC 2.1.1.364) (Homologous to ALR protein) (Myeloid/lymphoid or mixed-lineage leukemia protein 3)	1	0	1	0	0	0	1	-	0	0	0	0	0	1	0	0	0	0	0	0	0	1	0	1	0	0	0	1	1	1	1	0	medulloblastoma
KMT2D	1	O14686	KMT2D ALR MLL2 MLL4	reviewed	Histone-lysine N-methyltransferase 2D (Lysine N-methyltransferase 2D) (EC 2.1.1.364) (ALL1-related protein) (Myeloid/lymphoid or mixed-lineage leukemia protein 2)	1	0	1	1	0	0	1	-	0	0	0	1	0	1	1	0	0	0	1	0	0	1	0	1	1	0	0	0	1	1	0	0	medulloblastoma, renal
KNL1	1	Q8NG31	KNL1 CASC5 KIAA1570	reviewed	Kinetochore scaffold 1 (ALL1-fused gene from chromosome 15q14 protein) (AF15q14) (Bub-linking kinetochore protein) (Blinkin) (Cancer susceptibility candidate gene 5 protein) (Cancer/testis antigen 29) (CT29) (Kinetochore-null protein 1) (Protein CASC5) (Protein D40/AF15q14)	1	0	1	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	1	1	0	0	0	0	AML
KNSTRN	2	Q9Y448	KNSTRN C15orf23 SKAP TRAF4AF1 HSD11	reviewed	Small kinetochore-associated protein (SKAP) (Kinetochore-localized astrin-binding protein) (Kinastrin) (Kinetochore-localized astrin/SPAG5-binding protein) (TRAF4-associated factor 1)	1	0	0	1	0	0	0	-	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	SCC
KRAS	1	P01116	KRAS KRAS2 RASK2	reviewed	GTPase KRas (EC 3.6.5.2) (K-Ras 2) (Ki-Ras) (c-K-ras) (c-Ki-ras) [Cleaved into: GTPase KRas, N-terminally processed]	1	0	0	1	0	1	0	1	1	0	0	1	0	0	0	0	0	0	1	1	1	1	1	1	1	0	1	0	1	1	0	1	pancreatic, colorectal, lung, thyroid, AML, other tumour types
KTN1	1	Q86UP2	KTN1 CG1 KIAA0004	reviewed	Kinectin (CG-1 antigen) (Kinesin receptor)	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	papillary thyroid
LARP4B	2	Q92615	LARP4B KIAA0217 LARP5	reviewed	La-related protein 4B (La ribonucleoprotein domain family member 4B) (La ribonucleoprotein domain family member 5) (La-related protein 5)	1	0	1	0	0	0	0	-	0	0	0	0	0	0	1	1	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	CRC, glioma
LASP1	1	Q14847	LASP1 MLN50	reviewed	LIM and SH3 domain protein 1 (LASP-1) (Metastatic lymph node gene 50 protein) (MLN 50)	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	AML
LATS1	1	O95835	LATS1 WARTS	reviewed	Serine/threonine-protein kinase LATS1 (EC 2.7.11.1) (Large tumor suppressor homolog 1) (WARTS protein kinase) (h-warts)	1	0	1	0	0	0	0	-	0	0	0	1	0	1	0	0	0	0	1	0	0	0	0	0	0	0	1	1	0	0	1	0	skin basal cell carcinoma
LATS2	1	Q9NRM7	LATS2 KPM	reviewed	Serine/threonine-protein kinase LATS2 (EC 2.7.11.1) (Kinase phosphorylated during mitosis protein) (Large tumor suppressor homolog 2) (Serine/threonine-protein kinase kpm) (Warts-like kinase)	1	0	1	0	0	0	0	-	0	0	0	0	0	1	1	1	0	0	1	0	0	0	0	0	0	0	1	1	1	0	1	0	malignant mesothelioma
LCK	1	P06239	LCK	reviewed	Tyrosine-protein kinase Lck (EC 2.7.10.2) (Leukocyte C-terminal Src kinase) (LSK) (Lymphocyte cell-specific protein-tyrosine kinase) (Protein YT16) (Proto-oncogene Lck) (T cell-specific protein-tyrosine kinase) (p56-LCK)	1	0	0	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	1	0	0	1	0	0	T-ALL
LCP1	2	P13796	LCP1 PLS2	reviewed	Plastin-2 (L-plastin) (LC64P) (Lymphocyte cytosolic protein 1) (LCP-1)	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	NHL
LEF1	1	Q9UJU2	LEF1	reviewed	Lymphoid enhancer-binding factor 1 (LEF-1) (T cell-specific transcription factor 1-alpha) (TCF1-alpha)	1	0	1	1	0	0	0	-	0	0	0	1	0	1	0	0	0	0	1	1	0	0	0	0	0	0	0	0	1	1	0	0	B-ALL, T-ALL, eyelid sebaceous carcinoma, AML, lymphomas
LEPROTL1	2	O95214	LEPROTL1 My047 UNQ577/PRO1139	reviewed	Leptin receptor overlapping transcript-like 1 (Endospanin-2)	1	0	1	0	0	0	0	-	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	lung cancer, colon cancer
LHFPL6	2	Q9Y693	LHFPL6 LHFP	reviewed	LHFPL tetraspan subfamily member 6 protein (Lipoma HMGIC fusion partner)	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	lipoma
LIFR	1	P42702	LIFR	reviewed	Leukemia inhibitory factor receptor (LIF receptor) (LIF-R) (CD antigen CD118)	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	salivary adenoma
LMNA	1	P02545	LMNA LMN1	reviewed	Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)]	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0	0	0	0	Spitzoid tumour
LMO1	1	P25800	LMO1 RBTN1 RHOM1 TTG1	reviewed	Rhombotin-1 (Cysteine-rich protein TTG-1) (LIM domain only protein 1) (LMO-1) (T-cell translocation protein 1)	1	1	0	1	1	1	0	-	0	1	1	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	T-ALL, neuroblastoma, neuroblastoma
LMO2	1	P25791	LMO2 RBTN2 RBTNL1 RHOM2 TTG2	reviewed	Rhombotin-2 (Cysteine-rich protein TTG-2) (LIM domain only protein 2) (LMO-2) (T-cell translocation protein 2)	1	0	0	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	T-ALL
LPP	1	Q93052	LPP	reviewed	Lipoma-preferred partner (LIM domain-containing preferred translocation partner in lipoma)	1	0	0	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	lipoma, leukaemia
LRIG3	1	Q6UXM1	LRIG3 LIG3 UNQ287/PRO326/PRO335	reviewed	Leucine-rich repeats and immunoglobulin-like domains protein 3 (LIG-3)	1	0	1	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	NSCLC
LRP1B	1	Q9NZR2	LRP1B LRPDIT	reviewed	Low-density lipoprotein receptor-related protein 1B (LRP-1B) (Low-density lipoprotein receptor-related protein-deleted in tumor) (LRP-DIT)	1	0	1	0	0	0	1	-	1	0	0	1	0	1	1	1	0	0	1	1	0	0	0	0	0	0	0	0	1	0	1	0	CLL, ovarian cancer, oesophageal squamous cell carcinoma, urothelial cancer
LSM14A	2	Q8ND56	LSM14A C19orf13 FAM61A RAP55 RAP55A	reviewed	Protein LSM14 homolog A (Protein FAM61A) (Protein SCD6 homolog) (Putative alpha-synuclein-binding protein) (AlphaSNBP) (RNA-associated protein 55A) (hRAP55) (hRAP55A)	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	Spitzoid tumour
LYL1	1	P12980	LYL1 BHLHA18	reviewed	Protein lyl-1 (Class A basic helix-loop-helix protein 18) (bHLHa18) (Lymphoblastic leukemia-derived sequence 1)	1	0	0	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	T-ALL
LYN	2	P07948	LYN JTK8	reviewed	Tyrosine-protein kinase Lyn (EC 2.7.10.2) (Lck/Yes-related novel protein tyrosine kinase) (V-yes-1 Yamaguchi sarcoma viral related oncogene homolog) (p53Lyn) (p56Lyn)	1	0	0	1	1	0	0	-	0	1	1	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	DLBCL, B-ALL, MPN
LZTR1	1	Q8N653	LZTR1 TCFL2	reviewed	Leucine-zipper-like transcriptional regulator 1 (LZTR-1)	1	1	1	0	0	1	0	-	0	0	0	1	0	1	1	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	glioblastoma, glioblastoma, schwannoma
MACC1	2	Q6ZN28	MACC1	reviewed	Metastasis-associated in colon cancer protein 1 (SH3 domain-containing protein 7a5)	1	0	0	1	0	0	0	-	0	0	0	1	0	0	0	0	0	0	1	0	0	0	1	0	0	0	1	0	1	0	0	0	liver, CRC
MAF	1	O75444	MAF	reviewed	Transcription factor Maf (Proto-oncogene c-Maf) (V-maf musculoaponeurotic fibrosarcoma oncogene homolog)	1	0	0	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	MM
MAFB	1	Q9Y5Q3	MAFB KRML	reviewed	Transcription factor MafB (Maf-B) (V-maf musculoaponeurotic fibrosarcoma oncogene homolog B)	1	0	0	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	MM
MALT1	1	Q9UDY8	MALT1 MLT	reviewed	Mucosa-associated lymphoid tissue lymphoma translocation protein 1 (EC 3.4.22.-) (MALT lymphoma-associated translocation) (Paracaspase)	1	0	0	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	MALT
MAML2	1	Q8IZL2	MAML2 KIAA1819	reviewed	Mastermind-like protein 2 (Mam-2)	1	0	0	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	salivary gland mucoepidermoid
MAP2K1	1	Q02750	MAP2K1 MEK1 PRKMK1	reviewed	Dual specificity mitogen-activated protein kinase kinase 1 (MAP kinase kinase 1) (MAPKK 1) (MKK1) (EC 2.7.12.2) (ERK activator kinase 1) (MAPK/ERK kinase 1) (MEK 1)	1	0	0	1	0	1	0	2	1	0	0	1	0	0	0	0	0	0	1	0	0	0	1	0	1	0	1	1	1	1	0	1	NSCLC, melanoma, colorectal
MAP2K2	1	P36507	MAP2K2 MEK2 MKK2 PRKMK2	reviewed	Dual specificity mitogen-activated protein kinase kinase 2 (MAP kinase kinase 2) (MAPKK 2) (EC 2.7.12.2) (ERK activator kinase 2) (MAPK/ERK kinase 2) (MEK 2)	1	0	0	1	0	1	0	2	1	0	0	1	0	0	0	0	0	0	1	0	0	0	1	0	1	0	1	0	1	1	0	1	NSCLC, melanoma
MAP2K4	1	P45985	MAP2K4 JNKK1 MEK4 MKK4 PRKMK4 SEK1 SERK1 SKK1	reviewed	Dual specificity mitogen-activated protein kinase kinase 4 (MAP kinase kinase 4) (MAPKK 4) (EC 2.7.12.2) (JNK-activating kinase 1) (MAPK/ERK kinase 4) (MEK 4) (SAPK/ERK kinase 1) (SEK1) (Stress-activated protein kinase kinase 1) (SAPK kinase 1) (SAPKK-1) (SAPKK1) (c-Jun N-terminal kinase kinase 1) (JNKK)	1	0	1	1	0	0	1	-	0	0	0	1	0	1	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	pancreatic, breast, colorectal
MAP3K1	1	Q13233	MAP3K1 MAPKKK1 MEKK MEKK1	reviewed	Mitogen-activated protein kinase kinase kinase 1 (EC 2.7.11.25) (MAPK/ERK kinase kinase 1) (MEK kinase 1) (MEKK 1)	1	0	1	1	0	0	1	-	0	0	0	1	1	1	1	0	0	1	1	0	0	0	0	0	0	0	1	0	1	1	0	0	luminal A breast
MAP3K13	1	O43283	MAP3K13 LZK	reviewed	Mitogen-activated protein kinase kinase kinase 13 (EC 2.7.11.25) (Leucine zipper-bearing kinase) (Mixed lineage kinase) (MLK)	1	0	1	1	0	0	1	-	0	0	0	0	0	0	1	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	breast
MAPK1	1	P28482	MAPK1 ERK2 PRKM1 PRKM2	reviewed	Mitogen-activated protein kinase 1 (MAP kinase 1) (MAPK 1) (EC 2.7.11.24) (ERT1) (Extracellular signal-regulated kinase 2) (ERK-2) (MAP kinase isoform p42) (p42-MAPK) (Mitogen-activated protein kinase 2) (MAP kinase 2) (MAPK 2)	1	0	0	1	0	1	0	-	0	0	0	1	0	0	0	0	0	0	1	1	0	0	0	0	1	0	1	0	1	0	0	0	CLL, ovarian mixed germ cell tumour, cervical carcinoma
MAX	1	P61244	MAX BHLHD4	reviewed	Protein max (Class D basic helix-loop-helix protein 4) (bHLHd4) (Myc-associated factor X)	1	1	1	0	0	0	1	-	0	0	0	1	0	1	1	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	pheochromocytoma, endometrioid carcinoma, colon carcinoma, pheochromocytoma
MB21D2	2	Q8IYB1	MB21D2 C3orf59	reviewed	Nucleotidyltransferase MB21D2 (EC 2.7.7.-) (Mab-21 domain-containing protein 2) (hMB21D2)	1	0	0	0	0	0	0	-	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	lung cancer
MDM2	1	Q00987	MDM2	reviewed	E3 ubiquitin-protein ligase Mdm2 (EC 2.3.2.27) (Double minute 2 protein) (Hdm2) (Oncoprotein Mdm2) (RING-type E3 ubiquitin transferase Mdm2) (p53-binding protein Mdm2)	1	0	0	1	0	1	0	-	0	0	0	0	0	0	0	0	1	0	1	1	1	1	0	0	0	0	0	0	0	0	0	0	sarcoma, glioma, colorectal, other tumour types
MDM4	1	O15151	MDM4 MDMX	reviewed	Protein Mdm4 (Double minute 4 protein) (Mdm2-like p53-binding protein) (Protein Mdmx) (p53-binding protein Mdm4)	1	0	0	1	0	1	0	-	0	0	0	0	0	0	0	0	1	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	glioblastoma, bladder, retinoblastoma
MECOM	1	Q03112	MECOM EVI1 MDS1 PRDM3	reviewed	Histone-lysine N-methyltransferase MECOM (EC 2.1.1.367) (Ecotropic virus integration site 1 protein homolog) (EVI-1) (MDS1 and EVI1 complex locus protein) (Myelodysplasia syndrome 1 protein) (Myelodysplasia syndrome-associated protein 1)	1	0	0	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	AML, CML, MDS
MED12	1	Q93074	MED12 ARC240 CAGH45 HOPA KIAA0192 TNRC11 TRAP230	reviewed	Mediator of RNA polymerase II transcription subunit 12 (Activator-recruited cofactor 240 kDa component) (ARC240) (CAG repeat protein 45) (Mediator complex subunit 12) (OPA-containing protein) (Thyroid hormone receptor-associated protein complex 230 kDa component) (Trap230) (Trinucleotide repeat-containing gene 11 protein)	1	0	1	0	0	1	0	-	0	0	0	1	1	0	0	0	0	1	1	0	1	0	0	0	0	0	0	1	1	1	0	0	uterine leiomyoma, fibroadenoma, phyllodes tumour
MEN1	1	O00255	MEN1 SCG2	reviewed	Menin	1	1	1	0	0	0	1	-	0	0	0	1	1	1	1	1	0	0	1	0	0	0	0	0	0	0	1	0	0	1	1	0	parathyroid tumours, pancreatic neuroendocrine tumour, parathyroid adenoma, pituitary adenoma, pancreatic islet cell, carcinoid
MET	1	P08581	MET	reviewed	Hepatocyte growth factor receptor (HGF receptor) (EC 2.7.10.1) (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met)	1	0	0	1	0	1	0	1	1	0	0	1	0	0	0	0	0	0	1	0	0	0	1	0	0	1	1	1	1	1	0	0	papillary renal, head-neck squamous cell, papillary renal
MGMT	2	P16455	MGMT	reviewed	Methylated-DNA--protein-cysteine methyltransferase	1	0	1	0	0	0	0	-	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	glioma
MITF	1	O75030	MITF BHLHE32	reviewed	Microphthalmia-associated transcription factor (Class E basic helix-loop-helix protein 32) (bHLHe32)	1	0	0	1	0	1	0	-	0	0	0	0	0	0	0	0	1	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	melanoma
MLF1	1	P58340	MLF1	reviewed	Myeloid leukemia factor 1 (Myelodysplasia-myeloid leukemia factor 1)	1	0	1	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	AML
MLH1	1	P40692	MLH1 COCA2	reviewed	DNA mismatch repair protein Mlh1 (MutL protein homolog 1)	1	1	1	0	0	0	1	-	0	0	0	1	1	1	1	1	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	colorectal, endometrial, ovarian, CNS tumours, colorectal, endometrial, ovarian, CNS
MLLT1	1	Q03111	MLLT1 ENL LTG19 YEATS1	reviewed	Protein ENL (YEATS domain-containing protein 1)	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	AL
MLLT10	1	P55197	MLLT10 AF10	reviewed	Protein AF-10 (ALL1-fused gene from chromosome 10 protein)	1	0	0	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	1	0	0	0	0	0	0	0	0	AL
MLLT11	1	Q13015	MLLT11 AF1Q	reviewed	Protein AF1q	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	ALL
MLLT3	1	P42568	MLLT3 AF9 YEATS3	reviewed	Protein AF-9 (ALL1-fused gene from chromosome 9 protein) (Myeloid/lymphoid or mixed-lineage leukemia translocated to chromosome 3 protein) (YEATS domain-containing protein 3)	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	ALL
MLLT6	1	P55198	MLLT6 AF17	reviewed	Protein AF-17 (ALL1-fused gene from chromosome 17 protein)	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	AL
MN1	1	Q10571	MN1	reviewed	Transcriptional activator MN1 (Probable tumor suppressor protein MN1)	1	0	0	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	AML, MDS
MNX1	2	P50219	MNX1 HLXB9	reviewed	Motor neuron and pancreas homeobox protein 1 (Homeobox protein HB9)	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	AML
MPL	1	P40238	MPL TPOR	reviewed	Thrombopoietin receptor (TPO-R) (Myeloproliferative leukemia protein) (Proto-oncogene c-Mpl) (CD antigen CD110)	1	1	0	1	0	1	0	-	0	0	0	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	MPN, MPN
MRTFA	1	Q969V6	MRTFA KIAA1438 MAL MKL1	reviewed	Myocardin-related transcription factor A (MRTF-A) (MKL/myocardin-like protein 1) (Megakaryoblastic leukemia 1 protein) (Megakaryocytic acute leukemia protein)	1	0	1	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	acute megakaryocytic leukaemia
MSH2	1	P43246	MSH2	reviewed	DNA mismatch repair protein Msh2 (hMSH2) (MutS protein homolog 2)	1	1	1	0	0	0	1	-	0	0	0	1	1	1	1	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	colorectal, endometrial, ovarian, colorectal, endometrial, ovarian
MSH6	1	P52701	MSH6 GTBP	reviewed	DNA mismatch repair protein Msh6 (hMSH6) (G/T mismatch-binding protein) (GTBP) (GTMBP) (MutS protein homolog 6) (MutS-alpha 160 kDa subunit) (p160)	1	1	1	0	0	0	1	-	0	0	0	1	1	1	1	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	colorectal, colorectal, endometrial, ovarian
MSI2	1	Q96DH6	MSI2	reviewed	RNA-binding protein Musashi homolog 2 (Musashi-2)	1	0	0	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	CML
MSN	1	P26038	MSN	reviewed	Moesin (Membrane-organizing extension spike protein)	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	ALCL
MTCP1	1	P56278	MTCP1 C6.1B	reviewed	Protein p13 MTCP-1 (p13MTCP1) (Mature T-cell proliferation-1 type B1) (MTCP-1 type B1)	1	0	0	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	T cell prolymphocytic leukaemia
MTOR	1	P42345	MTOR FRAP FRAP1 FRAP2 RAFT1 RAPT1	reviewed	Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin and FKBP12 target 1) (Rapamycin target protein 1)	1	0	0	1	0	1	0	-	1	0	0	1	0	1	0	0	0	0	1	0	0	0	1	0	1	0	1	0	1	1	0	0	endometrial carcinoma, head and neck, clear cell renal cell carcinoma, anaplastic thyroid cancer, urothelial cell carcinoma, central nervous system tumours, testicular germ cell tumours and other tumour types
MUC1	1	P15941	MUC1 PUM	reviewed	"Mucin-1 (MUC-1) (Breast carcinoma-associated antigen DF3) (Cancer antigen 15-3) (CA 15-3) (Carcinoma-associated mucin) (Episialin) (H23AG) (Krebs von den Lungen-6) (KL-6) (PEMT) (Peanut-reactive urinary mucin) (PUM) (Polymorphic epithelial mucin) (PEM) (Tumor-associated epithelial membrane antigen) (EMA) (Tumor-associated mucin) (CD antigen CD227) [Cleaved into: Mucin-1 subunit alpha (MUC1-NT) (MUC1-alpha); Mucin-1 subunit beta (MUC1-beta) (MUC1-CT)]"	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	B-NHL
MUC16	2	Q8WXI7	MUC16 CA125	reviewed	Mucin-16 (MUC-16) (Ovarian cancer-related tumor marker CA125) (CA-125) (Ovarian carcinoma antigen CA125)	1	0	0	1	0	0	0	-	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	HNSCC, melanoma
MUC4	2	Q99102	MUC4	reviewed	"Mucin-4 (MUC-4) (Ascites sialoglycoprotein) (ASGP) (Pancreatic adenocarcinoma mucin) (Testis mucin) (Tracheobronchial mucin) [Cleaved into: Mucin-4 alpha chain (Ascites sialoglycoprotein 1) (ASGP-1); Mucin-4 beta chain (Ascites sialoglycoprotein 2) (ASGP-2)]"	1	0	0	1	0	0	0	-	0	0	0	1	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	HNSCC
MUTYH	1	Q9UIF7	MUTYH MYH	reviewed	Adenine DNA glycosylase (EC 3.2.2.31) (MutY homolog) (hMYH)	0	1	1	0	0	0	1	-	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	colorectal
MYB	1	P10242	MYB	reviewed	Transcriptional activator Myb (Proto-oncogene c-Myb)	1	0	0	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	adenoid cystic carcinoma
MYC	1	P01106	MYC BHLHE39	reviewed	Myc proto-oncogene protein (Class E basic helix-loop-helix protein 39) (bHLHe39) (Proto-oncogene c-Myc) (Transcription factor p64)	1	0	0	1	1	1	0	-	0	1	1	0	0	0	0	0	1	0	1	1	0	0	1	1	1	1	1	1	1	1	0	0	Burkitt lymphoma, amplified in other cancers, B-CLL
MYCL	1	P12524	MYCL BHLHE38 LMYC MYCL1	reviewed	Protein L-Myc (Class E basic helix-loop-helix protein 38) (bHLHe38) (Protein L-Myc-1) (V-myc myelocytomatosis viral oncogene homolog)	1	0	0	1	0	1	0	-	0	0	0	0	0	0	0	0	1	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	small cell lung carcinoma
MYCN	1	P04198	MYCN BHLHE37 NMYC	reviewed	N-myc proto-oncogene protein (Class E basic helix-loop-helix protein 37) (bHLHe37)	1	0	0	1	0	1	0	-	0	0	0	1	0	0	0	0	1	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	neuroblastoma, Wilms tumour
MYD88	1	Q99836	MYD88	reviewed	Myeloid differentiation primary response protein MyD88	1	0	0	1	0	1	0	-	0	0	0	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	1	0	1	1	0	1	ABC-DLBCL
MYH11	1	P35749	MYH11 KIAA0866	reviewed	Myosin-11 (Myosin heavy chain 11) (Myosin heavy chain, smooth muscle isoform) (SMMHC)	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	AML
MYH9	1	P35579	MYH9	reviewed	Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA)	1	0	1	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	ALCL
MYO5A	1	Q9Y4I1	MYO5A MYH12	reviewed	Unconventional myosin-Va (Dilute myosin heavy chain, non-muscle) (Myosin heavy chain 12) (Myosin-12) (Myoxin)	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	Spitzoid tumour
MYOD1	1	P15172	MYOD1 BHLHC1 MYF3 MYOD	reviewed	Myoblast determination protein 1 (Class C basic helix-loop-helix protein 1) (bHLHc1) (Myogenic factor 3) (Myf-3)	1	0	0	1	0	1	0	-	0	0	0	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	embryonal rhabdomyosarcoma
N4BP2	2	Q86UW6	N4BP2 B3BP KIAA1413	reviewed	NEDD4-binding protein 2 (N4BP2) (EC 3.-.-.-) (BCL-3-binding protein)	1	0	1	0	0	0	0	-	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	lung cancer
NAB2	1	Q15742	NAB2 MADER	reviewed	NGFI-A-binding protein 2 (EGR-1-binding protein 2) (Melanoma-associated delayed early response protein) (Protein MADER)	1	0	1	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	0	1	1	1	0	0	0	0	0	0	0	0	0	solitary fibrous tumour, meningeal haemangiopericytoma
NACA	2	E9PAV3	NACA	reviewed	Nascent polypeptide-associated complex subunit alpha, muscle-specific form (Alpha-NAC, muscle-specific form) (skNAC)	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	NHL
NBEA	2	Q8NFP9	NBEA BCL8B KIAA1544 LYST2	reviewed	Neurobeachin (Lysosomal-trafficking regulator 2) (Protein BCL8B)	1	0	0	0	0	0	0	-	0	0	1	0	0	0	1	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	large intestine carcinoma, multiple myeloma
NBN	1	O60934	NBN NBS NBS1 P95	reviewed	Nibrin (Cell cycle regulatory protein p95) (Nijmegen breakage syndrome protein 1)	0	1	1	0	0	0	1	-	0	0	0	1	0	1	1	0	0	0	1	1	1	1	0	0	0	0	0	0	0	0	0	0	NHL, glioma, medulloblastoma, rhabdomyosarcoma
NCKIPSD	2	Q9NZQ3	NCKIPSD AF3P21 SPIN90	reviewed	NCK-interacting protein with SH3 domain (54 kDa VacA-interacting protein) (54 kDa vimentin-interacting protein) (VIP54) (90 kDa SH3 protein interacting with Nck) (AF3p21) (Dia-interacting protein 1) (DIP-1) (Diaphanous protein-interacting protein) (SH3 adapter protein SPIN90) (WASP-interacting SH3-domain protein) (WISH) (Wiskott-Aldrich syndrome protein-interacting protein)	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	ALL
NCOA1	1	Q15788	NCOA1 BHLHE74 SRC1	reviewed	Nuclear receptor coactivator 1 (NCoA-1) (EC 2.3.1.48) (Class E basic helix-loop-helix protein 74) (bHLHe74) (Protein Hin-2) (RIP160) (Renal carcinoma antigen NY-REN-52) (Steroid receptor coactivator 1) (SRC-1)	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	alveolar rhabdomyosarcoma
NCOA2	1	Q15596	NCOA2 BHLHE75 SRC2 TIF2	reviewed	Nuclear receptor coactivator 2 (NCoA-2) (Class E basic helix-loop-helix protein 75) (bHLHe75) (Transcriptional intermediary factor 2) (hTIF2)	1	0	0	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	AML, chondrosarcoma, rhabdomyosarcoma
NCOA4	1	Q13772	NCOA4 ARA70 ELE1 RFG	reviewed	Nuclear receptor coactivator 4 (NCoA-4) (Androgen receptor coactivator 70 kDa protein) (70 kDa AR-activator) (70 kDa androgen receptor coactivator) (Androgen receptor-associated protein of 70 kDa) (Ret-activating protein ELE1)	1	0	1	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	papillary thyroid
NCOR1	1	O75376	NCOR1 KIAA1047	reviewed	Nuclear receptor corepressor 1 (N-CoR) (N-CoR1)	1	0	1	0	0	0	1	-	0	0	0	1	0	1	1	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	breast
NCOR2	1	Q9Y618	NCOR2 CTG26	reviewed	Nuclear receptor corepressor 2 (N-CoR2) (CTG repeat protein 26) (SMAP270) (Silencing mediator of retinoic acid and thyroid hormone receptor) (SMRT) (T3 receptor-associating factor) (TRAC) (Thyroid-, retinoic-acid-receptor-associated corepressor)	1	0	1	0	0	1	0	-	0	0	0	1	0	1	1	0	0	1	1	0	0	0	0	0	0	0	1	1	0	0	1	0	prostate
NDRG1	1	Q92597	NDRG1 CAP43 DRG1 RTP	reviewed	Protein NDRG1 (Differentiation-related gene 1 protein) (DRG-1) (N-myc downstream-regulated gene 1 protein) (Nickel-specific induction protein Cap43) (Reducing agents and tunicamycin-responsive protein) (RTP) (Rit42)	1	0	1	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	1	0	0	0	0	1	0	0	0	0	1	1	1	0	prostate
NF1	1	P21359	NF1	reviewed	Neurofibromin (Neurofibromatosis-related protein NF-1) [Cleaved into: Neurofibromin truncated]	1	1	1	0	1	0	1	1	1	1	0	1	1	1	1	1	0	1	0	0	0	1	1	0	0	0	1	0	1	0	1	0	neurofibroma, glioma, neurofibroma, glioma
NF2	1	P35240	NF2 SCH	reviewed	Merlin (Moesin-ezrin-radixin-like protein) (Neurofibromin-2) (Schwannomerlin) (Schwannomin)	1	1	1	0	0	0	1	-	1	0	0	1	1	1	1	1	0	1	0	0	0	1	0	0	1	0	0	0	1	0	1	0	meningioma, acoustic neuroma, renal, meningioma, acoustic neuroma
NFATC2	1	Q13469	NFATC2 NFAT1 NFATP	reviewed	Nuclear factor of activated T-cells, cytoplasmic 2 (NF-ATc2) (NFATc2) (NFAT pre-existing subunit) (NF-ATp) (T-cell transcription factor NFAT1)	1	0	0	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	Ewing sarcoma
NFE2L2	1	Q16236	NFE2L2 NRF2	reviewed	Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nrf-2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2)	1	0	1	1	0	1	0	-	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	1	0	1	0	0	0	0	0	NSCLC, HNSCC
NFIB	1	O00712	NFIB	reviewed	Nuclear factor 1 B-type (NF1-B) (Nuclear factor 1/B) (CCAAT-box-binding transcription factor) (CTF) (Nuclear factor I/B) (NF-I/B) (NFI-B) (TGGCA-binding protein)	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	adenoid cystic carcinoma, lipoma
NFKB2	1	Q00653	NFKB2 LYT10	reviewed	Nuclear factor NF-kappa-B p100 subunit (DNA-binding factor KBF2) (H2TF1) (Lymphocyte translocation chromosome 10 protein) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 2) (Oncogene Lyt-10) (Lyt10) [Cleaved into: Nuclear factor NF-kappa-B p52 subunit]	1	0	1	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	B-NHL
NFKBIE	1	O00221	NFKBIE IKBE	reviewed	NF-kappa-B inhibitor epsilon (NF-kappa-BIE) (I-kappa-B-epsilon) (IkB-E) (IkB-epsilon) (IkappaBepsilon)	1	0	1	0	0	1	1	-	0	0	0	1	0	0	1	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	CLL, desmoplastic melanoma
NIN	1	Q8N4C6	NIN KIAA1565	reviewed	Ninein (hNinein) (Glycogen synthase kinase 3 beta-interacting protein) (GSK3B-interacting protein)	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	MPN
NKX2-1	1	P43699	NKX2-1 NKX2A TITF1 TTF1	reviewed	Homeobox protein Nkx-2.1 (Homeobox protein NK-2 homolog A) (Thyroid nuclear factor 1) (Thyroid transcription factor 1) (TTF-1) (Thyroid-specific enhancer-binding protein) (T/EBP)	1	0	1	1	0	1	0	-	0	0	0	0	0	0	0	0	1	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	NSCLC
NONO	1	Q15233	NONO NRB54	reviewed	Non-POU domain-containing octamer-binding protein (NonO protein) (54 kDa nuclear RNA- and DNA-binding protein) (p54(nrb)) (p54nrb) (55 kDa nuclear protein) (NMT55) (DNA-binding p52/p100 complex, 52 kDa subunit)	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	1	1	0	0	papillary renal
NOTCH1	1	P46531	NOTCH1	reviewed	Neurogenic locus notch homolog protein 1	1	0	1	1	1	1	1	-	0	1	1	1	0	0	0	0	0	1	1	1	0	0	1	1	1	0	1	0	0	1	0	0	T-ALL, breast, bladder, skin SCC, lung SCC, head and neck SCC
NOTCH2	1	Q04721	NOTCH2	reviewed	"Neurogenic locus notch homolog protein 2 (Notch 2) (hN2) [Cleaved into: Notch 2 extracellular truncation (N2ECD); Notch 2 intracellular domain (N2ICD)]"	1	0	1	1	0	1	1	-	0	0	0	1	0	1	1	0	0	0	1	1	0	0	0	0	0	0	1	0	1	1	1	0	marginal zone lymphoma, DLBCL, bladder
NPM1	1	P06748	NPM1 NPM	reviewed	Nucleophosmin (NPM) (Nucleolar phosphoprotein B23) (Nucleolar protein NO38) (Numatrin)	1	0	0	1	1	1	0	-	0	1	1	0	0	0	1	0	0	0	0	1	0	0	0	0	1	0	1	1	1	1	1	0	NHL, APL, AML
NR4A3	1	Q92570	NR4A3 CHN CSMF MINOR NOR1 TEC	reviewed	Nuclear receptor subfamily 4 group A member 3 (Mitogen-induced nuclear orphan receptor) (Neuron-derived orphan receptor 1) (Nuclear hormone receptor NOR-1)	1	0	0	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	extraskeletal myxoid chondrosarcoma
NRAS	1	P01111	NRAS HRAS1	reviewed	GTPase NRas (EC 3.6.5.2) (Transforming protein N-Ras)	1	0	0	1	0	1	0	1	1	0	0	1	0	0	0	0	0	0	1	1	0	0	0	1	0	0	1	0	1	1	0	0	melanoma, MM, AML, thyroid
NRG1	1	Q02297	NRG1 GGF HGL HRGA NDF SMDF	reviewed	Pro-neuregulin-1, membrane-bound isoform (Pro-NRG1) [Cleaved into: Neuregulin-1 (Acetylcholine receptor-inducing activity) (ARIA) (Breast cancer cell differentiation factor p45) (Glial growth factor) (Heregulin) (HRG) (Neu differentiation factor) (Sensory and motor neuron-derived factor)]	1	0	1	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	NSCLC
NSD1	1	Q96L73	NSD1 ARA267 KMT3B	reviewed	Histone-lysine N-methyltransferase, H3 lysine-36 specific (EC 2.1.1.357) (Androgen receptor coactivator 267 kDa protein) (Androgen receptor-associated protein of 267 kDa) (H3-K36-HMTase) (Lysine N-methyltransferase 3B) (Nuclear receptor-binding SET domain-containing protein 1) (NR-binding SET domain-containing protein)	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	AML
NSD2	1	O96028	NSD2 KIAA1090 MMSET TRX5 WHSC1	reviewed	Histone-lysine N-methyltransferase NSD2 (EC 2.1.1.357) (Multiple myeloma SET domain-containing protein) (MMSET) (Nuclear SET domain-containing protein 2) (Protein trithorax-5) (Wolf-Hirschhorn syndrome candidate 1 protein)	1	0	0	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	MM
NSD3	1	Q9BZ95	NSD3 WHSC1L1 DC28	reviewed	Histone-lysine N-methyltransferase NSD3 (EC 2.1.1.370) (EC 2.1.1.371) (Nuclear SET domain-containing protein 3) (Protein whistle) (WHSC1-like 1 isoform 9 with methyltransferase activity to lysine) (Wolf-Hirschhorn syndrome candidate 1-like protein 1) (WHSC1-like protein 1)	1	0	0	1	1	1	0	-	0	1	1	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	AML
NT5C2	1	P49902	NT5C2 NT5B NT5CP PNT5	reviewed	Cytosolic purine 5'-nucleotidase (EC 3.1.3.5) (EC 3.1.3.99) (Cytosolic 5'-nucleotidase II) (cN-II) (Cytosolic IMP/GMP-specific 5'-nucleotidase) (Cytosolic nucleoside phosphotransferase 5'N) (EC 2.7.1.77) (High Km 5'-nucleotidase)	1	0	0	1	0	1	0	-	1	0	0	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	1	0	0	1	0	0	relapse ALL
NTHL1	2	P78549	NTHL1 NTH1 OCTS3	reviewed	Endonuclease III-like protein 1 (hNTH1) (EC 3.2.2.-) (EC 4.2.99.18) (Bifunctional DNA N-glycosylase/DNA-(apurinic or apyrimidinic site) lyase) (DNA glycosylase/AP lyase)	0	1	1	0	0	0	0	-	0	0	0	0	1	1	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	CRC
NTRK1	1	P04629	NTRK1 MTC TRK TRKA	reviewed	High affinity nerve growth factor receptor (EC 2.7.10.1) (Neurotrophic tyrosine kinase receptor type 1) (TRK1-transforming tyrosine kinase protein) (Tropomyosin-related kinase A) (Tyrosine kinase receptor) (Tyrosine kinase receptor A) (Trk-A) (gp140trk) (p140-TrkA)	1	0	1	1	1	1	0	1	0	1	1	0	0	0	0	0	1	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	papillary thyroid, Spitzoid tumour
NTRK3	1	Q16288	NTRK3 TRKC	reviewed	NT-3 growth factor receptor (EC 2.7.10.1) (GP145-TrkC) (Trk-C) (Neurotrophic tyrosine kinase receptor type 3) (TrkC tyrosine kinase)	1	0	0	1	1	1	0	1	0	1	1	0	0	0	0	0	0	0	1	0	1	0	0	0	0	0	0	0	0	0	0	0	congenital fibrosarcoma, secretory breast
NUMA1	1	Q14980	NUMA1 NMP22 NUMA	reviewed	Nuclear mitotic apparatus protein 1 (Nuclear matrix protein-22) (NMP-22) (Nuclear mitotic apparatus protein) (NuMA protein) (SP-H antigen)	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	APL
NUP214	1	P35658	NUP214 CAIN CAN KIAA0023	reviewed	Nuclear pore complex protein Nup214 (214 kDa nucleoporin) (Nucleoporin Nup214) (Protein CAN)	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	AML, T-ALL
NUP98	1	P52948	NUP98 ADAR2	reviewed	"Nuclear pore complex protein Nup98-Nup96 (EC 3.4.21.-) [Cleaved into: Nuclear pore complex protein Nup98 (98 kDa nucleoporin) (Nucleoporin Nup98) (Nup98); Nuclear pore complex protein Nup96 (96 kDa nucleoporin) (Nucleoporin Nup96) (Nup96)]"	1	0	0	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	AML
NUTM1	1	Q86Y26	NUTM1 C15orf55 NUT	reviewed	NUT family member 1 (Nuclear protein in testis)	1	0	0	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	lethal midline carcinoma
NUTM2B	1	A6NNL0	NUTM2B FAM22B	reviewed	NUT family member 2B	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	endometrial stromal sarcoma
NUTM2D	1	Q5VT03	NUTM2D FAM22D	reviewed	NUT family member 2D	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	endometrial stromal sarcoma
OLIG2	1	Q13516	OLIG2 BHLHB1 BHLHE19 PRKCBP2 RACK17	reviewed	Oligodendrocyte transcription factor 2 (Oligo2) (Class B basic helix-loop-helix protein 1) (bHLHb1) (Class E basic helix-loop-helix protein 19) (bHLHe19) (Protein kinase C-binding protein 2) (Protein kinase C-binding protein RACK17)	1	0	0	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	T-ALL
OMD	2	Q99983	OMD SLRR2C UNQ190/PRO216	reviewed	Osteomodulin (Keratan sulfate proteoglycan osteomodulin) (KSPG osteomodulin) (Osteoadherin) (OSAD)	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	aneurysmal bone cyst
P2RY8	1	Q86VZ1	P2RY8	reviewed	P2Y purinoceptor 8 (P2Y8)	1	0	0	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	B-ALL, Down syndrome associated ALL
PABPC1	2	P11940	PABPC1 PAB1 PABP PABP1 PABPC2	reviewed	Polyadenylate-binding protein 1 (PABP-1) (Poly(A)-binding protein 1)	1	0	1	1	0	0	0	-	0	0	0	1	0	0	1	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	HNSCC, biliary tract carcinoma
PAFAH1B2	1	P68402	PAFAH1B2 PAFAHB	reviewed	Platelet-activating factor acetylhydrolase IB subunit alpha2 (EC 3.1.1.47) (PAF acetylhydrolase 30 kDa subunit) (PAF-AH 30 kDa subunit) (PAF-AH subunit beta) (PAFAH subunit beta)	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	1	0	0	0	0	0	0	0	MLCLS
PALB2	1	Q86YC2	PALB2 FANCN	reviewed	Partner and localizer of BRCA2	0	1	1	0	0	0	1	1	0	0	0	1	0	1	1	0	0	0	1	1	0	1	0	0	0	0	0	0	0	0	0	0	Wilms tumour, medulloblastoma, AML ,breast
PATZ1	1	Q9HBE1	PATZ1 PATZ RIAZ ZBTB19 ZNF278 ZSG	reviewed	POZ-, AT hook-, and zinc finger-containing protein 1 (BTB/POZ domain zinc finger transcription factor) (Protein kinase A RI subunit alpha-associated protein) (Zinc finger and BTB domain-containing protein 19) (Zinc finger protein 278) (Zinc finger sarcoma gene protein)	1	0	1	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	Ewing sarcoma
PAX3	1	P23760	PAX3 HUP2	reviewed	Paired box protein Pax-3 (HuP2)	1	0	0	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	1	1	1	0	alveolar rhabdomyosarcoma
PAX5	1	Q02548	PAX5	reviewed	Paired box protein Pax-5 (B-cell-specific transcription factor) (BSAP)	1	0	1	1	1	1	0	-	0	1	1	1	1	0	1	1	0	0	0	1	0	0	0	0	0	0	1	0	1	1	0	0	NHL, ALL, B-ALL
PAX7	1	P23759	PAX7 HUP1	reviewed	Paired box protein Pax-7 (HuP1)	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	1	1	0	0	alveolar rhabdomyosarcoma
PAX8	1	Q06710	PAX8	reviewed	Paired box protein Pax-8	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	1	0	1	1	0	0	follicular thyroid
PBRM1	1	Q86U86	PBRM1 BAF180 PB1	reviewed	Protein polybromo-1 (hPB1) (BRG1-associated factor 180) (BAF180) (Polybromo-1D)	1	0	1	0	0	0	1	-	0	0	0	1	1	1	1	1	0	1	1	0	0	0	0	0	1	1	1	1	1	0	1	1	clear cell renal carcinoma, breast
PBX1	1	P40424	PBX1 PRL	reviewed	Pre-B-cell leukemia transcription factor 1 (Homeobox protein PBX1) (Homeobox protein PRL)	1	0	0	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	1	0	1	0	1	0	1	0	0	0	0	0	pre B-ALL, myoepithelioma
PCBP1	2	Q15365	PCBP1	reviewed	Poly(rC)-binding protein 1 (Alpha-CP1) (Heterogeneous nuclear ribonucleoprotein E1) (hnRNP E1) (Nucleic acid-binding protein SUB2.3)	1	0	0	0	0	0	0	-	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	CRC
PCM1	1	Q15154	PCM1	reviewed	Pericentriolar material 1 protein (PCM-1) (hPCM-1)	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	papillary thyroid, CML, MPN
PDCD1LG2	1	Q9BQ51	PDCD1LG2 B7DC CD273 PDCD1L2 PDL2	reviewed	Programmed cell death 1 ligand 2 (PD-1 ligand 2) (PD-L2) (PDCD1 ligand 2) (Programmed death ligand 2) (Butyrophilin B7-DC) (B7-DC) (CD antigen CD273)	1	0	0	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	PMBL, Hodgkin lymphoma
PDE4DIP	1	Q5VU43	PDE4DIP CMYA2 KIAA0454 KIAA0477 MMGL	reviewed	Myomegalin (Cardiomyopathy-associated protein 2) (Phosphodiesterase 4D-interacting protein)	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	MPN
PDGFB	1	P01127	PDGFB PDGF2 SIS	reviewed	Platelet-derived growth factor subunit B (PDGF subunit B) (PDGF-2) (Platelet-derived growth factor B chain) (Platelet-derived growth factor beta polypeptide) (Proto-oncogene c-Sis) (Becaplermin)	1	0	0	1	1	1	0	1	0	1	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	DFSP
PDGFRA	1	P16234	PDGFRA PDGFR2 RHEPDGFRA	reviewed	Platelet-derived growth factor receptor alpha (PDGF-R-alpha) (PDGFR-alpha) (EC 2.7.10.1) (Alpha platelet-derived growth factor receptor) (Alpha-type platelet-derived growth factor receptor) (CD140 antigen-like family member A) (CD140a antigen) (Platelet-derived growth factor alpha receptor) (Platelet-derived growth factor receptor 2) (PDGFR-2) (CD antigen CD140a)	1	1	0	1	1	1	0	1	1	1	1	1	0	0	0	0	0	1	0	1	1	1	1	0	0	0	1	0	1	1	1	0	GIST, idiopathic hypereosinophilic syndrome, paediatric glioblastoma, GIST
PDGFRB	1	P09619	PDGFRB PDGFR PDGFR1	reviewed	Platelet-derived growth factor receptor beta (PDGF-R-beta) (PDGFR-beta) (EC 2.7.10.1) (Beta platelet-derived growth factor receptor) (Beta-type platelet-derived growth factor receptor) (CD140 antigen-like family member B) (Platelet-derived growth factor receptor 1) (PDGFR-1) (CD antigen CD140b)	1	0	0	1	1	1	0	1	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	MPN, AML, CMML, CML
PER1	1	O15534	PER1 KIAA0482 PER RIGUI	reviewed	Period circadian protein homolog 1 (hPER1) (Circadian clock protein PERIOD 1) (Circadian pacemaker protein Rigui)	1	0	1	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	1	0	0	0	1	0	AML, CMML
PHF6	1	Q8IWS0	PHF6 CENP-31 KIAA1823	reviewed	PHD finger protein 6 (PHD-like zinc finger protein)	1	0	1	0	0	0	1	-	0	0	0	1	1	1	1	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	ETP ALL
PHOX2B	1	Q99453	PHOX2B PMX2B	reviewed	Paired mesoderm homeobox protein 2B (Neuroblastoma Phox) (NBPhox) (PHOX2B homeodomain protein) (Paired-like homeobox 2B)	1	1	1	0	0	0	1	-	0	0	0	1	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	0	1	0	1	0	neuroblastoma, neuroblastoma
PICALM	1	Q13492	PICALM CALM	reviewed	Phosphatidylinositol-binding clathrin assembly protein (Clathrin assembly lymphoid myeloid leukemia protein)	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	1	0	0	0	0	0	0	0	T-ALL, AML
PIK3CA	1	P42336	PIK3CA	reviewed	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (PI3-kinase subunit alpha) (PI3K-alpha) (PI3Kalpha) (PtdIns-3-kinase subunit alpha) (EC 2.7.1.137) (EC 2.7.1.153) (Phosphatidylinositol 4,5-bisphosphate 3-kinase 110 kDa catalytic subunit alpha) (PtdIns-3-kinase subunit p110-alpha) (p110alpha) (Phosphoinositide 3-kinase alpha) (Phosphoinositide-3-kinase catalytic alpha polypeptide) (Serine/threonine protein kinase PIK3CA) (EC 2.7.11.1)	1	0	0	1	0	1	0	1	1	0	0	1	0	0	0	0	0	0	1	0	0	1	1	0	0	0	1	0	1	1	0	0	colorectal, gastric, glioblastoma, breast
PIK3CB	1	P42338	PIK3CB PIK3C1	reviewed	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform (PI3-kinase subunit beta) (PI3K-beta) (PI3Kbeta) (PtdIns-3-kinase subunit beta) (EC 2.7.1.153) (Phosphatidylinositol 4,5-bisphosphate 3-kinase 110 kDa catalytic subunit beta) (PtdIns-3-kinase subunit p110-beta) (p110beta)	1	0	0	1	0	0	0	-	1	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	1	1	0	0	0	0	SCC, NSCLC
PIK3R1	1	P27986	PIK3R1 GRB1	reviewed	Phosphatidylinositol 3-kinase regulatory subunit alpha (PI3-kinase regulatory subunit alpha) (PI3K regulatory subunit alpha) (PtdIns-3-kinase regulatory subunit alpha) (Phosphatidylinositol 3-kinase 85 kDa regulatory subunit alpha) (PI3-kinase subunit p85-alpha) (PtdIns-3-kinase regulatory subunit p85-alpha)	1	0	1	0	0	0	1	-	0	0	0	1	0	0	1	0	0	1	1	0	0	1	0	1	0	0	0	0	1	0	1	0	glioblastoma, ovarian, colorectal
PIM1	1	P11309	PIM1	reviewed	Serine/threonine-protein kinase pim-1 (EC 2.7.11.1)	1	0	0	1	1	1	0	-	0	1	1	1	0	0	0	0	0	0	0	1	0	0	1	0	1	0	1	0	1	1	0	0	NHL
PLAG1	1	Q6DJT9	PLAG1	reviewed	Zinc finger protein PLAG1 (Pleiomorphic adenoma gene 1 protein)	1	0	0	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	salivary adenoma, lipoblastoma
PLCG1	1	P19174	PLCG1 PLC1	reviewed	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 (EC 3.1.4.11) (PLC-148) (Phosphoinositide phospholipase C-gamma-1) (Phospholipase C-II) (PLC-II) (Phospholipase C-gamma-1) (PLC-gamma-1)	1	0	0	1	1	1	0	-	0	1	0	1	0	0	0	0	0	0	1	0	0	0	1	0	0	0	1	0	1	1	0	0	angiosarcoma
PML	1	P29590	PML MYL PP8675 RNF71 TRIM19	reviewed	Protein PML (E3 SUMO-protein ligase PML) (EC 2.3.2.-) (Promyelocytic leukemia protein) (RING finger protein 71) (RING-type E3 SUMO transferase PML) (Tripartite motif-containing protein 19) (TRIM19)	1	0	1	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	APL, ALL
PMS1	2	P54277	PMS1 PMSL1	reviewed	PMS1 protein homolog 1 (DNA mismatch repair protein PMS1)	0	1	0	0	0	0	1	-	0	0	0	1	0	1	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	colorectal, endometrial, ovarian
PMS2	1	P54278	PMS2 PMSL2	reviewed	Mismatch repair endonuclease PMS2 (EC 3.1.-.-) (DNA mismatch repair protein PMS2) (PMS1 protein homolog 2)	0	1	1	0	0	0	1	-	0	0	0	1	0	1	1	0	0	0	1	0	0	0	0	0	0	0	1	1	1	0	1	0	colorectal, endometrial, ovarian, medulloblastoma, glioma
POLD1	1	P28340	POLD1 POLD	reviewed	DNA polymerase delta catalytic subunit (EC 2.7.7.7) (3'-5' exodeoxyribonuclease) (EC 3.1.11.-) (DNA polymerase subunit delta p125)	1	1	1	0	0	0	0	-	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	CRC, CRC
POLE	1	Q07864	POLE POLE1	reviewed	DNA polymerase epsilon catalytic subunit A (EC 2.7.7.7) (3'-5' exodeoxyribonuclease) (EC 3.1.11.-) (DNA polymerase II subunit A)	1	1	1	0	0	0	1	-	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	colorectal carcinoma, endometrioid carcinoma, stomach carcinoma, skin cancer, colorectal cancer susceptibility
POLG	2	P54098	POLG MDP1 POLG1 POLGA	reviewed	DNA polymerase subunit gamma-1 (EC 2.7.7.7) (Mitochondrial DNA polymerase catalytic subunit) (PolG-alpha)	1	0	1	0	0	0	0	-	0	0	0	0	0	1	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	CRC
POLQ	1	O75417	POLQ POLH	reviewed	DNA polymerase theta (EC 2.7.7.7) (DNA polymerase eta)	1	1	1	1	0	0	0	-	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	oral SCC, breast cancer
POT1	1	Q9NUX5	POT1	reviewed	Protection of telomeres protein 1 (hPot1) (POT1-like telomere end-binding protein)	1	0	1	0	0	1	0	-	0	0	0	1	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	1	0	0	0	0	CLL
POU2AF1	1	Q16633	POU2AF1 BOB1 OBF1	reviewed	POU domain class 2-associating factor 1 (B-cell-specific coactivator OBF-1) (BOB-1) (OCA-B) (OCT-binding factor 1)	1	0	0	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	NHL
POU5F1	1	Q01860	POU5F1 OCT3 OCT4 OTF3	reviewed	POU domain, class 5, transcription factor 1 (Octamer-binding protein 3) (Oct-3) (Octamer-binding protein 4) (Oct-4) (Octamer-binding transcription factor 3) (OTF-3)	1	0	0	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	1	1	0	0	sarcoma
PPARG	1	P37231	PPARG NR1C3	reviewed	Peroxisome proliferator-activated receptor gamma (PPAR-gamma) (Nuclear receptor subfamily 1 group C member 3)	1	0	1	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	1	1	0	follicular thyroid
PPFIBP1	1	Q86W92	PPFIBP1 KIAA1230	reviewed	Liprin-beta-1 (Protein tyrosine phosphatase receptor type f polypeptide-interacting protein-binding protein 1) (PTPRF-interacting protein-binding protein 1) (hSGT2)	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	1	0	1	0	0	0	0	0	0	0	0	0	0	0	Spitzoid tumour, inflammatory myofibroblastic tumour
PPM1D	1	O15297	PPM1D WIP1	reviewed	Protein phosphatase 1D (EC 3.1.3.16) (Protein phosphatase 2C isoform delta) (PP2C-delta) (Protein phosphatase magnesium-dependent 1 delta) (p53-induced protein phosphatase 1)	1	0	0	1	0	1	0	-	0	0	0	1	0	1	1	0	1	0	1	0	0	0	0	0	0	0	1	1	0	1	0	0	glioma, ovarian cancer, breast cancer
PPP2R1A	1	P30153	PPP2R1A	reviewed	Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform (Medium tumor antigen-associated 61 kDa protein) (PP2A subunit A isoform PR65-alpha) (PP2A subunit A isoform R1-alpha)	1	0	1	0	0	1	0	-	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	clear cell ovarian carcinoma
PPP6C	1	O00743	PPP6C PPP6	reviewed	Serine/threonine-protein phosphatase 6 catalytic subunit (PP6C) (EC 3.1.3.16) [Cleaved into: Serine/threonine-protein phosphatase 6 catalytic subunit, N-terminally processed]	1	0	1	0	0	1	0	-	0	0	0	1	0	1	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0	0	0	0	melanoma
PRCC	1	Q92733	PRCC TPRC	reviewed	Proline-rich protein PRCC (Papillary renal cell carcinoma translocation-associated gene protein)	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	papillary renal
PRDM1	1	O75626	PRDM1 BLIMP1	reviewed	PR domain zinc finger protein 1 (EC 2.1.1.-) (BLIMP-1) (Beta-interferon gene positive regulatory domain I-binding factor) (PR domain-containing protein 1) (Positive regulatory domain I-binding factor 1) (PRDI-BF1) (PRDI-binding factor 1)	1	0	1	0	0	0	1	-	0	0	0	1	1	1	1	1	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	DLBCL
PRDM16	1	Q9HAZ2	PRDM16 KIAA1675 MEL1 PFM13	reviewed	Histone-lysine N-methyltransferase PRDM16 (EC 2.1.1.367) (PR domain zinc finger protein 16) (PR domain-containing protein 16) (Transcription factor MEL1) (MDS1/EVI1-like gene 1)	1	0	0	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	MDS, AML
PRDM2	2	Q13029	PRDM2 KMT8 RIZ	reviewed	PR domain zinc finger protein 2 (EC 2.1.1.355) (GATA-3-binding protein G3B) (Lysine N-methyltransferase 8) (MTB-ZF) (MTE-binding protein) (PR domain-containing protein 2) (Retinoblastoma protein-interacting zinc finger protein) (Zinc finger protein RIZ)	1	0	1	0	0	0	0	-	0	0	0	0	0	0	1	0	0	1	1	0	0	1	0	0	0	0	0	0	0	0	0	0	glioma, colon adenocarcinoma, gastric carcinoma, ovarian carcinoma, HNSCC
PREX2	1	Q70Z35	PREX2 DEPDC2	reviewed	Phosphatidylinositol 3,4,5-trisphosphate-dependent Rac exchanger 2 protein (P-Rex2) (PtdIns(3,4,5)-dependent Rac exchanger 2) (DEP domain-containing protein 2)	1	0	0	1	0	1	0	-	0	0	0	1	0	1	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	melanoma, pancreatic ductal adenocarcinoma
PRF1	1	P14222	PRF1 PFP	reviewed	Perforin-1 (P1) (Cytolysin) (Lymphocyte pore-forming protein) (PFP)	0	1	1	0	0	0	1	-	0	0	0	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	various leukaemia, lymphoma
PRKACA	1	P17612	PRKACA PKACA	reviewed	cAMP-dependent protein kinase catalytic subunit alpha (PKA C-alpha) (EC 2.7.11.11)	1	0	0	1	0	1	0	-	0	0	1	1	0	1	0	0	0	0	1	0	0	0	0	0	0	0	1	0	0	1	0	0	fibrolamellar hepatocellular carcinoma, cortisol secreting adrenal adenoma
PRKAR1A	1	P10644	PRKAR1A PKR1 PRKAR1 TSE1	reviewed	cAMP-dependent protein kinase type I-alpha regulatory subunit (Tissue-specific extinguisher 1) (TSE1)	1	1	1	1	1	1	1	-	0	1	1	1	1	1	1	0	0	0	1	0	1	0	0	0	0	0	1	0	1	1	0	0	papillary thyroid, myxoma, endocrine, papillary thyroid
PRKCB	2	P05771	PRKCB PKCB PRKCB1	reviewed	Protein kinase C beta type (PKC-B) (PKC-beta) (EC 2.7.11.13)	1	0	0	0	0	0	0	-	0	0	0	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	adult T-cell lymphoma-leukaemia
PRPF40B	2	Q6NWY9	PRPF40B HYPC	reviewed	Pre-mRNA-processing factor 40 homolog B (Huntingtin yeast partner C) (Huntingtin-interacting protein C)	1	0	0	0	0	0	0	-	0	0	0	0	0	1	1	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	melanoma, colon carcinoma, MDS
PRRX1	1	P54821	PRRX1 PMX1	reviewed	Paired mesoderm homeobox protein 1 (Homeobox protein PHOX1) (Paired-related homeobox protein 1) (PRX-1)	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	AML
PSIP1	1	O75475	PSIP1 DFS70 LEDGF PSIP2	reviewed	PC4 and SFRS1-interacting protein (CLL-associated antigen KW-7) (Dense fine speckles 70 kDa protein) (DFS 70) (Lens epithelium-derived growth factor) (Transcriptional coactivator p75/p52)	1	0	0	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	1	1	1	0	0	0	AML
PTCH1	1	Q13635	PTCH1 PTCH	reviewed	Protein patched homolog 1 (PTC) (PTC1)	1	1	1	0	0	0	1	-	0	0	0	1	1	1	1	0	0	0	1	0	1	0	0	0	0	0	0	0	0	0	0	0	skin basal cell, medulloblastoma, skin basal cell, medulloblastoma
PTEN	1	P60484	PTEN MMAC1 TEP1	reviewed	Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN (EC 3.1.3.16) (EC 3.1.3.48) (EC 3.1.3.67) (Mutated in multiple advanced cancers 1) (Phosphatase and tensin homolog)	1	1	1	0	0	1	0	-	1	0	0	1	1	1	1	1	0	0	1	1	1	1	0	1	1	1	1	1	1	0	1	0	glioma, prostate, endometrial, harmartoma, glioma, prostate, endometrial
PTK6	1	Q13882	PTK6 BRK	reviewed	Protein-tyrosine kinase 6 (EC 2.7.10.2) (Breast tumor kinase) (Tyrosine-protein kinase BRK)	1	0	1	1	0	1	0	-	0	0	0	1	0	1	0	0	0	0	1	0	0	0	0	0	0	0	1	0	1	1	1	0	renal, gastric, head and neck, ovarian, others
PTPN11	1	Q06124	PTPN11 PTP2C SHPTP2	reviewed	Tyrosine-protein phosphatase non-receptor type 11 (EC 3.1.3.48) (Protein-tyrosine phosphatase 1D) (PTP-1D) (Protein-tyrosine phosphatase 2C) (PTP-2C) (SH-PTP2) (SHP-2) (Shp2) (SH-PTP3)	1	0	0	1	0	1	0	-	0	0	0	1	0	0	0	0	0	0	0	1	0	0	1	0	1	1	1	1	1	1	1	1	JMML, AML, MDS
PTPN13	1	Q12923	PTPN13 PNP1 PTP1E PTPL1	reviewed	Tyrosine-protein phosphatase non-receptor type 13 (EC 3.1.3.48) (Fas-associated protein-tyrosine phosphatase 1) (FAP-1) (PTP-BAS) (Protein-tyrosine phosphatase 1E) (PTP-E1) (hPTPE1) (Protein-tyrosine phosphatase PTPL1)	1	1	1	0	0	0	1	-	0	0	0	1	0	1	0	0	0	0	1	0	0	0	0	0	0	0	1	0	1	0	0	0	lung, NSCLC, gastric, peritoneal carcinomatosis, hepatocellular
PTPN6	2	P29350	PTPN6 HCP PTP1C	reviewed	Tyrosine-protein phosphatase non-receptor type 6 (EC 3.1.3.48) (Hematopoietic cell protein-tyrosine phosphatase) (Protein-tyrosine phosphatase 1C) (PTP-1C) (Protein-tyrosine phosphatase SHP-1) (SH-PTP1)	1	0	1	0	0	0	0	-	0	0	0	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	DLBCL
PTPRB	1	P23467	PTPRB PTPB	reviewed	Receptor-type tyrosine-protein phosphatase beta (Protein-tyrosine phosphatase beta) (R-PTP-beta) (EC 3.1.3.48) (Vascular endothelial protein tyrosine phosphatase) (VE-PTP)	1	0	1	0	0	0	1	-	0	0	0	1	1	1	1	0	0	0	1	0	0	0	1	0	0	0	0	0	1	0	1	1	angiosarcoma
PTPRC	1	P08575	PTPRC CD45	reviewed	Receptor-type tyrosine-protein phosphatase C (EC 3.1.3.48) (Leukocyte common antigen) (L-CA) (T200) (CD antigen CD45)	1	0	1	0	0	0	1	-	0	0	0	1	1	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	T-ALL
PTPRD	2	P23468	PTPRD	reviewed	Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48)	1	0	1	0	0	0	0	-	0	0	0	1	0	1	0	1	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	lung cancer, kidney cancer, HNSCC, glioblastoma
PTPRK	1	Q15262	PTPRK PTPK	reviewed	Receptor-type tyrosine-protein phosphatase kappa (Protein-tyrosine phosphatase kappa) (R-PTP-kappa) (EC 3.1.3.48)	1	0	1	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	colorectal
PTPRT	1	O14522	PTPRT KIAA0283	reviewed	Receptor-type tyrosine-protein phosphatase T (R-PTP-T) (EC 3.1.3.48) (Receptor-type tyrosine-protein phosphatase rho) (RPTP-rho)	1	0	1	0	0	0	0	-	0	0	0	1	0	1	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	1	0	HNSCC, colorectal cancer, gastric cancer, lung cancer, melanoma
PWWP2A	2	Q96N64	PWWP2A KIAA1935 MST101	reviewed	PWWP domain-containing protein 2A	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	Spitzoid tumour
QKI	1	Q96PU8	QKI HKQ	reviewed	Protein quaking (Hqk) (HqkI)	1	0	1	1	0	1	0	-	0	0	1	1	0	0	1	0	0	0	1	0	0	1	0	0	0	0	1	0	0	0	1	0	angiocentric glioma, colorectal cancer
RABEP1	1	Q15276	RABEP1 RAB5EP RABPT5 RABPT5A	reviewed	Rab GTPase-binding effector protein 1 (Rabaptin-4) (Rabaptin-5) (Rabaptin-5alpha) (Renal carcinoma antigen NY-REN-17)	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0	1	0	CMML
RAC1	1	P63000	RAC1 TC25 MIG5	reviewed	Ras-related C3 botulinum toxin substrate 1 (EC 3.6.5.2) (Cell migration-inducing gene 5 protein) (Ras-like protein TC25) (p21-Rac1)	1	0	0	1	0	1	0	-	0	0	0	1	0	0	1	0	0	0	1	0	0	0	1	0	0	1	1	1	1	1	0	0	melanoma, carcinoma
RAD17	2	O75943	RAD17 R24L	reviewed	Cell cycle checkpoint protein RAD17 (hRad17) (RF-C/activator 1 homolog)	1	0	1	0	0	0	0	-	0	0	0	0	0	0	0	1	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	lymphoma, colon cancer
RAD21	1	O60216	RAD21 HR21 KIAA0078 NXP1 SCC1	reviewed	Double-strand-break repair protein rad21 homolog (hHR21) (Nuclear matrix protein 1) (NXP-1) (SCC1 homolog) [Cleaved into: 64-kDa C-terminal product (64-kDa carboxy-terminal product) (65-kDa carboxy-terminal product)]	1	0	1	1	0	0	1	-	0	0	0	1	0	1	1	0	0	0	1	1	0	0	0	0	0	0	1	1	1	0	0	0	AML, endometrium, colorectal, lung
RAD51B	1	O15315	RAD51B RAD51L1 REC2	reviewed	DNA repair protein RAD51 homolog 2 (R51H2) (RAD51 homolog B) (Rad51B) (RAD51-like protein 1)	1	0	1	0	1	1	0	1	0	1	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	lipoma, uterine leiomyoma
RAF1	1	P04049	RAF1 RAF	reviewed	RAF proto-oncogene serine/threonine-protein kinase (EC 2.7.11.1) (Proto-oncogene c-RAF) (cRaf) (Raf-1)	1	0	0	1	1	1	0	2	0	1	1	0	0	0	0	0	1	0	1	0	0	1	1	0	0	0	1	0	1	1	0	0	pilocytic astrocytoma, prostate
RALGDS	2	Q12967	RALGDS KIAA1308 RGF	reviewed	Ral guanine nucleotide dissociation stimulator (RalGDS) (Ral guanine nucleotide exchange factor) (RalGEF)	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	PMBL, Hodgkin lymphoma,
RANBP2	1	P49792	RANBP2 NUP358	reviewed	E3 SUMO-protein ligase RanBP2 (EC 2.3.2.-) (358 kDa nucleoporin) (Nuclear pore complex protein Nup358) (Nucleoporin Nup358) (Ran-binding protein 2) (RanBP2) (p270)	1	0	1	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	inflammatory myofibroblastic tumour
RAP1GDS1	1	P52306	RAP1GDS1	reviewed	Rap1 GTPase-GDP dissociation stimulator 1 (Exchange factor smgGDS) (SMG GDS protein) (SMG P21 stimulatory GDP/GTP exchange protein)	1	0	0	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	1	0	0	T-ALL
RARA	1	P10276	RARA NR1B1	reviewed	Retinoic acid receptor alpha (RAR-alpha) (Nuclear receptor subfamily 1 group B member 1)	1	0	0	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	APL
RB1	1	P06400	RB1	reviewed	Retinoblastoma-associated protein (p105-Rb) (p110-RB1) (pRb) (Rb) (pp110)	1	1	1	0	0	0	1	-	1	0	0	1	1	1	1	1	0	0	1	1	1	1	0	0	1	1	1	1	1	0	1	0	retinoblastoma, sarcoma, breast, small cell lung carcinoma, retinoblastoma, sarcoma, breast, small cell lung carcinoma
RBM10	1	P98175	RBM10 DXS8237E GPATC9 GPATCH9 KIAA0122	reviewed	RNA-binding protein 10 (G patch domain-containing protein 9) (RNA-binding motif protein 10) (RNA-binding protein S1-1) (S1-1)	1	0	1	0	0	0	1	-	0	0	0	1	0	1	1	0	0	0	1	0	0	0	0	0	0	0	1	0	0	0	1	0	lung adenocarcinoma
RBM15	1	Q96T37	RBM15 OTT OTT1	reviewed	RNA-binding protein 15 (One-twenty two protein 1) (RNA-binding motif protein 15)	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	acute megakaryocytic leukaemia
RECQL4	1	O94761	RECQL4 RECQ4	reviewed	ATP-dependent DNA helicase Q4 (EC 3.6.4.12) (DNA helicase, RecQ-like type 4) (RecQ4) (RTS) (RecQ protein-like 4)	0	1	1	1	0	0	1	-	0	0	0	0	1	1	1	0	0	0	0	0	1	0	0	0	0	0	1	1	1	0	0	0	osteosarcoma, skin basal cell, skin sqamous cell
REL	1	Q04864	REL	reviewed	Proto-oncogene c-Rel	1	0	0	1	0	1	0	-	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	Hodgkin lymphoma
RET	1	P07949	RET CDHF12 CDHR16 PTC RET51	reviewed	"Proto-oncogene tyrosine-protein kinase receptor Ret (EC 2.7.10.1) (Cadherin family member 12) (Proto-oncogene c-Ret) [Cleaved into: Soluble RET kinase fragment; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment]"	1	1	0	1	1	1	0	1	0	1	1	1	0	1	1	0	0	0	1	0	0	1	0	0	0	1	1	0	1	1	0	1	medullary thyroid, papillary thyroid, pheochromocytoma, NSCLC, Spitzoid tumour, medullary thyroid,  papillary thyroid, pheochromocytoma
RFWD3	2	Q6PCD5	RFWD3 RNF201	reviewed	E3 ubiquitin-protein ligase RFWD3 (EC 2.3.2.27) (RING finger and WD repeat domain-containing protein 3) (RING finger protein 201)	1	1	1	0	0	0	0	-	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	lung cancer
RGPD3	2	A6NKT7	RGPD3 RGP3	reviewed	RanBP2-like and GRIP domain-containing protein 3	1	0	0	0	0	0	0	-	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	endometrioid adenocarcinoma
RGS7	2	P49802	RGS7	reviewed	Regulator of G-protein signaling 7 (RGS7)	1	0	0	0	0	0	0	-	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	melanoma
RHOA	1	P61586	RHOA ARH12 ARHA RHO12	reviewed	Transforming protein RhoA (EC 3.6.5.2) (Rho cDNA clone 12) (h12)	1	0	1	1	0	1	0	-	0	0	0	1	0	0	1	0	0	1	1	1	0	0	0	0	0	0	1	1	1	0	1	1	diffuse gastric, T cell lymphomas, paediatric Burkitt lymphoma
RHOH	1	Q15669	RHOH ARHH TTF	reviewed	Rho-related GTP-binding protein RhoH (GTP-binding protein TTF) (Translocation three four protein)	1	0	1	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	1	0	1	0	1	0	NHL
RMI2	1	Q96E14	RMI2 C16orf75	reviewed	RecQ-mediated genome instability protein 2 (hRMI2) (BLM-associated protein of 18 kDa) (BLAP18)	1	0	1	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	PMBL, Hodgkin lymphoma
RNF213	1	Q63HN8	RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR	reviewed	E3 ubiquitin-protein ligase RNF213 (EC 2.3.2.27) (EC 3.6.4.-) (ALK lymphoma oligomerization partner on chromosome 17) (Mysterin) (RING finger protein 213) (RING-type E3 ubiquitin transferase RNF213)	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	ALCL
RNF43	1	Q68DV7	RNF43	reviewed	E3 ubiquitin-protein ligase RNF43 (EC 2.3.2.27) (RING finger protein 43) (RING-type E3 ubiquitin transferase RNF43)	1	0	1	0	0	0	1	-	0	0	0	1	1	1	1	0	0	0	1	0	0	0	0	1	0	0	1	0	0	0	1	0	cholangiocarcinoma, ovary, pancreas
ROBO2	2	Q9HCK4	ROBO2 KIAA1568	reviewed	Roundabout homolog 2	1	0	1	0	0	0	0	-	0	0	0	0	0	0	1	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	colorectal adenocarcinoma, melanoma
ROS1	1	P08922	ROS1 MCF3 ROS	reviewed	Proto-oncogene tyrosine-protein kinase ROS (EC 2.7.10.1) (Proto-oncogene c-Ros) (Proto-oncogene c-Ros-1) (Receptor tyrosine kinase c-ros oncogene 1) (c-Ros receptor tyrosine kinase)	1	0	0	1	1	1	0	1	1	1	1	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	1	0	0	glioblastoma, NSCLC, Spitzoid tumour, cholangiocarcinoma, borderline ovarian
RPL10	1	P27635	RPL10 DXS648E QM	reviewed	60S ribosomal protein L10 (Laminin receptor homolog) (Large ribosomal subunit protein uL16) (Protein QM) (Ribosomal protein L10) (Tumor suppressor QM)	1	0	1	0	0	1	0	-	0	0	0	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	T-ALL
RPL22	1	P35268	RPL22	reviewed	60S ribosomal protein L22 (EBER-associated protein) (EAP) (Epstein-Barr virus small RNA-associated protein) (Heparin-binding protein HBp15) (Large ribosomal subunit protein eL22)	1	0	1	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	AML, CML
RPL5	1	P46777	RPL5 MSTP030	reviewed	60S ribosomal protein L5 (Large ribosomal subunit protein uL18)	1	0	1	0	0	1	0	-	0	0	0	1	0	1	1	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	T-ALL
RPN1	1	P04843	RPN1	reviewed	Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1 (Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 67 kDa subunit) (Ribophorin I) (RPN-I) (Ribophorin-1)	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	AML
RSPO2	1	Q6UXX9	RSPO2 UNQ9384/PRO34209	reviewed	R-spondin-2 (Roof plate-specific spondin-2) (hRspo2)	1	0	1	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	colorectal
RSPO3	1	Q9BXY4	RSPO3 PWTSR THSD2	reviewed	R-spondin-3 (Protein with TSP type-1 repeat) (hPWTSR) (Roof plate-specific spondin-3) (hRspo3) (Thrombospondin type-1 domain-containing protein 2)	1	0	0	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	colorectal
RUNX1	1	Q01196	RUNX1 AML1 CBFA2	reviewed	Runt-related transcription factor 1 (Acute myeloid leukemia 1 protein) (Core-binding factor subunit alpha-2) (CBF-alpha-2) (Oncogene AML-1) (Polyomavirus enhancer-binding protein 2 alpha B subunit) (PEA2-alpha B) (PEBP2-alpha B) (SL3-3 enhancer factor 1 alpha B subunit) (SL3/AKV core-binding factor alpha B subunit)	1	0	1	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	AML, pre B-ALL, T-ALL
RUNX1T1	1	Q06455	RUNX1T1 AML1T1 CBFA2T1 CDR ETO MTG8 ZMYND2	reviewed	Protein CBFA2T1 (Cyclin-D-related protein) (Eight twenty one protein) (Protein ETO) (Protein MTG8) (Zinc finger MYND domain-containing protein 2)	1	0	1	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	1	0	AML
S100A7	2	P31151	S100A7 PSOR1 S100A7C	reviewed	Protein S100-A7 (Psoriasin) (S100 calcium-binding protein A7)	1	0	0	0	1	0	0	-	0	1	1	1	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	melanoma, T-cell lymphoma
SALL4	1	Q9UJQ4	SALL4 ZNF797	reviewed	Sal-like protein 4 (Zinc finger protein 797) (Zinc finger protein SALL4)	1	0	0	1	0	0	0	-	0	0	0	1	0	0	1	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	colorectal cancer, breast cancer, prostate cancer, glioblastoma, melanoma
SBDS	1	Q9Y3A5	SBDS CGI-97	reviewed	Ribosome maturation protein SBDS (Shwachman-Bodian-Diamond syndrome protein)	0	1	1	0	0	0	1	-	0	0	0	0	0	1	1	0	0	1	0	1	0	0	0	0	0	0	0	0	0	0	0	0	AML, MDS
SDC4	1	P31431	SDC4	reviewed	Syndecan-4 (SYND4) (Amphiglycan) (Ryudocan core protein)	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	NSCLC
SDHA	1	P31040	SDHA SDH2 SDHF	reviewed	Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial (EC 1.3.5.1) (Flavoprotein subunit of complex II) (Fp)	1	1	1	0	0	0	1	-	0	0	0	1	0	1	0	0	0	0	0	0	1	1	1	0	1	0	0	0	0	0	0	0	GIST, paraganglioma, paraganglioma
SDHAF2	1	Q9NX18	SDHAF2 C11orf79 PGL2 SDH5	reviewed	Succinate dehydrogenase assembly factor 2, mitochondrial (SDH assembly factor 2) (SDHAF2)	0	1	1	0	0	0	1	-	0	0	0	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	paraganglioma
SDHB	1	P21912	SDHB SDH SDH1	reviewed	Succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial (EC 1.3.5.1) (Iron-sulfur subunit of complex II) (Ip)	0	1	1	0	0	0	1	-	0	0	0	1	0	1	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	paraganglioma, pheochromocytoma
SDHC	1	Q99643	SDHC CYB560 SDH3	reviewed	Succinate dehydrogenase cytochrome b560 subunit, mitochondrial (Integral membrane protein CII-3) (QPs-1) (QPs1) (Succinate dehydrogenase complex subunit C) (Succinate-ubiquinone oxidoreductase cytochrome B large subunit) (CYBL)	0	1	1	0	0	0	1	-	0	0	0	1	0	1	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	paraganglioma, pheochromocytoma
SDHD	1	O14521	SDHD SDH4	reviewed	Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial (CybS) (CII-4) (QPs3) (Succinate dehydrogenase complex subunit D) (Succinate-ubiquinone oxidoreductase cytochrome b small subunit) (Succinate-ubiquinone reductase membrane anchor subunit)	0	1	1	0	0	0	1	-	0	0	0	1	1	1	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	paraganglioma, pheochromocytoma
Sep-05	2	Q99719	SEPTIN5 PNUTL1 SEPT5	reviewed	Septin-5 (Cell division control-related protein 1) (CDCrel-1) (Peanut-like protein 1)	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	AML
Sep-06	2	Q14141	SEPTIN6 KIAA0128 SEP2 SEPT6	reviewed	Septin-6	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	AML
Sep-09	2	Q9UHD8	SEPTIN9 KIAA0991 MSF SEPT9	reviewed	Septin-9 (MLL septin-like fusion protein MSF-A) (MLL septin-like fusion protein) (Ovarian/Breast septin) (Ov/Br septin) (Septin D1)	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	AML*
SET	1	Q01105	SET	reviewed	Protein SET (HLA-DR-associated protein II) (Inhibitor of granzyme A-activated DNase) (IGAAD) (PHAPII) (Phosphatase 2A inhibitor I2PP2A) (I-2PP2A) (Template-activating factor I) (TAF-I)	1	0	0	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	T-ALL
SETBP1	1	Q9Y6X0	SETBP1 KIAA0437	reviewed	SET-binding protein (SEB)	1	1	0	1	1	1	0	-	0	1	1	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	aCML, sAML, MDS/MPN-U, CMML, JMML, neuroepithelial tumours
SETD1B	2	Q9UPS6	SETD1B KIAA1076 KMT2G SET1B	reviewed	Histone-lysine N-methyltransferase SETD1B (EC 2.1.1.364) (Lysine N-methyltransferase 2G) (SET domain-containing protein 1B) (hSET1B)	1	0	1	0	0	0	0	-	0	0	0	0	0	0	1	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	CRC, endometrium
SETD2	1	Q9BYW2	SETD2 HIF1 HYPB KIAA1732 KMT3A SET2 HSPC069	reviewed	Histone-lysine N-methyltransferase SETD2 (EC 2.1.1.359) (HIF-1) (Huntingtin yeast partner B) (Huntingtin-interacting protein 1) (HIP-1) (Huntingtin-interacting protein B) (Lysine N-methyltransferase 3A) (Protein-lysine N-methyltransferase SETD2) (EC 2.1.1.-) (SET domain-containing protein 2) (hSET2) (p231HBP)	1	0	1	0	0	0	1	-	0	0	0	1	1	1	1	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	clear cell renal carcinoma
SETDB1	2	Q15047	SETDB1 ESET KIAA0067 KMT1E	reviewed	Histone-lysine N-methyltransferase SETDB1 (EC 2.1.1.366) (ERG-associated protein with SET domain) (ESET) (Histone H3-K9 methyltransferase 4) (H3-K9-HMTase 4) (Lysine N-methyltransferase 1E) (SET domain bifurcated 1)	1	0	0	1	0	0	0	-	0	0	0	1	0	0	1	0	0	0	1	0	0	0	0	1	0	1	1	0	1	1	0	0	malignant mesothelioma
SF3B1	1	O75533	SF3B1 SAP155	reviewed	Splicing factor 3B subunit 1 (Pre-mRNA-splicing factor SF3b 155 kDa subunit) (SF3b155) (Spliceosome-associated protein 155) (SAP 155)	1	0	0	1	0	1	0	-	0	0	0	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	myelodysplastic syndrome
SFPQ	1	P23246	SFPQ PSF	reviewed	Splicing factor, proline- and glutamine-rich (100 kDa DNA-pairing protein) (hPOMp100) (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)	1	0	1	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	1	0	0	0	0	0	papillary renal
SFRP4	1	Q6FHJ7	SFRP4 FRPHE	reviewed	Secreted frizzled-related protein 4 (sFRP-4) (Frizzled protein, human endometrium) (FrpHE)	1	0	1	0	0	0	1	-	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	colorectal cancer, melanoma, SCC, gastric cancer, oesophageal SCC
SGK1	2	O00141	SGK1 SGK	reviewed	Serine/threonine-protein kinase Sgk1 (EC 2.7.11.1) (Serum/glucocorticoid-regulated kinase 1)	1	0	0	1	0	0	0	-	0	0	0	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	Nodular lymphocyte predominant Hodgkin lymphoma
SH2B3	1	Q9UQQ2	SH2B3 LNK	reviewed	SH2B adapter protein 3 (Lymphocyte adapter protein) (Lymphocyte-specific adapter protein Lnk) (Signal transduction protein Lnk)	1	0	1	0	0	0	1	-	0	0	0	1	0	1	1	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	MPN, sAML, erythrocytosis, B-ALL
SH3GL1	1	Q99961	SH3GL1 CNSA1 SH3D2B	reviewed	Endophilin-A2 (EEN fusion partner of MLL) (Endophilin-2) (Extra eleven-nineteen leukemia fusion gene protein) (EEN) (SH3 domain protein 2B) (SH3 domain-containing GRB2-like protein 1)	1	0	0	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	AL
SHTN1	2	A0MZ66	SHTN1 KIAA1598	reviewed	Shootin-1 (Shootin1)	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	Spitzoid tumour
SIRPA	2	P78324	SIRPA BIT MFR MYD1 PTPNS1 SHPS1 SIRP	reviewed	Tyrosine-protein phosphatase non-receptor type substrate 1 (SHP substrate 1) (SHPS-1) (Brain Ig-like molecule with tyrosine-based activation motifs) (Bit) (CD172 antigen-like family member A) (Inhibitory receptor SHPS-1) (Macrophage fusion receptor) (MyD-1 antigen) (Signal-regulatory protein alpha-1) (Sirp-alpha-1) (Signal-regulatory protein alpha-2) (Sirp-alpha-2) (Signal-regulatory protein alpha-3) (Sirp-alpha-3) (p84) (CD antigen CD172a)	1	0	1	0	0	0	0	-	0	0	0	0	0	0	1	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	HNSCC, colorectal cancer, Lung SCC
SIX1	1	Q15475	SIX1	reviewed	Homeobox protein SIX1 (Sine oculis homeobox homolog 1)	1	0	0	1	0	0	0	-	0	0	0	1	0	0	0	0	0	0	0	0	0	1	1	1	1	0	1	1	1	1	0	0	Wilms tumour
SIX2	2	Q9NPC8	SIX2	reviewed	Homeobox protein SIX2 (Sine oculis homeobox homolog 2)	1	0	0	1	0	0	0	-	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	Wilms tumour
SKI	2	P12755	SKI	reviewed	Ski oncogene (Proto-oncogene c-Ski)	1	0	0	1	0	0	0	-	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	melanoma
SLC34A2	1	O95436	SLC34A2	reviewed	Sodium-dependent phosphate transport protein 2B (Sodium-phosphate transport protein 2B) (Na(+)-dependent phosphate cotransporter 2B) (NaPi3b) (Sodium/phosphate cotransporter 2B) (Na(+)/Pi cotransporter 2B) (NaPi-2b) (Solute carrier family 34 member 2)	1	0	1	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	1	0	0	0	0	1	0	0	0	0	1	1	1	0	NSCLC
SLC45A3	1	Q96JT2	SLC45A3 PCANAP6 PRST	reviewed	Solute carrier family 45 member 3 (Prostate cancer-associated protein 6) (Prostein)	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	prostate
SMAD2	1	Q15796	SMAD2 MADH2 MADR2	reviewed	Mothers against decapentaplegic homolog 2 (MAD homolog 2) (Mothers against DPP homolog 2) (JV18-1) (Mad-related protein 2) (hMAD-2) (SMAD family member 2) (SMAD 2) (Smad2) (hSMAD2)	1	0	1	0	0	0	1	-	0	0	0	1	0	1	0	0	0	0	1	0	0	0	0	1	0	0	1	0	1	0	1	0	colorectal carcinoma, hepatocellular carcinoma
SMAD3	1	P84022	SMAD3 MADH3	reviewed	Mothers against decapentaplegic homolog 3 (MAD homolog 3) (Mad3) (Mothers against DPP homolog 3) (hMAD-3) (JV15-2) (SMAD family member 3) (SMAD 3) (Smad3) (hSMAD3)	1	0	1	0	0	0	1	-	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	1	0	1	1	1	0	colorectal carcinoma, oral squamous cell carcinoma
SMAD4	1	Q13485	SMAD4 DPC4 MADH4	reviewed	Mothers against decapentaplegic homolog 4 (MAD homolog 4) (Mothers against DPP homolog 4) (Deletion target in pancreatic carcinoma 4) (SMAD family member 4) (SMAD 4) (Smad4) (hSMAD4)	1	1	1	0	0	0	1	-	0	0	0	1	0	1	1	1	0	0	1	0	0	0	1	0	0	0	0	1	1	0	1	1	colorectal, pancreatic, small intestine, gastrointestinal polyp
SMARCA4	1	P51532	SMARCA4 BAF190A BRG1 SNF2B SNF2L4	reviewed	Transcription activator BRG1 (EC 3.6.4.-) (ATP-dependent helicase SMARCA4) (BRG1-associated factor 190A) (BAF190A) (Mitotic growth and transcription activator) (Protein BRG-1) (Protein brahma homolog 1) (SNF2-beta) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 4)	1	0	1	0	0	0	1	-	0	0	0	1	1	1	1	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	NSCLC, SCCOHT
SMARCB1	1	Q12824	SMARCB1 BAF47 INI1 SNF5L1	reviewed	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1 (BRG1-associated factor 47) (BAF47) (Integrase interactor 1 protein) (SNF5 homolog) (hSNF5)	1	1	1	0	0	0	1	1	0	0	0	0	1	1	1	1	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	malignant rhabdoid, malignant rhabdoid
SMARCD1	1	Q96GM5	SMARCD1 BAF60A	reviewed	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 1 (60 kDa BRG-1/Brm-associated factor subunit A) (BRG1-associated factor 60A) (BAF60A) (SWI/SNF complex 60 kDa subunit)	1	0	1	0	0	0	1	-	0	0	0	0	0	1	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	breast
SMARCE1	1	Q969G3	SMARCE1 BAF57	reviewed	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1 (BRG1-associated factor 57) (BAF57)	0	1	1	0	0	0	1	-	0	0	0	1	0	1	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	meningioma
SMC1A	2	Q14683	SMC1A DXS423E KIAA0178 SB1.8 SMC1 SMC1L1	reviewed	Structural maintenance of chromosomes protein 1A (SMC protein 1A) (SMC-1-alpha) (SMC-1A) (Sb1.8)	1	0	1	0	0	0	0	-	0	0	0	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	AML
SMO	1	Q99835	SMO SMOH	reviewed	Smoothened homolog (SMO) (Protein Gx)	1	0	0	1	0	1	0	-	1	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	skin basal cell
SND1	1	Q7KZF4	SND1 TDRD11	reviewed	Staphylococcal nuclease domain-containing protein 1 (EC 3.1.31.1) (100 kDa coactivator) (EBNA2 coactivator p100) (Tudor domain-containing protein 11) (p100 co-activator)	1	0	0	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	pancreas acinar carcinoma
SNX29	2	Q8TEQ0	SNX29 RUNDC2A	reviewed	Sorting nexin-29 (RUN domain-containing protein 2A)	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	PMBL, Hodgkin lymphoma
SOCS1	1	O15524	SOCS1 SSI1 TIP3	reviewed	Suppressor of cytokine signaling 1 (SOCS-1) (JAK-binding protein) (JAB) (STAT-induced STAT inhibitor 1) (SSI-1) (Tec-interacting protein 3) (TIP-3)	1	0	1	0	0	0	1	-	0	0	0	0	0	0	1	0	0	1	0	1	0	0	0	0	0	0	0	0	0	0	0	0	Hodgkin lymphoma, PMBL
SOX2	1	P48431	SOX2	reviewed	Transcription factor SOX-2	1	0	0	1	0	1	0	-	0	0	0	0	0	0	0	0	1	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	NSCLC, oesophageal squamous carcinoma
SOX21	2	Q9Y651	SOX21 SOX25 SOXA	reviewed	Transcription factor SOX-21 (SOX-A)	1	0	1	0	0	0	0	-	0	0	0	0	0	0	0	1	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	multiple myeloma
SPECC1	2	Q5M775	SPECC1 CYTSB NSP5	reviewed	Cytospin-B (Nuclear structure protein 5) (NSP5) (Sperm antigen HCMOGT-1) (Sperm antigen with calponin homology and coiled-coil domains 1)	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	JMML
SPEN	1	Q96T58	SPEN KIAA0929 MINT SHARP	reviewed	Msx2-interacting protein (SMART/HDAC1-associated repressor protein) (SPEN homolog)	1	0	1	0	0	0	1	-	0	0	0	1	0	1	1	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	SMZL, adenoid cystic carcinoma, DLBCL
SPOP	1	O43791	SPOP	reviewed	Speckle-type POZ protein (HIB homolog 1) (Roadkill homolog 1)	1	1	1	0	0	0	1	-	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	1	1	1	0	1	0	prostate, endometrial, prostate cancer
SRC	1	P12931	SRC SRC1	reviewed	Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)	1	0	0	1	0	1	0	-	0	0	0	1	0	1	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	colorectal cancer, endometrial carcinoma
SRGAP3	2	O43295	SRGAP3 ARHGAP14 KIAA0411 KIAA1156 MEGAP SRGAP2	reviewed	SLIT-ROBO Rho GTPase-activating protein 3 (srGAP3) (Mental disorder-associated GAP) (Rho GTPase-activating protein 14) (WAVE-associated Rac GTPase-activating protein) (WRP)	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	pilocytic astrocytoma
SRSF2	1	Q01130	SRSF2 SFRS2	reviewed	Serine/arginine-rich splicing factor 2 (Protein PR264) (Splicing component, 35 kDa) (Splicing factor SC35) (SC-35) (Splicing factor, arginine/serine-rich 2)	1	0	0	1	0	1	0	-	0	0	0	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	MDS, CLL
SRSF3	1	P84103	SRSF3 SFRS3 SRP20	reviewed	Serine/arginine-rich splicing factor 3 (Pre-mRNA-splicing factor SRP20) (Splicing factor, arginine/serine-rich 3)	1	0	0	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	follicular lymphoma
SS18	1	Q15532	SS18 SSXT SYT	reviewed	Protein SSXT (Protein SYT) (Synovial sarcoma translocated to X chromosome protein)	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	synovial sarcoma
SS18L1	1	O75177	SS18L1 CREST KIAA0693	reviewed	Calcium-responsive transactivator (SS18-like protein 1) (SYT homolog 1)	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	synovial sarcoma
SSX1	1	Q16384	SSX1	reviewed	Protein SSX1 (Cancer/testis antigen 5.1) (CT5.1) (Synovial sarcoma, X breakpoint 1)	1	0	0	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	synovial sarcoma
SSX2	1	Q16385	"SSX2 SSX2A; SSX2B"	reviewed	Protein SSX2 (Cancer/testis antigen 5.2) (CT5.2) (Synovial sarcoma, X breakpoint 2) (Tumor antigen HOM-MEL-40)	1	0	0	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	synovial sarcoma
SSX4	1	O60224	"SSX4 SSX4A; SSX4B"	reviewed	Protein SSX4 (Cancer/testis antigen 5.4) (CT5.4)	1	0	0	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	synovial sarcoma
STAG1	2	Q8WVM7	STAG1 SA1 SCC3	reviewed	Cohesin subunit SA-1 (SCC3 homolog 1) (Stromal antigen 1)	1	0	1	0	0	0	0	-	0	0	0	1	0	1	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	colorectal cancer, AML
STAG2	1	Q8N3U4	STAG2 SA2	reviewed	Cohesin subunit SA-2 (SCC3 homolog 2) (Stromal antigen 2)	1	0	1	0	0	0	1	-	0	0	0	1	1	1	1	0	0	0	1	1	1	1	0	1	0	0	0	1	0	0	0	0	bladder carcinoma, glioblastoma, melanoma, Ewing's sarcoma, myeloid neoplasms
STAT3	1	P40763	STAT3 APRF	reviewed	Signal transducer and activator of transcription 3 (Acute-phase response factor)	1	1	0	1	0	1	0	-	0	0	0	1	0	0	0	0	0	1	0	1	0	0	0	0	0	0	0	0	0	0	0	0	T-cell large granular lymphocytic leukaemia, paediatric large granular lymphocytic leukaemia
STAT5B	1	P51692	STAT5B	reviewed	Signal transducer and activator of transcription 5B	1	0	1	1	1	1	0	-	0	1	1	1	0	0	0	0	0	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	large granular lymphocytic leukaemia, skin basal cell, APL
STAT6	1	P42226	STAT6	reviewed	Signal transducer and activator of transcription 6 (IL-4 Stat)	1	0	0	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	solitary fibrous tumour, meningeal haemangiopericytoma
STIL	1	Q15468	STIL SIL	reviewed	SCL-interrupting locus protein (TAL-1-interrupting locus protein)	1	0	0	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	T-ALL
STK11	1	Q15831	STK11 LKB1 PJS	reviewed	Serine/threonine-protein kinase STK11 (EC 2.7.11.1) (Liver kinase B1) (LKB1) (hLKB1) (Renal carcinoma antigen NY-REN-19)	1	1	1	0	0	0	1	-	0	0	0	1	1	1	1	1	0	0	1	0	1	1	0	0	0	0	0	0	0	0	0	0	NSCLC, pancreatic, jejunal hamartoma, ovarian, testicular, pancreatic
STRN	1	O43815	STRN	reviewed	Striatin	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	anaplastic thyroid, papillary thyroid, lung
SUFU	1	Q9UMX1	SUFU UNQ650/PRO1280	reviewed	Suppressor of fused homolog (SUFUH)	1	1	1	0	0	0	1	-	0	0	0	0	1	0	1	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	medulloblastoma, medulloblastoma
SUZ12	1	Q15022	SUZ12 CHET9 JJAZ1 KIAA0160	reviewed	Polycomb protein SUZ12 (Chromatin precipitated E2F target 9 protein) (ChET 9 protein) (Joined to JAZF1 protein) (Suppressor of zeste 12 protein homolog)	1	0	1	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	1	1	0	0	endometrial stromal tumour
SYK	1	P43405	SYK	reviewed	Tyrosine-protein kinase SYK (EC 2.7.10.2) (Spleen tyrosine kinase) (p72-Syk)	1	0	0	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	MDS, peripheral T-cell lymphoma
TAF15	1	Q92804	TAF15 RBP56 TAF2N	reviewed	TATA-binding protein-associated factor 2N (68 kDa TATA-binding protein-associated factor) (TAF(II)68) (TAFII68) (RNA-binding protein 56)	1	0	0	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	extraskeletal myxoid chondrosarcoma, ALL
TAL1	1	P17542	TAL1 BHLHA17 SCL TCL5	reviewed	T-cell acute lymphocytic leukemia protein 1 (TAL-1) (Class A basic helix-loop-helix protein 17) (bHLHa17) (Stem cell protein) (T-cell leukemia/lymphoma protein 5)	1	0	0	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	lymphoblastic leukaemia/biphasic
TAL2	1	Q16559	TAL2 BHLHA19	reviewed	T-cell acute lymphocytic leukemia protein 2 (TAL-2) (Class A basic helix-loop-helix protein 19) (bHLHa19)	1	0	0	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	T-ALL
TBL1XR1	1	Q9BZK7	TBL1XR1 IRA1 TBLR1	reviewed	F-box-like/WD repeat-containing protein TBL1XR1 (Nuclear receptor corepressor/HDAC3 complex subunit TBLR1) (TBL1-related protein 1) (Transducin beta-like 1X-related protein 1)	1	0	1	1	1	0	1	-	0	1	0	1	0	0	1	0	0	0	1	1	1	0	0	0	0	0	0	0	1	1	1	0	splenic marginal zone lymphoma, primary central nervous system lymphoma, colorectal carcinoma, gallbladder carcinoma
TBX3	1	O15119	TBX3	reviewed	T-box transcription factor TBX3 (T-box protein 3)	1	0	1	1	0	1	0	-	0	0	0	1	0	1	1	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	breast, large intestine, skin
TCEA1	1	P23193	TCEA1 GTF2S TFIIS	reviewed	Transcription elongation factor A protein 1 (Transcription elongation factor S-II protein 1) (Transcription elongation factor TFIIS.o)	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	salivary adenoma
TCF12	1	Q99081	TCF12 BHLHB20 HEB HTF4	reviewed	Transcription factor 12 (TCF-12) (Class B basic helix-loop-helix protein 20) (bHLHb20) (DNA-binding protein HTF4) (E-box-binding protein) (Transcription factor HTF-4)	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	extraskeletal myxoid chondrosarcoma
TCF3	1	P15923	TCF3 BHLHB21 E2A ITF1	reviewed	Transcription factor E2-alpha (Class B basic helix-loop-helix protein 21) (bHLHb21) (Immunoglobulin enhancer-binding factor E12/E47) (Immunoglobulin transcription factor 1) (Kappa-E2-binding factor) (Transcription factor 3) (TCF-3) (Transcription factor ITF-1)	1	0	1	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	pre B-ALL
TCF7L2	1	Q9NQB0	TCF7L2 TCF4	reviewed	Transcription factor 7-like 2 (HMG box transcription factor 4) (T-cell-specific transcription factor 4) (T-cell factor 4) (TCF-4) (hTCF-4)	1	0	0	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	1	0	1	1	0	0	colorectal
TCL1A	1	P56279	TCL1A TCL1	reviewed	T-cell leukemia/lymphoma protein 1A (Oncogene TCL-1) (Oncogene TCL1) (Protein p14 TCL1)	1	0	0	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	1	0	0	1	0	0	T-CLL
TEC	2	P42680	TEC PSCTK4	reviewed	Tyrosine-protein kinase Tec (EC 2.7.10.2)	1	0	0	1	1	0	0	-	0	1	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	myxoid chondrosarcoma
TENT5C	1	Q5VWP2	TENT5C FAM46C	reviewed	Terminal nucleotidyltransferase 5C (EC 2.7.7.19) (Non-canonical poly(A) polymerase FAM46C)	1	0	1	0	0	0	1	-	0	0	0	1	0	0	1	0	0	1	0	1	0	0	0	0	0	0	0	0	0	0	0	0	MM
TERT	1	O14746	TERT EST2 TCS1 TRT	reviewed	Telomerase reverse transcriptase (EC 2.7.7.49) (HEST2) (Telomerase catalytic subunit) (Telomerase-associated protein 2) (TP2)	1	1	1	1	0	1	0	-	0	0	0	1	0	0	0	0	0	0	1	0	0	1	1	1	0	0	1	1	1	1	0	0	melanoma, glioblastoma, hepatocellular carcinoma, bladder, skin basal cell, skin squamous cell, mesothelioma, medulloblastoma, other tumour types, melanoma
TET1	1	Q8NFU7	TET1 CXXC6 KIAA1676 LCX	reviewed	Methylcytosine dioxygenase TET1 (EC 1.14.11.n2) (CXXC-type zinc finger protein 6) (Leukemia-associated protein with a CXXC domain) (Ten-eleven translocation 1 gene protein)	1	0	1	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	1	0	1	0	1	0	AML
TET2	1	Q6N021	TET2 KIAA1546 Nbla00191	reviewed	Methylcytosine dioxygenase TET2 (EC 1.14.11.n2)	1	0	1	0	0	0	1	-	1	0	0	1	0	1	1	0	0	0	0	1	0	0	0	0	1	0	0	1	1	1	1	0	MDS
TFE3	1	P19532	TFE3 BHLHE33	reviewed	Transcription factor E3 (Class E basic helix-loop-helix protein 33) (bHLHe33)	1	0	0	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	papillary renal, alveolar soft part sarcoma, renal
TFEB	1	P19484	TFEB BHLHE35	reviewed	Transcription factor EB (Class E basic helix-loop-helix protein 35) (bHLHe35)	1	0	0	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	1	0	1	0	0	0	0	0	0	0	0	0	0	0	renal cell carcinoma (childhood epithelioid)
TFG	1	Q92734	TFG	reviewed	Protein TFG (TRK-fused gene protein)	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	1	1	1	0	0	0	0	0	0	0	0	0	0	0	papillary thyroid, ALCL, NSCLC, extraskeletal myxoid chondrosarcoma
TFPT	2	P0C1Z6	TFPT INO80F	reviewed	TCF3 fusion partner (INO80 complex subunit F) (Protein FB1)	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	pre-B ALL
TFRC	2	P02786	TFRC	reviewed	Transferrin receptor protein 1 (TR) (TfR) (TfR1) (Trfr) (T9) (p90) (CD antigen CD71) [Cleaved into: Transferrin receptor protein 1, serum form (sTfR)]	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	NHL
TGFBR2	1	P37173	TGFBR2	reviewed	TGF-beta receptor type-2 (TGFR-2) (EC 2.7.11.30) (TGF-beta type II receptor) (Transforming growth factor-beta receptor type II) (TGF-beta receptor type II) (TbetaR-II)	1	1	1	0	0	0	1	-	0	0	0	1	0	1	1	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	1	0	head and neck, colorectal, colorectal
THRAP3	2	Q9Y2W1	THRAP3 BCLAF2 TRAP150	reviewed	Thyroid hormone receptor-associated protein 3 (BCLAF1 and THRAP3 family member 2) (Thyroid hormone receptor-associated protein complex 150 kDa component) (Trap150)	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	aneurysmal bone cyst
TLX1	1	P31314	TLX1 HOX11 TCL3	reviewed	T-cell leukemia homeobox protein 1 (Homeobox protein Hox-11) (Proto-oncogene TCL-3) (T-cell leukemia/lymphoma protein 3)	1	0	0	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	T-ALL
TLX3	1	O43711	TLX3 HOX11L2	reviewed	T-cell leukemia homeobox protein 3 (Homeobox protein Hox-11L2)	1	0	0	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	T-ALL
TMEM127	1	O75204	TMEM127	reviewed	Transmembrane protein 127	0	1	1	0	0	0	1	-	0	0	0	0	0	1	1	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	pheochromocytoma, renal cell carcinoma
TMPRSS2	1	O15393	TMPRSS2 PRSS10	reviewed	"Transmembrane protease serine 2 (EC 3.4.21.-) (Serine protease 10) [Cleaved into: Transmembrane protease serine 2 non-catalytic chain; Transmembrane protease serine 2 catalytic chain]"	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	prostate
TMSB4X	2	P62328	TMSB4X TB4X THYB4 TMSB4	reviewed	Thymosin beta-4 (T beta-4) (Fx) [Cleaved into: Hematopoietic system regulatory peptide (Seraspenide)]	1	0	0	1	0	0	0	-	0	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	DLBCL
TNC	2	P24821	TNC HXB	reviewed	Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C)	1	0	0	1	0	0	0	-	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	SCC, melanoma
TNFAIP3	1	P21580	TNFAIP3 OTUD7C	reviewed	"Tumor necrosis factor alpha-induced protein 3 (TNF alpha-induced protein 3) (EC 2.3.2.-) (EC 3.4.19.12) (OTU domain-containing protein 7C) (Putative DNA-binding protein A20) (Zinc finger protein A20) [Cleaved into: A20p50; A20p37]"	1	0	1	0	0	0	1	-	0	0	0	0	0	1	1	1	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	1	marginal zone B-cell lymphomas, Hodgkin lymphoma, PMBL
TNFRSF14	1	Q92956	TNFRSF14 HVEA HVEM UNQ329/PRO509	reviewed	Tumor necrosis factor receptor superfamily member 14 (Herpes virus entry mediator A) (Herpesvirus entry mediator A) (HveA) (Tumor necrosis factor receptor-like 2) (TR2) (CD antigen CD270)	1	0	1	0	0	0	1	-	0	0	0	1	0	1	1	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	follicular lymphoma
TNFRSF17	1	Q02223	TNFRSF17 BCM BCMA	reviewed	Tumor necrosis factor receptor superfamily member 17 (B-cell maturation protein) (CD antigen CD269)	1	0	0	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	intestinal T-cell lymphoma
TOP1	1	P11387	TOP1	reviewed	DNA topoisomerase 1 (EC 5.6.2.1) (DNA topoisomerase I)	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	AML*
TP53	1	P04637	TP53 P53	reviewed	Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53)	1	1	1	1	1	0	1	-	0	1	1	1	0	1	1	0	0	0	1	1	1	1	1	1	1	1	1	1	1	0	1	1	breast, colorectal, lung, sarcoma, adrenocortical, glioma, Spitzoid tumour, multiple other tumour types, breast, sarcoma, adrenocortical carcinoma, glioma, multiple other tumour types
TP63	1	Q9H3D4	TP63 KET P63 P73H P73L TP73L	reviewed	Tumor protein 63 (p63) (Chronic ulcerative stomatitis protein) (CUSP) (Keratinocyte transcription factor KET) (Transformation-related protein 63) (TP63) (Tumor protein p73-like) (p73L) (p40) (p51)	1	1	1	1	0	0	0	-	0	0	1	1	0	1	0	0	0	0	1	0	0	0	0	0	0	0	1	0	1	1	0	0	HNSCC, DLBCL, NSCLC
TPM3	1	P06753	TPM3	reviewed	Tropomyosin alpha-3 chain (Gamma-tropomyosin) (Tropomyosin-3) (Tropomyosin-5) (hTM5)	1	0	1	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	papillary thyroid, ALCL, NSCLC, Spitzoid tumour
TPM4	1	P67936	TPM4	reviewed	Tropomyosin alpha-4 chain (TM30p1) (Tropomyosin-4)	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	ALCL
TPR	1	P12270	TPR	reviewed	Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein)	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	papillary thyroid, NSCLC
TRAF7	1	Q6Q0C0	TRAF7 RFWD1 RNF119	reviewed	E3 ubiquitin-protein ligase TRAF7 (EC 2.3.2.27) (RING finger and WD repeat-containing protein 1) (RING finger protein 119) (RING-type E3 ubiquitin transferase TRAF7) (TNF receptor-associated factor 7)	1	0	1	0	0	1	0	-	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	1	0	0	0	0	0	meningioma
TRD	1	A0JD36	TRDV2	reviewed	T cell receptor delta variable 2	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	T-cell leukaemia
TRIM24	1	O15164	TRIM24 RNF82 TIF1 TIF1A	reviewed	Transcription intermediary factor 1-alpha (TIF1-alpha) (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRIM24) (RING finger protein 82) (RING-type E3 ubiquitin transferase TIF1-alpha) (Tripartite motif-containing protein 24)	1	0	1	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	APL
TRIM27	1	P14373	TRIM27 RFP RNF76	reviewed	Zinc finger protein RFP (EC 2.3.2.27) (RING finger protein 76) (RING-type E3 ubiquitin transferase TRIM27) (Ret finger protein) (Tripartite motif-containing protein 27)	1	0	0	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	papillary thyroid
TRIM33	1	Q9UPN9	TRIM33 KIAA1113 RFG7 TIF1G	reviewed	E3 ubiquitin-protein ligase TRIM33 (EC 2.3.2.27) (Ectodermin homolog) (RET-fused gene 7 protein) (Protein Rfg7) (RING-type E3 ubiquitin transferase TRIM33) (Transcription intermediary factor 1-gamma) (TIF1-gamma) (Tripartite motif-containing protein 33)	1	0	1	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	papillary thyroid
TRIP11	1	Q15643	TRIP11 CEV14	reviewed	Thyroid receptor-interacting protein 11 (TR-interacting protein 11) (TRIP-11) (Clonal evolution-related gene on chromosome 14 protein) (Golgi-associated microtubule-binding protein 210) (GMAP-210) (Trip230)	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	AML
TRRAP	1	Q9Y4A5	TRRAP PAF400	reviewed	Transformation/transcription domain-associated protein (350/400 kDa PCAF-associated factor) (PAF350/400) (STAF40) (Tra1 homolog)	1	0	0	1	0	1	0	-	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	melanoma
TSC1	1	Q92574	TSC1 KIAA0243 TSC	reviewed	Hamartin (Tuberous sclerosis 1 protein)	1	1	1	0	0	0	1	1	0	0	0	1	1	1	1	1	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	renal cell carcinoma, bladder carcinoma, hamartoma, renal cell carcinoma, tuberous sclerosis tuber
TSC2	1	P49815	TSC2 TSC4	reviewed	Tuberin (Tuberous sclerosis 2 protein)	1	1	1	0	0	0	1	1	0	0	0	1	1	1	1	1	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	pulmonary lymphangioleiomyomatosis (LAM), renal angiomyolipoma, HNSCC, hamartoma, renal cell carcinoma, tuberous sclerosis tuber
TSHR	1	P16473	TSHR LGR3	reviewed	Thyrotropin receptor (Thyroid-stimulating hormone receptor) (TSH-R)	1	1	0	1	0	1	0	-	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	toxic thyroid adenoma, thyroid adenoma
U2AF1	1	Q01081	U2AF1 U2AF35 U2AFBP FP793	reviewed	Splicing factor U2AF 35 kDa subunit (U2 auxiliary factor 35 kDa subunit) (U2 small nuclear RNA auxiliary factor 1) (U2 snRNP auxiliary factor small subunit)	1	0	0	1	0	1	0	-	0	0	0	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	CLL, MDS
UBR5	1	O95071	UBR5 EDD EDD1 HYD KIAA0896	reviewed	E3 ubiquitin-protein ligase UBR5 (EC 2.3.2.26) (E3 ubiquitin-protein ligase, HECT domain-containing 1) (HECT-type E3 ubiquitin transferase UBR5) (Hyperplastic discs protein homolog) (hHYD) (Progestin-induced protein)	1	0	0	1	0	0	1	-	0	0	0	1	1	1	1	0	0	0	1	1	0	0	1	0	0	0	1	1	1	1	0	0	mantle cell lymphoma, gastric, colorectal
USP44	2	Q9H0E7	USP44	reviewed	Ubiquitin carboxyl-terminal hydrolase 44 (EC 3.4.19.12) (Deubiquitinating enzyme 44) (Ubiquitin thioesterase 44) (Ubiquitin-specific-processing protease 44)	1	0	1	0	0	0	0	-	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	lung cancer, colon cancer
USP6	1	P35125	USP6 HRP1 TRE2	reviewed	Ubiquitin carboxyl-terminal hydrolase 6 (EC 3.4.19.12) (Deubiquitinating enzyme 6) (Proto-oncogene TRE-2) (Ubiquitin thioesterase 6) (Ubiquitin-specific-processing protease 6)	1	0	0	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	aneurysmal bone cyst
USP8	1	P40818	USP8 KIAA0055 UBPY	reviewed	Ubiquitin carboxyl-terminal hydrolase 8 (EC 3.4.19.12) (Deubiquitinating enzyme 8) (Ubiquitin isopeptidase Y) (hUBPy) (Ubiquitin thioesterase 8) (Ubiquitin-specific-processing protease 8)	1	0	0	1	0	1	0	-	0	0	0	1	0	1	0	0	0	0	1	0	0	0	0	0	1	0	0	1	0	0	0	0	corticotroph adenoma
USP9X	2	Q93008	USP9X DFFRX FAM USP9	reviewed	Probable ubiquitin carboxyl-terminal hydrolase FAF-X (EC 3.4.19.12) (Deubiquitinating enzyme FAF-X) (Fat facets in mammals) (hFAM) (Fat facets protein-related, X-linked) (Ubiquitin thioesterase FAF-X) (Ubiquitin-specific protease 9, X chromosome) (Ubiquitin-specific-processing protease FAF-X)	1	1	0	0	1	0	0	-	0	1	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	colon carcinoma, colon carcinoma
VAV1	2	P15498	VAV1 VAV	reviewed	Proto-oncogene vav	1	0	0	0	1	0	0	-	0	1	1	0	0	0	0	0	0	1	0	1	0	0	0	0	0	0	0	0	0	0	0	0	T-cell lymphoma
VHL	1	P40337	VHL	reviewed	von Hippel-Lindau disease tumor suppressor (Protein G7) (pVHL)	1	1	1	0	0	0	1	-	0	0	0	1	1	1	1	1	0	0	1	0	1	1	1	0	1	0	1	0	1	0	1	0	renal, haemangioma, pheochromocytoma, renal, haemangioma, pheochromocytoma
VTI1A	2	Q96AJ9	VTI1A	reviewed	Vesicle transport through interaction with t-SNAREs homolog 1A (Vesicle transport v-SNARE protein Vti1-like 2) (Vti1-rp2)	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	colorectal
WAS	1	P42768	WAS IMD2	reviewed	Wiskott-Aldrich syndrome protein (WASp)	0	1	0	1	0	0	1	-	0	0	0	1	1	1	1	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0	0	0	lymphoma
WDCP	1	Q9H6R7	WDCP C2orf44 PP384	reviewed	WD repeat and coiled-coil-containing protein	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	colorectal
WIF1	1	Q9Y5W5	WIF1 UNQ191/PRO217	reviewed	Wnt inhibitory factor 1 (WIF-1)	1	0	1	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	1	0	0	0	0	1	0	0	0	0	0	0	0	0	pleomorphic salivary gland adenoma
WNK2	2	Q9Y3S1	WNK2 KIAA1760 PRKWNK2 SDCCAG43 P/OKcl.13	reviewed	Serine/threonine-protein kinase WNK2 (EC 2.7.11.1) (Antigen NY-CO-43) (Protein kinase lysine-deficient 2) (Protein kinase with no lysine 2) (Serologically defined colon cancer antigen 43)	1	0	1	0	0	0	0	-	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	gastric cancer
WRN	1	Q14191	WRN RECQ3 RECQL2	reviewed	Werner syndrome ATP-dependent helicase (EC 3.6.4.12) (DNA helicase, RecQ-like type 3) (RecQ3) (Exonuclease WRN) (EC 3.1.-.-) (RecQ protein-like 2)	0	1	1	0	0	0	1	-	0	0	0	1	1	1	1	0	0	0	1	1	1	1	0	0	0	0	0	0	0	0	0	0	osteosarcoma, meningioma, other tumour types
WT1	1	P19544	WT1	reviewed	Wilms tumor protein (WT33)	1	1	1	1	1	0	1	-	0	1	1	1	1	1	1	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	Wilms tumour, desmoplastic small round cell tumour, Wilms tumour
WWTR1	1	Q9GZV5	WWTR1 TAZ	reviewed	WW domain-containing transcription regulator protein 1 (Transcriptional coactivator with PDZ-binding motif)	1	0	0	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	epithelioid haemangioendothelioma
XPA	1	P23025	XPA XPAC	reviewed	DNA repair protein complementing XP-A cells (Xeroderma pigmentosum group A-complementing protein)	0	1	1	0	0	0	1	-	0	0	0	1	1	1	1	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	skin basal cell, skin squamous cell, melanoma
XPC	1	Q01831	XPC XPCC	reviewed	DNA repair protein complementing XP-C cells (Xeroderma pigmentosum group C-complementing protein) (p125)	0	1	1	0	0	0	1	-	0	0	0	1	1	1	1	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	skin basal cell, skin squamous cell, melanoma
XPO1	1	O14980	XPO1 CRM1	reviewed	Exportin-1 (Exp1) (Chromosome region maintenance 1 protein homolog)	1	0	0	1	0	1	0	-	0	0	0	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	1	0	0	1	0	0	CLL
YWHAE	1	P62258	YWHAE	reviewed	14-3-3 protein epsilon (14-3-3E)	1	0	1	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	endometrial stromal sarcoma
ZBTB16	1	Q05516	ZBTB16 PLZF ZNF145	reviewed	Zinc finger and BTB domain-containing protein 16 (Promyelocytic leukemia zinc finger protein) (Zinc finger protein 145) (Zinc finger protein PLZF)	1	0	1	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	1	0	0	0	0	0	0	0	0	APL
ZCCHC8	2	Q6NZY4	ZCCHC8	reviewed	Zinc finger CCHC domain-containing protein 8 (TRAMP-like complex RNA-binding factor ZCCHC8)	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	Spitzoid tumour
ZEB1	2	P37275	ZEB1 AREB6 TCF8	reviewed	Zinc finger E-box-binding homeobox 1 (NIL-2-A zinc finger protein) (Negative regulator of IL2) (Transcription factor 8) (TCF-8)	1	0	0	1	0	0	0	-	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	CCRCC, melanoma
ZFHX3	1	Q15911	ZFHX3 ATBF1 C16orf47	reviewed	Zinc finger homeobox protein 3 (AT motif-binding factor 1) (AT-binding transcription factor 1) (Alpha-fetoprotein enhancer-binding protein) (Zinc finger homeodomain protein 3) (ZFH-3)	1	0	1	0	0	1	0	-	0	0	0	1	0	1	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	1	0	endometrial, gastric, prostate
ZMYM2	1	Q9UBW7	ZMYM2 FIM RAMP ZNF198	reviewed	Zinc finger MYM-type protein 2 (Fused in myeloproliferative disorders protein) (Rearranged in atypical myeloproliferative disorder protein) (Zinc finger protein 198)	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	MPN, NHL
ZMYM3	2	Q14202	ZMYM3 DXS6673E KIAA0385 ZNF261	reviewed	Zinc finger MYM-type protein 3 (Zinc finger protein 261)	1	0	1	0	0	0	0	-	0	0	0	0	0	0	1	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	CRC, breast cancer
ZNF331	1	Q9NQX6	ZNF331 RITA ZNF361 ZNF463	reviewed	Zinc finger protein 331 (C2H2-like zinc finger protein rearranged in thyroid adenomas) (Zinc finger protein 361) (Zinc finger protein 463)	1	0	1	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	follicular thyroid adenoma
ZNF384	1	Q8TF68	ZNF384 CAGH1 CIZ NMP4 TNRC1	reviewed	Zinc finger protein 384 (CAG repeat protein 1) (CAS-interacting zinc finger protein) (Nuclear matrix transcription factor 4) (Nuclear matrix protein 4) (Trinucleotide repeat-containing gene 1 protein)	1	0	0	0	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	ALL
ZNF429	2	Q86V71	ZNF429	reviewed	Zinc finger protein 429	1	0	0	0	0	0	0	-	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	GBM
ZNF479	2	Q96JC4	ZNF479	reviewed	Zinc finger protein 479 (Zinc finger protein Kr19) (HKr19)	1	0	0	0	0	0	0	-	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	lung cancer, bladder carcinoma, prostate carcinoma
ZNF521	1	Q96K83	ZNF521 EHZF LIP3	reviewed	Zinc finger protein 521 (Early hematopoietic zinc finger protein) (LYST-interacting protein 3)	1	0	0	1	1	1	0	-	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	ALL
ZNRF3	2	Q9ULT6	ZNRF3 KIAA1133 RNF203	reviewed	E3 ubiquitin-protein ligase ZNRF3 (EC 2.3.2.27) (RING finger protein 203) (RING-type E3 ubiquitin transferase ZNRF3) (Zinc/RING finger protein 3)	1	0	1	0	0	0	0	-	0	0	0	1	0	1	1	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	colorectal cancer, adrenocortical carcinoma, gastric cancer
ZRSR2	1	Q15696	ZRSR2 U2AF1-RS2 U2AF1L2 U2AF1RS2 URP	reviewed	U2 small nuclear ribonucleoprotein auxiliary factor 35 kDa subunit-related protein 2 (CCCH type zinc finger, RNA-binding motif and serine/arginine rich protein 2) (Renal carcinoma antigen NY-REN-20) (U2(RNU2) small nuclear RNA auxiliary factor 1-like 2) (U2AF35-related protein) (URP)	1	0	1	0	0	0	1	-	0	0	0	1	1	0	1	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	MDS, CLL
																			178	178	62	26																